Sentence,class,file
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/dc/57/idr-8-359.PMC4631416.pdf
Available from: http://www.otsuka.,Non-OADS,/arxiv_data1/oa_pdf/dc/57/idr-8-359.PMC4631416.pdf
Available  from: https://clinicaltrials.gov/ct2/show/NCT01856634?term =delam anid+pediatric&rank =2.,Non-OADS,/arxiv_data1/oa_pdf/dc/57/idr-8-359.PMC4631416.pdf
Available  from: http://clinicaltrials.gov/ct2/show/NCT01859923?term =delaman id&rank=1.,OADS,/arxiv_data1/oa_pdf/dc/57/idr-8-359.PMC4631416.pdf
"Available from: https://www.engage.england.nhs.uk/ consultation/specialised-services-consultation/user_uploads/bedaquiline- delamanid-policy-upd.pd f. Accessed September  27, 2015.",Non-OADS,/arxiv_data1/oa_pdf/dc/57/idr-8-359.PMC4631416.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/002552/ WC500166232.pd f. Accessed September  27, 2015.",Non-OADS,/arxiv_data1/oa_pdf/dc/57/idr-8-359.PMC4631416.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/dc/57/idr-8-359.PMC4631416.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/57/idr-8-359.PMC4631416.pdf
Available from: http://www.resisttb.,Non-OADS,/arxiv_data1/oa_pdf/dc/57/idr-8-359.PMC4631416.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/65/82/ppa-9-1539.PMC4631417.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1539–1548Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1539OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9128 4Variation in medication adherence across patient  behavioral segments: a multi-country study in  hypertension robert sandy Ulla connor coMac Analytics, inc, Providence,   ri, UsAObjectives:  This study determines the following for a hypertensive patient population: 1) the  prevalence of patient worldview clusters; 2) differences in medication adherence across these  clusters; and 3) the adherence predictive power of the clusters relative to measures of patients’  concerns over their medication’s cost, side effects, and efficacy.",Non-OADS,/arxiv_data1/oa_pdf/65/82/ppa-9-1539.PMC4631417.pdf
"The Adherence Research Network created by the US National  Institutes of Health is evidence of the recognition in the USA of the importance of  raising adherence levels.4 To understand adherence, researchers have examined a wide correspondence: robert sandy coMac Analytics, 265 laurel Avenue,  Providence, ri 02906, UsA Tel +1 317 332 0772 email icjz100@iU.ed u Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Sandy and Connor Running head recto: Adherence by patient behavioral segment DOI: http://dx.doi.org/10.2147/PPA.S91284",Non-OADS,/arxiv_data1/oa_pdf/65/82/ppa-9-1539.PMC4631417.pdf
Available from:  https://www.healthprize.com/corporate/ourSolution/overview.d o  15.,Non-OADS,/arxiv_data1/oa_pdf/65/82/ppa-9-1539.PMC4631417.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/65/82/ppa-9-1539.PMC4631417.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/65/1c/ppa-9-1531.PMC4631418.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1531–1537Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1531OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9081 6Who takes the medicine?,Non-OADS,/arxiv_data1/oa_pdf/65/1c/ppa-9-1531.PMC4631418.pdf
"This indicates better adherence in developing  countries than developed ones.5 Use of fixed dose combinations,3 as well as factors correspondence: Wondu Teshome PO Box 898, hawassa, ethiopia Tel +251 91 176 1805 email wondu_teshome@yahoo.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Teshome et al Running head recto: Adherence to antiretroviral therapy in Southern Ethiopia DOI: http://dx.doi.org/10.2147/PPA.S90816",Non-OADS,/arxiv_data1/oa_pdf/65/1c/ppa-9-1531.PMC4631418.pdf
"Open-access statement In accordance with WHO’s open-access publication policy  for all work funded by WHO or authored/coauthored by  WHO staff members, the WHO retains the copyright of this  publication through a Creative Commons Attribution IGO  license ( http://creativecommons.org/licenses/by/3.0/igo/ legalcod e) which permits unrestricted use, distribution, and  reproduction in any medium provided the original work is  properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/1c/ppa-9-1531.PMC4631418.pdf
Avail - able from: http://www.who.int/hiv/pub/progressreports/update2014/en /.,Non-OADS,/arxiv_data1/oa_pdf/65/1c/ppa-9-1531.PMC4631418.pdf
Available from: http://www.who.int/hiv/pub/meetingreports/ewi_meet - ing_report/en /.,Non-OADS,/arxiv_data1/oa_pdf/65/1c/ppa-9-1531.PMC4631418.pdf
Available from: http://www.who.int/hiv/pub/guidelines/arv2013/ operational/adherence/en /.,Non-OADS,/arxiv_data1/oa_pdf/65/1c/ppa-9-1531.PMC4631418.pdf
Avail - able from: http://www.csa.gov.et /.,Non-OADS,/arxiv_data1/oa_pdf/65/1c/ppa-9-1531.PMC4631418.pdf
Available  from: http://www.who.int/hiv/pub/arv/adult2010/en /.,Non-OADS,/arxiv_data1/oa_pdf/65/1c/ppa-9-1531.PMC4631418.pdf
"Available from: http://www.aidstar-one.com/focus_areas/treatment/ resources/technical_briefs/adult_adherence_treatment_and_reten - tion_car e. Accessed June 11, 2015.",Non-OADS,/arxiv_data1/oa_pdf/65/1c/ppa-9-1531.PMC4631418.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/65/1c/ppa-9-1531.PMC4631418.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a1/aa/ppa-9-1549.PMC4631419.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1549–1560Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1549OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8765 9Associations of quality of life, pain, and self- reported arthritis with age, employment, bleed  rate, and utilization of hemophilia treatment  center and health care provider services: results  in adults with hemophilia in the her O study Angela l Forsyth1 Michelle Witkop2 Angela lambing3 cesar garrido4 spencer Dunn5 David l cooper6 Diane J nugent7 1Biorx, cincinnati, Oh, UsA; 2Munson  Medical center, Traverse city, M i, UsA;   3henry Ford hospital, Detroit, M i,   UsA; 4Asociacion Venezolana para la  hemofilia, caracas, Venezuela; 5center  for inherited Blood Disorders,   Orange, cA, UsA; 6novo nordisk  inc., Plainsboro, nJ, UsA; 7children’s  hospital of Orange county, center  for inherited Blood Disorders,   Orange, cA, UsAIntroduction:  Severe hemophilia and subsequent hemophilic arthropathy result in joint pain  and impaired health-related quality of life (HRQoL).",Non-OADS,/arxiv_data1/oa_pdf/a1/aa/ppa-9-1549.PMC4631419.pdf
"Keywords:  hemophilia, quality of life, HERO, pain Introduction Severe congenital hemophilia A (HA) and hemophilia B (HB) are associated with  various types of bleeding, of which 70%–80% of bleeds are hemarthroses (joint  bleeds).1 According to a retrospective data analysis of patients with severe hemophilia  in the UK, the most common joints affected in adult persons with hemophilia (PWH)  were the ankle (60.0%), knee (12.9%), and elbow (14.3%), although bleeding also  occurred in the hips, shoulders, wrist, hands, and feet.2 Recurrent joint bleeding can  result in acute and subsequent chronic hemophilic synovitis, leading to irreversible correspondence: Angela l Forsyth Biorx: reBUilD hemophilia Program,  7167 e Kemper road, cincinnati,  Oh 45249, UsA Tel +1 856 669 8307 Fax +1 877 588 8470 email aforsyth@biorx.ne t Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Forsyth et al Running head recto: HERO: quality of life in adults DOI: http://dx.doi.org/10.2147/PPA.S87659",Non-OADS,/arxiv_data1/oa_pdf/a1/aa/ppa-9-1549.PMC4631419.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/a1/aa/ppa-9-1549.PMC4631419.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/50/77/ott-8-3169.PMC4631420.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3169–3173OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3169Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8975 2Treating patients with advanced rectal cancer  and lateral pelvic lymph nodes with preoperative  chemoradiotherapy based on pretreatment imaging Yasunori Otowa Kimihiro Yamashita Kiyonori Kanemitsu Yasuo sumi Masashi Yamamoto shingo Kanaji Tatsuya imanishi T etsu nakamura satoshi suzuki Kenichi Tanaka Y oshihiro Kakeji Division of gastrointestinal surgery,   Department of surgery, Kobe  University graduate school of  Medicine, Kobe, JapanAbstract:  Preoperative chemoradiotherapy (CRT) and lateral pelvic lymph node (LPLN)  dissection (LPLD) based on pretreatment imaging are performed to improve oncological  outcomes at our institution.",Non-OADS,/arxiv_data1/oa_pdf/50/77/ott-8-3169.PMC4631420.pdf
"Thus, we hypothesized correspondence: Yasunori Otowa Division of gastrointestinal surgery,  Department of surgery, Kobe University  graduate school of Medicine,  Kusunoki-chou 7-5-2, chuo-ku,  Kobe 650-0017, Japan Tel +81 78 382 5925  Fax +81 78 382 5939 email otoway@med.kobe-u.ac.j p Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Otowa et al Running head recto: Chemoradiotherapy for rectal cancer and LPLN DOI: http://dx.doi.org/10.2147/OTT.S89752",Non-OADS,/arxiv_data1/oa_pdf/50/77/ott-8-3169.PMC4631420.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/50/77/ott-8-3169.PMC4631420.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/77/ott-8-3169.PMC4631420.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/03/43/ott-8-3175.PMC4631421.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3175–3184OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3175Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9169 6mir-122 inhibits metastasis and epithelial– mesenchymal transition of non-small-cell lung  cancer cells haifeng Qin1 Jiping sha2 caixia Jiang3 Xuemei gao2 lili Qu1 haiying Yan4 Tianjiao Xu5 Qiyu Jiang6 hongjun gao1 1Department of Pulmonary neoplasm  internal Medicine, affiliated hospital  of academy of the Military Medical  sciences, Beijing, 2Department of  rehabilitation, Zhangqiu city People’s  hospital, Zhangqiu, 3Department of  endocrinology, Zhangqiu city People’s  hospital, Zhangqiu, 4Department of  Oncology, cancer hospital of ci  county, handan, 5Department of  Oncology, 477 hospital of People’s  liberation army, Xiangyang, 6center  of Technical and service, the 302nd  hospital of People’s liberation army,   Beijing, People’s republic of chinaAbstract:  miR-122 may function as a novel tumor suppressor.",Non-OADS,/arxiv_data1/oa_pdf/03/43/ott-8-3175.PMC4631421.pdf
"NSCLC, which is the most common type of lung cancer, makes up nearly 80%  proportion of clinical lung cancer cases.7,8 NSCLC can be further categorized into  three subtypes: adenocarcinoma (AC), squamous cell carcinoma, and large cell  carcinoma (LCC), and AC accounts for approximately most common subtype of  NSCLC diagnosed in patients.9 NSCLC is one of the most fatal human malignancies, correspondence: hongjun gao Department of Pulmonary neoplasm  Internal Medicine, Affiliated Hospital of  academy of the Military Medical sciences,  no 8 Fengtai east street, Fengtai District,  Beijing 100071, People’s republic  of china Tel +86 10 6693 2552 Fax +86 10 5112 8605 email hongjungao307@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Qin et al Running head recto: Metastasis inhibitory role of miR-122 in NSCLC DOI: http://dx.doi.org/10.2147/OTT.S91696",Non-OADS,/arxiv_data1/oa_pdf/03/43/ott-8-3175.PMC4631421.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/03/43/ott-8-3175.PMC4631421.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/43/ott-8-3175.PMC4631421.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/12/5b/ott-8-3067.PMC4631422.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3067–3077OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3067Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8488 8a Dna vaccine encoding mutated hPV58  me6e7-Fc-gPi fusion antigen and gM-csF and  B7.1 he Wang1 Jiyun Yu2 li li1 1Department of gynecologic  Oncology, affiliated Tumor hospital  of guangxi Medical University,   nanning, guangxi, 2institute of Basic  Medical sciences, academy of Military  Medical sciences, Beijing, People’s  republic of chinaBackground:  Persistent infection with high-risk human papillomavirus (HPV) is a predominant  cause of cervical cancer, and HPV58 is the third most common virus detected in the patients with  cervical cancer in Asia.",Non-OADS,/arxiv_data1/oa_pdf/12/5b/ott-8-3067.PMC4631422.pdf
"Keywords:  human papillomavirus type 58, E6 gene, E7 gene, DNA vaccine, immunogenicity Introduction Cervical cancer is the second most common cancer in women worldwide and the  most common cancer in women in most developing countries.1 Strong molecular  epidemiological evidence indicates that persistent infection with high-risk human  papillomavirus (HPV) is the major cause of invasive cervical cancer and cervical  intraepithelial neoplasia, and HPV can be detected in 99.7% of cervical cancer  patients.2 Two prophylactic HPV vaccines, Gardasil, a quadrivalent HPV16/18/6/11  virus-like particles vaccine3 from Merck & Co., Inc. (NJ, USA), and another bivalent  HPV16/18 virus-like particles vaccine from GlaxoSmithKline plc (London, UK), correspondence: li li Department of gynecologic Oncology,  Affiliated Tumor Hospital of Guangxi  Medical University, 71 he Di road,  nanning 530021, guangxi, People’s  republic of china Tel +86 771 531 0430 email lili_temp@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Wang et al Running head recto: DNA vaccine encoding HPV58 mE6E7 fusion antigen and GM-CSF and B7.1 DOI: http://dx.doi.org/10.2147/OTT.S84888",Non-OADS,/arxiv_data1/oa_pdf/12/5b/ott-8-3067.PMC4631422.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/12/5b/ott-8-3067.PMC4631422.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/12/5b/ott-8-3067.PMC4631422.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d7/cf/opth-9-2027.PMC4631423.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 2027–2032Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2027Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9097 9intravitreal ranibizumab as a primary or  a combined treatment for severe retinopathy  of prematurity Odalis arámbulo1 gabriel Dib1 Juan iturralde1 Fahir Duran1 Miguel Brito1 João B Fortes Filho2 1Department of Ophthalmology,   University hospital of Maracaibo,   Maracaibo, Venezuela; 2Department of  Ophthalmology, hospital de Clínicas  de Porto alegre, Federal University  of rio grande do sul, Porto alegre,   rs, BrazilPurpose:  The aim of the study was to assess the outcomes of severe retinopathy of prematurity  (ROP) in zone I or posterior zone II treated with intravitreal ranibizumab (IVR) as monotherapy  or combined treatment with laser photocoagulation.",Non-OADS,/arxiv_data1/oa_pdf/d7/cf/opth-9-2027.PMC4631423.pdf
"Keywords:  aggressive posterior ROP, bevacizumab, prematurity, ranibizumab, retinopathy of  prematurity, therapy, treatment, VEGF Introduction Aggressive posterior retinopathy of prematurity (AP-ROP) is an uncommon, severe,  and rapidly progressing presentation of ROP.1 AP-ROP, when not promptly diagnosed and treated, can progress to retinal detach - ment and blindness (stage 4 or 5 of ROP).2,3 AP-ROP, usually, occurs in more immature  or sicker babies with extremely low birth weight (BW) as described in North America  or Western European countries, as well as in bigger babies in Latin American, East  European, or Asian countries.4 Laser photocoagulation remains the gold standard for the treatment of severe  ROP in threshold or in type 1 prethreshold diseases according to the randomized  trials Cryo-ROP and ETROP,5,6 but the anatomical and visual results of laser or cryo - therapy in patients with severe ROP affecting zone I or posterior zone II are usually  unfavorable.2,7–11 The role of vascular endothelial growth factor (VEGF) in the pathogenesis of  ROP is well defined.12–15 Currently, bevacizumab is the most studied drug for ROP Correspondence: João B Fortes Filho hospital de Clínicas de Porto alegre,  Federal University of rio grande do sul,  rua ramiro Barcelos, 2350 Porto alegre,  rs 90035-903, Brazil Tel +55 51 9969 8081 email joaoborgesfortes@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Arámbulo et al Running head recto: Intravitreal ranibizumab for severe ROP DOI: http://dx.doi.org/10.2147/OPTH.S90979",Non-OADS,/arxiv_data1/oa_pdf/d7/cf/opth-9-2027.PMC4631423.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/d7/cf/opth-9-2027.PMC4631423.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/cf/opth-9-2027.PMC4631423.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c6/01/ndt-11-2801.PMC4631424.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2801–2810Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2801Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6347 0Connectomics in psychiatric research: advances  and applications Miao Cao* Zhijiang wang* Y ong He State Key Laboratory of Cognitive  Neuroscience and Learning and  iDG/McGovern institute for Brain  Research, Beijing Normal University,   Beijing, People’s Republic of China *These authors contributed equally  to this workAbstract:  Psychiatric disorders disturb higher cognitive functions and severely compromise  human health.",Non-OADS,/arxiv_data1/oa_pdf/c6/01/ndt-11-2801.PMC4631424.pdf
"Psychiatric disorders can have an  early onset (eg, autism in childhood and schizophrenia in young adulthood) or a Correspondence: Yong He State Key Laboratory of Cognitive  Neuroscience and Learning and iDG/ McGovern institute for Brain Research,  Beijing Normal University, Beijing  100875, People’s Republic of China Tel/fax +86 10 5880 2036 email yong.he@bnu.edu.c n Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Cao et al Running head recto: Connectomics in psychiatric disorders DOI: http://dx.doi.org/10.2147/NDT.S63470",Non-OADS,/arxiv_data1/oa_pdf/c6/01/ndt-11-2801.PMC4631424.pdf
Available from:  http://proxy.med.sc.edu/login?url=http://psychiatryonline.org/book.,Non-OADS,/arxiv_data1/oa_pdf/c6/01/ndt-11-2801.PMC4631424.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c6/01/ndt-11-2801.PMC4631424.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/01/ndt-11-2801.PMC4631424.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2f/63/ndt-11-2825.PMC4631425.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2825–2831Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2825OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9117 0Neurological soft signs might be endophenotype  candidates for patients with deficit syndrome  schizophrenia Yakup albayrak1 Esra Soydaş Akyol2 Murat Beyazyüz1 saliha Baykal1 Murat Kuloglu3 1Department of Psychiatry, Faculty  of Medicine, Namık Kemal University,   T ekirdag, 2Department of Psychiatry,   Yenimahalle education and research  hospital, ankara, 3Department of  Psychiatry, Faculty of Medicine,   Akdeniz University, Antalya, T urkeyBackground:  Schizophrenia is a chronic, disabling, disorder that affects approximately 1%  of the population.",Non-OADS,/arxiv_data1/oa_pdf/2f/63/ndt-11-2825.PMC4631425.pdf
"Currently, it may be correspondence: Yakup albayrak Namık Kemal Universitesi Uygulama ve  Arastırma Hastanesi PsikiyatriPoliklinigi  Tunca Caddesi 100, Yıl mah, Tekirdag  59000, Turkey Tel +90 505 635 5434 email dr.fuge@hotmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Albayrak et al Running head recto: Neurological soft signs and deficit syndrome schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S91170",Non-OADS,/arxiv_data1/oa_pdf/2f/63/ndt-11-2825.PMC4631425.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/2f/63/ndt-11-2825.PMC4631425.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/63/ndt-11-2825.PMC4631425.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/98/c8/jpr-8-767.PMC4631426.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 767–770Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  767ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S8677 7landmark-based versus ultrasound-guided  ilioinguinal/iliohypogastric nerve blocks   in the treatment of chronic postherniorrhaphy  groin pain: a retrospective study Drew Trainor1 susan Moeschler2 Matthew Pingree1,2 Brian hoelzer2 Zhen Wang2 William Mauck2 Wenchun Qu1,2 1Department of Physical Medicine  and Rehabilitation, 2Department of  anesthesiology, Division of Pain  Medicine, Mayo clinic, Rochester,    Mn, Usa correspondence: Drew Trainor   Department of Physical Medicine and  Rehabilitation, Mayo clinic, 200 First  street sW, Rochester, Mn  55905, Usa   Tel +1 507 284 5000  Fax +1 507 284 3431  email trainor.drew@mayo.ed uBackground:  Chronic postherniorrhaphy groin pain (CPGP) is a debilitating condition, which  is often refractory to conservative medical management.",Non-OADS,/arxiv_data1/oa_pdf/98/c8/jpr-8-767.PMC4631426.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/98/c8/jpr-8-767.PMC4631426.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/c8/jpr-8-767.PMC4631426.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/3c/jaa-8-115.PMC4631427.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Asthma and Allergy 2015:8 115–123Journal of Asthma and Allergy Dove press submit your manuscript | www.dovepress.co m Dove press  115Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S8912 1Managing nut-induced anaphylaxis: challenges and  solutions Jeanne M Lomas Kirsi M Järvinen Division of Pediatric Allergy and  immunology, University of Rochester  School of Medicine and Dentistry,   Rochester, NY, USA Correspondence: Kirsi M Järvinen   Division of Pediatric Allergy and  immunology, University of Rochester  School of Medicine and Dentistry,  601 elmwood Avenue, Box 611,  Rochester, NY, USA   Tel +1 585 276 7295   Fax +1 585 276 1449   email k irsi_jarvinen-seppo@URMC.",Non-OADS,/arxiv_data1/oa_pdf/80/3c/jaa-8-115.PMC4631427.pdf
"Avail - able from: http://www.ers.usda.gov/data-products/food-availability- (per-capita)-data-system.asp x. Accessed May 10, 2015.",Non-OADS,/arxiv_data1/oa_pdf/80/3c/jaa-8-115.PMC4631427.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-asthma-and-allergy-journa lThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi - ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/80/3c/jaa-8-115.PMC4631427.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/3c/jaa-8-115.PMC4631427.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b5/b1/ijn-10-6773.PMC4631428.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 6773–6788International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6773OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9323 7T umor-targeted and ph-controlled delivery of  doxorubicin using gold nanorods for lung cancer  therapy Narsireddy amreddy1,2 ranganayaki Muralidharan1,2 anish Babu1,2 Meghna Mehta2,3 elyse V Johnson4 Yan D Zhao2,5 anupama Munshi2,3 rajagopal ramesh1,2,6 1Department of Pathology,   2stephenson cancer center,   3Department of radiation Oncology  University of Oklahoma health  sciences center, Oklahoma city, OK,   Usa; 4cytoViva Inc., auburn, al, Usa;   5Department of Biostatistics and  epidemiology, 6graduate Program in  Biomedical sciences, University of  Oklahoma health sciences center,   Oklahoma city, OK, UsaBackground:  In lung cancer, the efficacy of conventional chemotherapy is limited due to poor  drug accumulation in tumors and nonspecific cytotoxicity.",Non-OADS,/arxiv_data1/oa_pdf/b5/b1/ijn-10-6773.PMC4631428.pdf
"Keywords:  doxorubicin, gold, lung cancer, nanoparticles, transferrin, tumor targeting Introduction The utility of doxorubicin (Dox) for cancer treatment is limited by its poor accumulation  in tumor tissue and cytotoxic side effects, especially irreversible cardiotoxicity, to  normal tissues.1–4 Therefore, methods to increase tumor-specific drug accumulation  and simultaneously reduce cytotoxicity to normal tissues will greatly improve the  efficacy of Dox.5 The overexpression of receptors on the surface of tumor cells is  one of several methods being tested to improve tumor-selective uptake of anticancer  drugs.6,7 Studies have demonstrated that tumor cells often express cell surface receptors  at high levels compared with normal cells; targeting these receptors for drug delivery  produces increased drug accumulation and therapeutic efficacy.8 One such receptor is  the transferrin receptor (TfR), which is overexpressed in a broad spectrum of human  cancer cells, including lung cancer.9correspondence: rajagopal ramesh Department of Pathology, stanton l  Young Biomedical research center,  The University of Oklahoma health  sciences center, Brc West suite 1403,  975 Ne 10th street, Oklahoma city,  OK 73104, Usa Tel +1 405 271 6101 email rajagopal-ramesh@ouhsc.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Amreddy et al Running head recto: Tumor-targeted and pH-controlled delivery of doxorubicin DOI: http://dx.doi.org/10.2147/IJN.S93237",Non-OADS,/arxiv_data1/oa_pdf/b5/b1/ijn-10-6773.PMC4631428.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b5/b1/ijn-10-6773.PMC4631428.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/b1/ijn-10-6773.PMC4631428.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/05/c2/jpr-8-741.PMC4631429.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 741–752Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  741Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S5560 0Spinal pain: current understanding, trends,   and the future of care Gregory F Parkin-Smith1 Lyndon G Amorin-w oods2–4 Stephanie J Davies5–7 Barrett e Losco8 Jon Adams9,10 1General Practice, Surgery 82,   Busselton, wA, Australia; 2School  of Health Professions, Murdoch  University, Murdoch, wA, Australia;   3Chiropractors’ Association of  Australia, Nedlands, wA, Australia;   4ACORN Project, 5wA Specialist  Pain Services, wA, Australia; 6School  of Physiotherapy, Curtin University,   Bentley, wA, Australia; 7School  of Medicine and Pharmacology,   University of western Australia,   Crawley, wA, Australia; 8Murdoch  University, Murdoch, wA, Australia;   9Faculty of Health, University of  T echnology Sydney, Ultimo, NSw ,   Australia; 10Australian Research  Centre in Complementary and  integrative Medicine, University of  T echnology Sydney, Ultimo, NSw ,   Australia Correspondence: Gregory F Parkin-Smith   General Practice, Surgery 82, 82 Bussell  Highway, Busselton, wA 6280, Australia   email g.parkin.smith@gmail.co mAbstract:  This commissioned review paper offers a summary of our current understanding of  nonmalignant spinal pain, particularly persistent pain.",Non-OADS,/arxiv_data1/oa_pdf/05/c2/jpr-8-741.PMC4631429.pdf
Available from: http://www.nzgg.org.,Non-OADS,/arxiv_data1/oa_pdf/05/c2/jpr-8-741.PMC4631429.pdf
Available from: https://www.clini - calguidelines.gov.au /.,Non-OADS,/arxiv_data1/oa_pdf/05/c2/jpr-8-741.PMC4631429.pdf
Available from: http://ww2.health.,Non-OADS,/arxiv_data1/oa_pdf/05/c2/jpr-8-741.PMC4631429.pdf
"Available from: http://www.slideshare.net/ ArthritisNT/pain-and-modern-medicine-stephanie-davie s. Accessed  June 8, 2015.",Non-OADS,/arxiv_data1/oa_pdf/05/c2/jpr-8-741.PMC4631429.pdf
"Available from: http://www.bupa.com.au/staticfiles/ BupaP3/Health%20and%20Wellness/MediaFiles/PDFs/MBF_Founda   tion_the_price_of_pain.pd f. Accessed 13 November, 2011.",Non-OADS,/arxiv_data1/oa_pdf/05/c2/jpr-8-741.PMC4631429.pdf
"Available from: http://www.pnml.com.au/ medicare-local-programs/68-programs/article/178-step s. Accessed   May 11, 2015.",Non-OADS,/arxiv_data1/oa_pdf/05/c2/jpr-8-741.PMC4631429.pdf
"Available from: https://clinicalnotes.net/martar-fa q. Accessed  May 11, 2015.",Non-OADS,/arxiv_data1/oa_pdf/05/c2/jpr-8-741.PMC4631429.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/05/c2/jpr-8-741.PMC4631429.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/05/c2/jpr-8-741.PMC4631429.pdf
Available from: http://www.fpm.anzca.edu.au/resources/ professional-documents/documents/Prescription%20Opioid%20Policy.,Non-OADS,/arxiv_data1/oa_pdf/05/c2/jpr-8-741.PMC4631429.pdf
Available from: http://ndarc.med.unsw.edu.au/resource/ accidental-opioid-induced-deaths-australia-200 8.,Non-OADS,/arxiv_data1/oa_pdf/05/c2/jpr-8-741.PMC4631429.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cd/90/jpr-8-729.PMC4631430.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 729–734Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  729Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S9310 6Palmitoylethanolamide, a neutraceutical, in nerve  compression syndromes: efficacy and safety in  sciatic pain and carpal tunnel syndrome Jan M Keppel Hesselink David J Kopsky institute for Neuropathic Pain, Bosch  en Duin, the Netherlands Correspondence: Jan M Keppel Hesselink   institute for Neuropathic Pain,  Spoorlaan 2a, 3735 Mv Bosch en Duin,  the Netherlands   email neuropathie7@gmail.co mAbstract:  Palmitoylethanolamide (PEA) is an endogenous lipid modulator in animals and  humans, and has been evaluated since the 1970s as an anti-inflammatory and analgesic drug in  more than 30 clinical trials, in a total of ∼6,000 patients.",Non-OADS,/arxiv_data1/oa_pdf/cd/90/jpr-8-729.PMC4631430.pdf
Or use: http://youtu.be/OxZ-tOCTQI U,Non-OADS,/arxiv_data1/oa_pdf/cd/90/jpr-8-729.PMC4631430.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/cd/90/jpr-8-729.PMC4631430.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/90/jpr-8-729.PMC4631430.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ea/f3/jpr-8-753.PMC4631431.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 753–765Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  753ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S9354 7an integrated safety analysis of intravenous  ibuprofen (caldolor®) in adults stephen R southworth1 emily J Woodward2 alex Peng2 amy D Rock2 1north Mississippi sports Medicine  and Orthopaedic clinic, P llc,   T upelo, M s, 2Department of Research  and Development, cumberland  Pharmaceuticals inc., nashville,    Tn, Usa correspondence: amy D Rock   Department of Research and   Development, cumberland   Pharmaceuticals inc.,  2525 West end   avenue, suite  950, nashville,   Tn 37203, Usa   Tel +1 615 255 0068  Fax +1 615 627 0630  email arock@cumberlandpharma.co mAbstract:  Intravenous (IV) nonsteroidal anti-inflammatory drugs such as IV ibuprofen are  increasingly used as a component of multimodal pain management in the inpatient and outpatient  settings.",Non-OADS,/arxiv_data1/oa_pdf/ea/f3/jpr-8-753.PMC4631431.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/ea/f3/jpr-8-753.PMC4631431.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/f3/jpr-8-753.PMC4631431.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT0165051 9.,Non-OADS,/arxiv_data1/oa_pdf/ea/f3/jpr-8-753.PMC4631431.pdf
Available from: https://clinicaltrials.gov/ct2/ show/NCT01901393?term =NCT01901393&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/ea/f3/jpr-8-753.PMC4631431.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b1/bf/ijn-10-6757.PMC4631432.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 6757–6772International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6757RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S9391 8Recent trends in the development of  nanophytobioactive compounds and delivery  systems for their possible role in reducing  oxidative stress in Parkinson’s disease models Palanivel Ganesan1,2 Hyun-Myung Ko2 In-Su Kim2 Dong-Kug Choi1,2 1Nanotechnology Research Center,   Department of Applied Life Science,   2Department of Biotechnology,   College of Biomedical and Health  Science, Konkuk University, Chungju,   Republic of KoreaAbstract:  Oxidative stress plays a very critical role in neurodegenerative diseases, such as  Parkinson’s disease (PD), which is the second most common neurodegenerative disease among  elderly people worldwide.",Non-OADS,/arxiv_data1/oa_pdf/b1/bf/ijn-10-6757.PMC4631432.pdf
"Phytobioactive compounds serve as natural antioxidants to reduce toxicity,  and are extensively used to reduce oxidative stress, repair the central nervous system,  and prevent PD.1,2 The phenolic compounds are the most beneficial, such as phenolic  acids and flavonoids, which reduce disease by scavenging free radicals and limiting  oxidative stress.2,6 In addition, flavonoids chelate metal ions, preventing formation of  free radicals and limits limiting the onset of PD.6–8 Oral administration is the most Correspondence: Dong-Kug Choi Nanotechnology Research Center,  Department of Applied Life Science,  College of Biomedical and Health Science,  Konkuk University, GLOCAL Campus,  268, Chungwon-daero, Chungju 380-701,  Republic of Korea Tel +82 43 840 3610 Fax +82 43 840 3872 email choidk@kku.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Ganesan et al Running head recto: Nanophytobioactive compounds preventive role in Parkinson’s disease DOI: http://dx.doi.org/10.2147/IJN.S93918",Non-OADS,/arxiv_data1/oa_pdf/b1/bf/ijn-10-6757.PMC4631432.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b1/bf/ijn-10-6757.PMC4631432.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/bf/ijn-10-6757.PMC4631432.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1a/57/ijn-10-6725.PMC4631433.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 6725–6739International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6725OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9024 9a novel nano-copper-bearing stainless steel with  reduced cu2+ release only inducing transient  foreign body reaction via affecting the activity  of NF-κB and caspase 3 lei Wang1,* ling ren2,* Tingting Tang1 Kerong Dai1 Ke Yang2 Y ongqiang hao1 1shanghai Key laboratory of  Orthopaedic Implants, Department  of Orthopaedics, shanghai Ninth  People’s hospital, shanghai JiaoT ong  University school of Medicine,   shanghai, People’s republic of china;   2Institute of Metal research, chinese  academy of sciences, shenyang,   People’s republic of china *These authors contributed equally  to this workAbstract:  Foreign body reaction induced by biomaterials is a serious problem in clinical  applications.",Non-OADS,/arxiv_data1/oa_pdf/1a/57/ijn-10-6725.PMC4631433.pdf
"Therefore, in addi - tion to good physical, chemical, and mechanical characteristics, the implants first must correspondence: Yongqiang hao shanghai Key laboratory of Orthopaedic  Implants, Department of Orthopaedics,  shanghai Ninth People’s hospital,  shanghai JiaoTong University school of  Medicine, shanghai JiaoTong University,  639 Zhizaoju road, shanghai 200011,  People’s republic of china Tel +86 21 2327 1699 Fax +86 21 6313 6856 email hyq_9hospital@hotmail.co m  Ke Yang Institute of Metal research, chinese   academy of sciences, 72  Wenhua road,  shenyang 110016, People’s republic   of china Tel +86 24 2397 1880 Fax +86 24 2397 1880 email kyang@imr.ac.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Wang et al Running head recto: Foreign body reaction evaluation of nano-copper bearing stainless steel DOI: http://dx.doi.org/10.2147/IJN.S90249",Non-OADS,/arxiv_data1/oa_pdf/1a/57/ijn-10-6725.PMC4631433.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/1a/57/ijn-10-6725.PMC4631433.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/57/ijn-10-6725.PMC4631433.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d8/35/ijn-10-6741.PMC4631434.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 6741–6756International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6741OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9137 7anti-hyperglycemic activity of selenium  nanoparticles in streptozotocin-induced diabetic  rats saleh al-Quraishy1 Mohamed a Dkhil1,2 ahmed esmat abdel  Moneim2 1Department of Zoology, college of  science, King saud University, riyadh,   saudi arabia; 2Department of Zoology  and entomology, Faculty of science,   helwan University, cairo, egyptAbstract:  The study was designed to investigate the anti-hyperglycemic activity of selenium  nanoparticles (SeNPs) in streptozotocin-induced diabetic rats.",Non-OADS,/arxiv_data1/oa_pdf/d8/35/ijn-10-6741.PMC4631434.pdf
"Keywords:  diabetes, selenium, liver, kidney, toxicity Introduction Diabetes mellitus (DM) is a chronic progressive metabolic disorder and a multifacto - rial disease associated with many pathological alterations including microvascular and   macrovascular complications that affect almost every part of the body.1 The International  Diabetes Federation have recently indicated that 8.3% of adults worldwide (387 million  people) have diabetes and the same organization predicts that by 2035 this figure will  rise to nearly 600 million people.2 Observational evidence from experimental and clini - cal studies indicates that oxidative stress is involved in both the pathogenesis and the  complications of DM.3,4 Based on observations of the beneficial effects of overexpres - sion of antioxidant enzymes in transgenic mouse models, catalytic antioxidants such as  the family of superoxide dismutase/catalase mimetic compounds are the most logical  choice for preventing diabetes-induced reactive oxygen species.4 Streptozotocin (STZ) is well known for its selective destruction of pancreatic  β-cells in islets of Langerhans, resulting in insulin deficiency and hyperglycemia and  has been extensively used in animals as a model to study the pathology and complica - tions of DM, and the effectiveness of potential interventions.1 STZ induces diabetes  by inducing rapid and irreversible necrosis in β-cells, but the induction of both type 1  and 2 diabetes is dependent on the dose of STZ and the animal and species used.5 Elemental selenium (Se) nanoparticles (SeNPs) have received great attention  because of their unique biological activities and low toxicity.6 These SeNPs also exhibit correspondence: ahmed esmat abdel  Moneim Department of Zoology and entomology,  Faculty of science, helwan University,  ain helwan, cairo 11795, egypt Tel +20 115 332 2079 email aest1977@hotmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Al-Quraishy et al Running head recto: Hypoglycemic effects of selenium nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S91377",Non-OADS,/arxiv_data1/oa_pdf/d8/35/ijn-10-6741.PMC4631434.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d8/35/ijn-10-6741.PMC4631434.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/35/ijn-10-6741.PMC4631434.pdf
"Data from TCTmd slide presentations, BVS 2014  meeting: http://www.tctmd.com/list.aspx?fid=968379 Scaffold Strut thickness Distensibility Poly-lactic acid platform ArterioSorb (Arterius, Bradford, UK) < 150 μm up to 3.5 mm size No DESolve AMI (Elixir Medical Corporation, Sunnyvale, CA, USA) 100 μm Self-correct to 0.25 mm  above nominal diameter Fortitude (Amaranth Medical, Mountain View, CA, USA) 120 μm Possible 1 mm   over-expansion MeRes (Meril Lifescience, Vapi, Gujarat, India) 100 μm No Mirage Microfiber Scaffold (ManLi Cardiology, Singapore,   Republic of Singapore)125 μm up to 3.0 mm size No Tyrosine polycarbonate alloy REVA Fantom (Reva Medical Inc., San Diego, CA, USA) 125 μm One of 3.0 mm caliber can  be post-dilated up to   4.87 mm REVA ReZolve (Reva Medical Inc., San Diego, CA, USA) 122 μm Not reported Magnesium structure AMS series (Biotronik, Berlin, Germany) No (165 μm) Allowed > 2.0 mm   post-dilatation DREAMS series (Biotronik, Berlin, Germany) 120 μm for DREAMS 1.0 Allowed > 2.0 mm   post-dilatation Nitride iron-based framework Iron-based Biocorrodible Scaffold (Lifetech Scientific Corporation,   Shenzhen, China)70 μm Not reported",Non-OADS,/arxiv_data1/oa_pdf/99/b8/PWKI-11-25696.PMC4631727.pdf
Data from ClinicalTri-als.gov: https://clinicaltrials.gov/ct2/show/study/NCT02453035?,OADS,/arxiv_data1/oa_pdf/99/b8/PWKI-11-25696.PMC4631727.pdf
"A pipeline based on the IMGT rhesus macaquegermline gene database ( http://www.imgt.org/ ), which contains 23 VH,3 2DH, and 8 JHgene segments, was implemented for pur - poses of comparison.",OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
"The putative germline gene sequence was added to each data set, and a multiple sequence alignment (MSA) generated by CLUSTALW2(50) was used as the input to construct a phylogenetic tree using DNAMLK( http://evolution.genetics.washington.edu/phylip/doc/dnamlk.html )i n the PHYLIP package v3.69 ( http://evolution.genetics.washington.edu/ phylip.html ).",OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
"ACKNOWLEDGMENTS This work was supported by grants from the Scripps Center for HIV/AIDS Immunology & Immunogen Discovery (CHAVI-ID UM1 AI 100663), theInternational AIDS Vaccine Initiative (IAVI) and its generous donors(who can be found at http://www.iavi.org ), and NIH/NIAID grants HIVRAD P01 AI104722 and R01AI102766.",Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1016/j.coi.2010.02.012 .,OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study.Nat Biotechnol 30:423– 433. http://dx.doi.org/10.1038/nbt.2197 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
Cell Host Mi- crobe 12:396 – 407. http://dx.doi.org/10.1016/j.chom.2012.09.008 .,OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1126/science.1207532 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
Science 329:856 – 861. http://dx.doi.org/10.1126/science.1187659 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
Immunity 40: 657– 668. http://dx.doi.org/10.1016/j.immuni.2014.04.009 .,OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1016/j.immuni.2013.04.012 .,OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
Nature 509:55– 62. http://dx.doi.org/10.1038/nature13036 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1038/nature13601 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1126/science.1207227 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
Nature 496:469 – 476. http://dx.doi.org/ 10.1038/nature12053 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1038/nri3516 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
Immunity 37:412– 425. http://dx.doi.org/10.1016/j.immuni.2012.08.012 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1126/science.1241144 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/ 10.1073/pnas.1306262110 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1371/ journal.ppat.1003754 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
Cell 161:470 – 485. http://dx.doi.org/ 10.1016/j.cell.2015.03.004 .,OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
Nat Rev Microbiol 10:852– 867. http://dx.doi.org/10.1038/ nrmicro2911 .,OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1016/j.tibtech.2007.05.004 .,OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
Trends Micro-biol 8:426 – 431. http://dx.doi.org/10.1016/S0966-842X(00)01816-3 .,OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1371/journal.pmed.0050173 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/ 10.1084/jem.20100025 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1016/ j.jim.2012.09.003 .,OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1126/ scitranslmed.3003752 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
Science329:811– 817. http://dx.doi.org/10.1126/science.1192819 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.4049/ jimmunol.1303334 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/ 10.1007/s00251-015-0844-3 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1126/science.1245625 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1126/ science.1245627 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
Nature 514:455– 461. http://dx.doi.org/ 10.1038/nature13808 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1016/j.celrep.2015.03.047 .,OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
BMC Immunol 15:9. http://dx.doi.org/10.1186/s12865-014-0029-0 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
Science 340:1232910. http://dx.doi.org/10.1126/science.1232910 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1056/NEJMra1204186 .,OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1038/ni.2871 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1016/ j.coviro.2015.03.013 .,OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1016/ j.chembiol.2013.12.006 .,OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/ 10.1038/nbt.2492 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1093/bioinformatics/ btm404 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1093/nar/25.17.3389 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
BMCBioinformatics 8:460. http://dx.doi.org/10.1186/1471-2105-8-460 .,OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/ 10.1128/JVI.79.16.10108-10125.2005 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1128/JVI.01142-09 .,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1128/JVI.02108-09 .B-cell response to an HIV-1 trimer vaccine November/December 2015 Volume 6 Issue 6 e01375-15®mbio.asm.org 17,Non-OADS,/arxiv_data1/oa_pdf/4c/eb/mBio.01375-15.PMC4631801.pdf
http://dx.doi.org/10.1007/s00253-006-0811-x .,Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/ 10.2105/AJPH.64.2.155 .,Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/10.2105/AJPH.55.10.1629 .,Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
Appl Environ Microbiol 75:6986 – 6991. http://dx.doi.org/10.1128/AEM.01605 -09.,OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
J Bacteriol 194: 4579 – 4588. http://dx.doi.org/10.1128/ JB.00791-12 .,Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/10.1371/journal.pone.0099349 .,Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/10.1111/mmi.12249 .,Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/10.1007/s00726-003-0016-x .,Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/10.1172/ JCI114472 .,Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/10.1042/bj0410337 .,Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/ 10.1146/annurev-micro-102912-142520 .,Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/ 10.1021/bi500401k .,Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/10.1039/ B512706H .,Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
Curr Opin Biotechnol 12: 419 – 425. http://dx.doi.org/10.1016/S0958-1669(00)00237-8 .,OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
Biotechnol Bioeng 87:804 – 811. http://dx.doi.org/10.1002/bit.20202 .,Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/10.1016/ j.jcis.2009.10.050 .,OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/10.1039/ c3ta12303k .,Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/ 10.1088/0953-8984/13/33/202 .,Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/10.1016/ j.cej.2014.07.130 .,OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
Appl Environ Microbiol 81:6660 – 6668. http://dx.doi.org/10.1128/AEM.02175-15 .,OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/10.1021/bc060077y .,Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/10.1007/ BF00374144 .,Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/ 10.1007/978-1-61779-191-8_19 .,Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
Chem Rev 70:639 – 665. http://dx.doi.org/10.1021/ cr60268a002 .,Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/10.1021/j100884a007 .Radian et al.,OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/10.1016/j.jcis.2008.09.031 .,OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
"http://dx.doi.org/10.1021/ed039p546 .42.Maaloe O, Ingraham GL, Maaloe O, Neidhardt FC .",Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/ 10.1016/j.watres.2007.07.025 .,OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
http://dx.doi.org/10.1046/j.1462-2920.2000.00079.x .,Non-OADS,/arxiv_data1/oa_pdf/49/aa/mBio.01477-15.PMC4631802.pdf
Clin Microbiol Rev 16:37– 64. http://dx.doi.org/10.1128/ CMR.16.1.37-64.2003 .,OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
Cell Microbiol5:809 – 820. http://dx.doi.org/10.1046/j.1462-5822.2003.00322.x .,OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
Cell Microbiol 9:861– 874. http://dx.doi.org/10.1111/j.1462 -5822.2006.00835.x .,OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
Infect Immun 70:889 – 898. http://dx.doi.org/10.1128/ IAI.70.2.889-898.2002 .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/10.1111/j.1365-2958.2011.07885.x .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
N Engl J Med 316:853– 856. http://dx.doi.org/10.1056/NEJM198704023161406 .,OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/10.1038/newbio232153a0 .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
Nature 364:639 – 642. http://dx.doi.org/10.1038/364639a0 .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/ 10.1016/j.chom.2011.05.005 .,OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
Cell Microbiol 9:610 – 618. http://dx.doi.org/10.1111/j.1462-5822.2006.00812.x .,OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/10.1016/j.yexmp.2007.08.014 .,OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/10.1080/15216540600719580 .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/10.1002/ pmic.200500632 .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/10.1093/humrep/ des050 .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
Nat Biotechnol 21:77– 80. http://dx.doi.org/10.1038/ nbt772 .,OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/ 10.1038/nrm2867 .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/10.1074/jbc.M511825200 .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/10.1038/nsmb796 .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/10.1152/ ajpcell.00426.2006 .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/ 10.1038/293302a0 .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/10.1007/BF00712034 .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/10.1074/ jbc.M610428200 .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/ 10.1074/jbc.M113.466136 .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/10.1016/j.cell.2006.02.012 .,OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
Regulation of actin ﬁlament network for- mation through ARP2/3 complex: activation by a diverse array of proteins.Annu Rev Biochem 70:649 – 676. http://dx.doi.org/10.1146/ annurev.biochem.70.1.649 .,OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
Mol CellBiol27:6615– 6628. http://dx.doi.org/10.1128/MCB.00367-07 .,OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
Trafﬁc 5:418 – 425. http://dx.doi.org/ 10.1111/j.1398-9219.2004.00184.x .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/ 10.1083/jcb.146.6.1319 .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/10.1128/IAI.71.3.1551-1556.2003 .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
Cell Death Differ 20:43– 48. http://dx.doi.org/10.1038/cdd.2012.73 .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/10.1099/vir.0.80105-0 .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
Microb Pathog 28:71– 80. http://dx.doi.org/10.1006/ mpat.1999.0327 .,OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/10.1016/j.micinf.2012.05.012 .,OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/10.1128/JB.02017-07 .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/ 10.1371/journal.pone.0027981 .,Non-OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
J Bacteriol 192:4122– 4133. http://dx.doi.org/10.1128/JB.00132-10 .Mohan Kumar et al.,OADS,/arxiv_data1/oa_pdf/dc/52/mBio.01541-15.PMC4631803.pdf
http://dx.doi.org/10.1038/nature12060 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/ 10.1016/S1567-1348(03)00004-2 .,OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
Virology 174:479 – 493. http://dx.doi.org/ 10.1016/0042-6822(90)90102-W .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1006/ viro.2002.1686 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1038/nsmb.2463 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1016/j.chom.2008.08.004 .,OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1128/JVI.00080-06 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1128/ JVI.75.16.7769-7773.2001 .,OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1016/ j.virol.2015.03.025 .,OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1128/ JVI.01140-14 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1128/JVI.00757-13 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
Proc Natl Acad Sc iUSA 110:6795– 6799. http://dx.doi.org/ 10.1073/pnas.1304300110 .,OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
JVirol 88:477– 482. http://dx.doi.org/10.1128/JVI.02641-13 .,OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/ 10.1038/nrmicro1690 .,OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/ 10.1371/journal.ppat.1002930 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1038/nsmb.1382 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1038/ nature03956 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1038/nm1240 .,OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1128/JVI.01732-06 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1371/journal.ppat.1000823 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1016/j.vaccine.2007.08.024 .,OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1016/S0140-6736(14)61060-6 .,OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1056/NEJMoa1411037 .,OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1111/j.1600-065X.2008.00676.x .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1128/JVI.01190-10 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
J Virol 87:8826 – 8842. http://dx.doi.org/10.1128/JVI.01314-13 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
Science 302:248. http://dx.doi.org/ 10.1126/science.1089316 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
EMBO Rep 12:602– 606. http://dx.doi.org/10.1038/ embor.2011.75 .,OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1371/ journal.ppat.1000060 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
"http://dx.doi.org/10.1038/304699a0 .48.Hogle JM, Chow M, Filman DJ .",Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/ 10.1126/science.2994218 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1128/JVI.00557 -09.,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1006/ viro.1997.8908 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1126/ science.1254426 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1038/emboj.2011.439 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1016/j.str.2012.01.014 .,OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/ 10.1128/JVI.00299-14 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1128/ JVI.01949-13 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1128/JVI.06072-11 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
Virology 346: 53– 65. http://dx.doi.org/10.1016/ j.virol.2005.10.030 .,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
http://dx.doi.org/10.1128/JVI.05559-11 .Strain-Speciﬁc Differences in DENV Neutralization November/December 2015 Volume 6 Issue 6 e01559-15®mbio.asm.org 11,Non-OADS,/arxiv_data1/oa_pdf/dc/db/mBio.01559-15.PMC4631804.pdf
J Infect Dis 194:479 – 485. http://dx.doi.org/10.1086/505877 .,Non-OADS,/arxiv_data1/oa_pdf/82/12/mBio.01741-15.PMC4631805.pdf
http://dx.doi.org/10.1056/NEJMoa1201964 .,OADS,/arxiv_data1/oa_pdf/82/12/mBio.01741-15.PMC4631805.pdf
http://dx.doi.org/10.1086/501356 .,Non-OADS,/arxiv_data1/oa_pdf/82/12/mBio.01741-15.PMC4631805.pdf
http://dx.doi.org/10.1128/AAC.49.9.3896-3902.2005 .,Non-OADS,/arxiv_data1/oa_pdf/82/12/mBio.01741-15.PMC4631805.pdf
http://dx.doi.org/10.1371/ journal.pone.0101311 .,Non-OADS,/arxiv_data1/oa_pdf/82/12/mBio.01741-15.PMC4631805.pdf
http://dx.doi.org/10.1128/mBio.00139-10 .,Non-OADS,/arxiv_data1/oa_pdf/82/12/mBio.01741-15.PMC4631805.pdf
http://dx.doi.org/10.1128/AAC.00334-06 .,Non-OADS,/arxiv_data1/oa_pdf/82/12/mBio.01741-15.PMC4631805.pdf
http://dx.doi.org/10.1592/phco.21.11.1010.34517 .,Non-OADS,/arxiv_data1/oa_pdf/82/12/mBio.01741-15.PMC4631805.pdf
http://dx.doi.org/10.1056/ NEJM200511243532123 .,OADS,/arxiv_data1/oa_pdf/82/12/mBio.01741-15.PMC4631805.pdf
http://dx.doi.org/10.1126/science.283.5407.1488 .,Non-OADS,/arxiv_data1/oa_pdf/82/12/mBio.01741-15.PMC4631805.pdf
Antimicrob Agents Chemother 54:4605– 4610. http://dx.doi.org/10.1128/AAC.00177-10 .16.,Non-OADS,/arxiv_data1/oa_pdf/82/12/mBio.01741-15.PMC4631805.pdf
http://dx.doi.org/10.1093/jac/dks153 .,Non-OADS,/arxiv_data1/oa_pdf/82/12/mBio.01741-15.PMC4631805.pdf
http://dx.doi.org/10.1086/655471 .,Non-OADS,/arxiv_data1/oa_pdf/82/12/mBio.01741-15.PMC4631805.pdf
http://dx.doi.org/10.1128/AAC.00708-08 .,Non-OADS,/arxiv_data1/oa_pdf/82/12/mBio.01741-15.PMC4631805.pdf
http://dx.doi.org/ 10.1128/AAC.00167-09 .,Non-OADS,/arxiv_data1/oa_pdf/82/12/mBio.01741-15.PMC4631805.pdf
"Accurate detection of outliers and subpopulations with Pmetrics, anonparametric and parametric pharmacometric modeling and simula-tion package for R. Ther Drug Monit 34:467– 476. http://dx.doi.org/ 10.1097/FTD.0b013e31825c4ba6 .",Non-OADS,/arxiv_data1/oa_pdf/82/12/mBio.01741-15.PMC4631805.pdf
http://dx.doi.org/10.1128/AAC.01439 -07.Brown et al.,OADS,/arxiv_data1/oa_pdf/82/12/mBio.01741-15.PMC4631805.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/22/ofv148.PMC4631903.pdf
Prosthetic Heart Valves; http://emedicine.medscape.com/ article/780702-overview#a0199.,Non-OADS,/arxiv_data1/oa_pdf/0f/86/KITP-12-25837.PMC4631909.pdf
http://www.wellsphere.com/heart-health-article/what- is-pannusformation-in-prosthetic-valves-what-is-the-clinical-significance/   629218.,Non-OADS,/arxiv_data1/oa_pdf/0f/86/KITP-12-25837.PMC4631909.pdf
II: 101-176;  http://www.ptkardio.pl/Wytyczne_ESC_dotyczace_rozpoznania_oraz_   leczenia_ostrej_i_przewleklej_niewydolnosci_serca_na_2012_rok-1821.,Non-OADS,/arxiv_data1/oa_pdf/e9/17/KITP-12-25842.PMC4631914.pdf
"23. http://practical-haemostasis.com/Factor%20Assays/VWF/vwf_assays_in - troduction.html (accessed on March 04, 2015)",Non-OADS,/arxiv_data1/oa_pdf/60/a2/KITP-12-25843.PMC4631915.pdf
"The inter-connectivity and the immediate interacting partners of the 126 proteins identified were evaluated by applying publicly available binary human protein–pro-tein interaction (PPI) data derived from Reactome (http://reacto- me.org), BIND (http://www.bind.ca), MINT (http://mint.bio.",OADS,/arxiv_data1/oa_pdf/48/50/emi201561a.PMC4631929.pdf
"uniroma2.it/mint/Welcome.do), HPRD (http://www.hprd.org),CORUM (http://mips.helmholtz-muenchen.de/genre/proj/corum/index.html).",Non-OADS,/arxiv_data1/oa_pdf/48/50/emi201561a.PMC4631929.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Enterovirus D68 in Brazil S Carney et al 2 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/87/5e/emi201566a.PMC4631932.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/c8/rjv132.PMC4631953.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1016/j.nicl.2015.09.0112213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
"The elements of S ijare given by Sij¼fexpð−jjXi−Xjjj2=rÞ Condition 1 0 otherwisegð 2Þ where the exponential is known as the heat kernel and is employed with the Frobenius norm ( Golub and van Loan, 1996 ),ris a control parameter usually referred to as radius of in ﬂuence, and Condition 1 states that tensors Xiand Xjshare the same class label and each of them is among thek-nearest neighbors of the other, while the indices iandjvary across1The adopted thresholding scheme can be downloaded from http://users.auth.gr/ ~stdimitr/software.html .523 S.I.",OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
"However, the use of the 2Source code can be downloaded from: ELM: http://www.ntu.edu.sg/eee/icis/cv/ egbhuang.htm .T s a : http://www.cad.zju.edu.cn/home/dengcai/Data/DimensionReduction.",OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
3http://www.humanbrainproject.eu/ andhttp://www.whitehouse.gov/infographics/ brain-initiative528 S.I.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1371/journal.pcbi.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1126/science.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1080/00031305.1992.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1073/ pnas.090364110619564605 .,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
"23 (3), 169– 209. http://dx.doi.org/10.1007/s11065-013-9237- 223974873 .",Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1111/j.1745-3984.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.03.04822484306 .,OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1126/science.109974515218136 .,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.12.04621195199 .,OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1093/brain/ awq17420826433 .,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
"78 (2), 89 –99.http://dx.doi.org/10.1016/j.ijpsycho.2010.06.00320598764 .Cortes, C., Vapnik, V., 1995.",Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1007/BF00994018 .,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1016/j.neuron.2012.03.,OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
"Methods 134 (1), 9 –21.http://dx.doi.org/10.1016/j.jneumeth.2003.10.00915102499 .",OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1016/j.neuroimage.2006.,OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1523/JNEUROSCI.3477-07.200717978035 .,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1016/j.clinph.2015.03.01125881782 .,OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1016/j.neuroimage.2013.06.03623777755 .,OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1016/j.jneumeth.,OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1016/j.nicl.2013.12.,OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1111/j.1469-1809.1936.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1016/j.neuroimage.2015.01.05425680519 .,OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1038/nrn220117704812 .,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1002/ana.2122417894381 .,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
"Neurosurgery 57 (4), 719– 726. http://dx.doi.org/10.1227/01.NEU.0000175725.75780.DD16239884 .",Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
"7 (4), 283 –28 9. http://dx.doi.org/ 10.1007/BF011952547577326 .",Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
"23 (4), 341 –350.http://dx.doi.org/10.1097/WCO.0b013e32833aa56720581686 .",Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1038/nn.310122561454 .,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1137/0611034 .,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
"5, 109– 119. http://dx.doi.org/10.1016/j.nicl.2014.06.004 .",OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.04.02922542638 .,OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1089/neu.2008.067219385722 .,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1016/j.jneumeth.2012.,OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
"3, 10. http://dx.doi.org/10.3389/fneur.",Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
"Online 8, 31. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1097/HTR.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1002/ (SICI)1097-0193(1999)8:4 b194::AID-HBM4 N3.0.CO;2-C10619414 .,OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
"87 (19), 198701. http://dx.doi.org/10.1103/PhysRevLett.87.",Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1097/01.HTR.0000271115.29954.2717510590 .,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1089/neu.2012.267923692211 .,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
"Brain Connect 1 (1), 49 –59.http://dx.doi.org/10.1089/brain.2011.",Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1002/ana.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
"87 (1 –3), 60 –66.http://dx.doi.org/10.1016/j.schres.",OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1016/j.neubiorev.2006.06.00716904745 .,OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.3171/2013.12.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1109/IEMBS.2010.562670221096408 .,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1016/j.tics.,OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
"Cortex 15 (9), 1332– 1342. http://dx.doi.org/10.1093/ cercor/bhi01615635061.",OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.3171/2013.12.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1038/nrneurol.2014.,OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1016/j.neuroimage.2009.11.,OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1093/cercor/bhj12716452642 .,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.3171/2013.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
"Lancet 2 (7872), 81 –84.http://dx.doi.org/10.1016/S0140- 6736(74)91639-04136544.",OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
"Physica D: Nonlinear Phenomena 58(1–4), 77 –94.http://dx.doi.org/10.1016/0167-2789(92)90102-S .530 S.I.",OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
"2, 1–7.http://dx.doi.org/10.1016/j.nicl.2012.10.00724179752 .Zhu, G.W., Wang, F., Liu, W.G., 2009.",OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1177/14732300090370040219761680 .,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
http://dx.doi.org/10.1142/ S0219519412400064 .531 S.I.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/main.PMC4632071.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1016/j.nicl.2015.10.005 2213-1582/© 2015 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
Coordinates of peak activation Region aLeft/Right BA x y z F Voxels Diagnosis-by-conditionDorsomedial frontal gyrus Right 6 1.5 1.5 53.5 8.46 42Cerebellar tonsil Left −10.5−52.5−33.5 7.33 36 Diagnosis-by-condition-by-emotionSuperior temporal gyrus Left 22 −49.5−55.5 17.5 5.65 33 Middle temporal gyrus Left 22 −55.5−37.5 5.5 6.68 102 Middle temporal gyrus Left 19 −40.5−79.5 20.5 6.47 31 Fusiform gyrus Left 37 −37.5−58.5−12.5 6.78 65 Fusiform gyrus Left 19 −22.5−55.5−6.5 5.46 51 Lingual gyrus Right 18 19.5 −88.5−9.5 5.12 35 Cuneus Left 18 −7.5−91.5 11.5 5.01 26 Culmen Left 20 −31.5−34.5−18.5 6.41 25 Culmen Right 10.5 −52.5−15.5 6.18 23 aAccording to the Talairach Daemon Atlas ( http://www.nitrc.org/projects/tal-daemon ).549 S. Hwang et al.,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
Coordinates of peak activation Region aLeft/right BA x y z F Voxels (A) Left lateral frontal gyrus seed Diagnosis-by-conditionLateral frontal gyrus Right 9 46.5 16.5 35.5 9.50 14*Claustrum Left −34.5−22.5 2.5 12.12 36 (B)Right amygdala seedDiagnosis-by-emotion Middle occipital gyrus Right 18 40.5 −79.5−6.5 12.53 21 Lentiform nucleus Left −22.5 −7.5−0.5 8.37 31 aAccording to the Talairach Daemon Atlas (http://www.nitrc.org/projects/tal-daemon ).550 S. Hwang et al.,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/ 10.1016/j.jaac.2012.01.008 (doi: S0890-8567(12)00043-3 [pii]).,OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1016/j.neuroimage.2006.11.048 (doi: S1053- 8119(06)01117-7 [pii]).,OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
"J. Psychiatry 167 (1), 61 –69.http://dx.doi.org/10.1176/appi.ajp.2009.09010043 (doi: appi.ajp.2009.09010043 [pii]).",Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1038/npp.2009.,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/ 10.1038/mp.2011.185 (doi: mp2011185 [pii]).,OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1176/appi.ajp.2012.,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/ 10.1093/brain/awt263 (doi: awt263 [pii]).,OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1146/annurev.ne.18.030195.001205 .,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1176/appi.ajp.2009.09070931 (doi: appi.ajp.2009.09070931 [pii]).,OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1177/ 1087054711428741 .,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1080/ 02699931.2010.544160 (doi: 933887834 [pii]).,OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1007/s12402-010- 0047-6.,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1016/j.neubiorev.2009.06.,OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
1 –14http://dx.doi.org/10.1017/ S0033291713000469 (doi: S0033291713000469 [pii]).,OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
"J. Psychiatry 165 (6), 712– 720. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1111/j.1469-7610.2009.02105.x .,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1002/hbm.21405 .,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
1–12http://dx.doi.org/10.1017/S0033291713001037 (doi: S0033291713001037 [pii]).,OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1037/0021-843X.115.3.,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1016/j.jaac.2012.11.009 (e162.,OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1176/appi.ajp.,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1111/j.1469-7610.2006.01612.x .,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1016/j.tics.2005.03.010 (doi: S1364-6613(05)00090-2 [pii]).,OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1162/089892902760807212 .,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1016/j.jaac.2010.07.009 (doi: S0890-8567(10)00563-0 [pii]).,OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.05.048 (doi: S1053- 8119(05)00363-0 [pii]).,OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
"213 (1), 24 –30.http://dx.doi.org/10.1016/ j.pscychresns.2013.01.004 (doi: S0925-4927(13)00022-X [pii]).",OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1016/j.cpr.2013.08.005 (doi: S0272-7358(13)00121-9 [pii]).,OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1016/j.pscychresns.2010.04.005 (doi: S0925- 4927(10)00118-6 [pii]).,OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
J. Psychiatry http://dx.doi.org/10.1176/appi.ajp.,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1111/j.1469-7610.2010.,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
http://dx.doi.org/10.1371/journal.pone.0062405 .554 S. Hwang et al.,OADS,/arxiv_data1/oa_pdf/c3/7d/main.PMC4632075.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis).LKB1 regulation of TNBC metastasis LV Rhodes et al 8 Oncogenesis (2015), 1 –8",Non-OADS,/arxiv_data1/oa_pdf/9c/87/oncsis201527a.PMC4632088.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/29/main.PMC4632112.pdf
"Received July 15, 2015 /C15Revision received July 27, 2015 /C15Accepted July 30, 2015 /C15Available online 6 August 2015 http://dx.doi.org/10.1016/j.molmet.2015.07.009 Original article 834MOLECULAR METABOLISM 4 (2015) 834 e845/C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/03/29/main.PMC4632112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/29/main.PMC4632112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/29/main.PMC4632112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/29/main.PMC4632112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/29/main.PMC4632112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/29/main.PMC4632112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/29/main.PMC4632112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/29/main.PMC4632112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/29/main.PMC4632112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/29/main.PMC4632112.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/03/29/main.PMC4632112.pdf
Journal of Visualized Experiments (95):52049. http://dx.doi.org/10.3791/52049 .,Non-OADS,/arxiv_data1/oa_pdf/03/29/main.PMC4632112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/29/main.PMC4632112.pdf
http://dx.doi.org/10.1152/ ajpendo.00571.2013 .,Non-OADS,/arxiv_data1/oa_pdf/03/29/main.PMC4632112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/29/main.PMC4632112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/29/main.PMC4632112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/dc/main.PMC4632113.pdf
"Received June 29, 2015 /C15Revision received July 27, 2015 /C15Accepted July 30, 2015 /C15Available online 12 August 2015 http://dx.doi.org/10.1016/j.molmet.2015.07.010 Original article MOLECULAR METABOLISM 4 (2015) 779 e794/C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/1a/dc/main.PMC4632113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/dc/main.PMC4632113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/dc/main.PMC4632113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/dc/main.PMC4632113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/dc/main.PMC4632113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/dc/main.PMC4632113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/dc/main.PMC4632113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/dc/main.PMC4632113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/dc/main.PMC4632113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/dc/main.PMC4632113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/dc/main.PMC4632113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/dc/main.PMC4632113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/dc/main.PMC4632113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/dc/main.PMC4632113.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1a/dc/main.PMC4632113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/dc/main.PMC4632113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/dc/main.PMC4632113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/dc/main.PMC4632113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/8e/main.PMC4632114.pdf
"Received July 20, 2015 /C15Revision received July 30, 2015 /C15Accepted August 5, 2015 /C15Available online 14 August 2015 http://dx.doi.org/10.1016/j.molmet.2015.08.001 Original article MOLECULAR METABOLISM 4 (2015) 811 e822/C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/d2/8e/main.PMC4632114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/8e/main.PMC4632114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/8e/main.PMC4632114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/8e/main.PMC4632114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/8e/main.PMC4632114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/8e/main.PMC4632114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/8e/main.PMC4632114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/8e/main.PMC4632114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/8e/main.PMC4632114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/8e/main.PMC4632114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/8e/main.PMC4632114.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d2/8e/main.PMC4632114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/8e/main.PMC4632114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/8e/main.PMC4632114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4632115.pdf
"Abbreviations: HFD, high-fat diet; BDNF, brain-derived neurotrophic factor; TrkB, tropomyosin receptor kinase B; VMH, ventromedial nucleus of the hypothalamus; PVH, paraventricular nucleus of the hypothalamus; NTS, nucleus of the solitary tract; DVC, dorsal vagal complex; eWAT, epididymal white adipose tissue; BAT, brown adipose tissue; GTT, glucose tolerance test; HPA axis, hypothalamic-pituitary-adrenal axis; Cre,Crerecombinase; Nkx2.1 , Nk2 homeobox 1 protein; Phox2b , paired-like homeobox 2b protein; Pomc , pro-opiomelanocortin; Npy, neuropeptide Y; Agrp , agouti-related peptide; LepR , leptin receptor; Mc4R , melanocortin 4 receptor; Ucp1 , uncoupling protein 1;Cidea , cell death-inducing DFFA-like effector a; Elovl3 , elongation of very long fatty acids-like 3; Pgc1a, peroxisome proliferator-activated receptor gamma coactivator 1 alpha; Ppar g, peroxisome proliferator-activated receptor gamma; Prdm16 , PR domain containing 16 Received July 29, 2015 /C15Revision received August 10, 2015 /C15Accepted August 11, 2015 /C15Available online 18 August 2015 http://dx.doi.org/10.1016/j.molmet.2015.08.002 Original article MOLECULAR METABOLISM 4 (2015) 867 e880/C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4632115.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4632115.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4632115.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4632115.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4632115.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4632115.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4632115.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4632115.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4632115.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4632115.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4632115.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4632115.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4632115.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4632115.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4632115.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4632115.pdf
"Cells were stained with DiI  before they were cultured onto each material to identify them  by fluorescence, (see Supplemental Digital Content 1, 2, and 3,  http://links.lww.com/ASAIo/A70, http://links.lww.com/ASAIo/A71, http://links.lww.com/ASAIo/A72) then we measured how far the cells could displace within 6 h. The migration distance  was quantified using the program AxioVision.",OADS,/arxiv_data1/oa_pdf/0e/5d/mat-61-718.PMC4632116.pdf
"Gen- eration of other animal models of PH and characterization ofthe presence or absence of vasoreactive PH are described in theSupplemental Digital Content 1 (seeSupplementary Material S1 , http://links.lww.com/JCVP/A207).",Non-OADS,/arxiv_data1/oa_pdf/a6/48/jcvp-66-457.PMC4632117.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/f5/main.PMC4632119.pdf
"Received August 6, 2015 /C15Revision received August 11, 2015 /C15Accepted August 18, 2015 /C15Available online 28 August 2015 http://dx.doi.org/10.1016/j.molmet.2015.08.003 Original article MOLECULAR METABOLISM 4 (2015) 795 e810/C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/b3/f5/main.PMC4632119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/f5/main.PMC4632119.pdf
"For adenovirus production shRNAs against TUSC5 were designed ( http://rnaidesigner.invitrogen.com/rnaiexpress/ ), cloned into pENTR-U6 and recombined into pAd-BLOCK-iT-DEST (Invitrogen).",Non-OADS,/arxiv_data1/oa_pdf/b3/f5/main.PMC4632119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/f5/main.PMC4632119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/f5/main.PMC4632119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/f5/main.PMC4632119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/f5/main.PMC4632119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/f5/main.PMC4632119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/f5/main.PMC4632119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/f5/main.PMC4632119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/f5/main.PMC4632119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/f5/main.PMC4632119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/f5/main.PMC4632119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/f5/main.PMC4632119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/f5/main.PMC4632119.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b3/f5/main.PMC4632119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/f5/main.PMC4632119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/f5/main.PMC4632119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/f5/main.PMC4632119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/8c/main.PMC4632125.pdf
"Received July 29, 2015 /C15Revision received August 18, 2015 /C15Accepted August 24, 2015 /C15Available online 4 September 2015 http://dx.doi.org/10.1016/j.molmet.2015.08.005 Brief communication MOLECULAR METABOLISM 4 (2015) 881 e889/C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/fe/8c/main.PMC4632125.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/8c/main.PMC4632125.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/8c/main.PMC4632125.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/8c/main.PMC4632125.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/8c/main.PMC4632125.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/8c/main.PMC4632125.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/8c/main.PMC4632125.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/8c/main.PMC4632125.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fe/8c/main.PMC4632125.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/8c/main.PMC4632125.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/8c/main.PMC4632125.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/33/b9/iranjradiol-12-03-14142.PMC4632131.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/8c/b9/iranjradiol-12-03-14979.PMC4632132.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ba/30/iranjradiol-12-03-15517.PMC4632133.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/90/47/iranjradiol-12-03-12366.PMC4632134.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/cd/6a/iranjradiol-12-03-15478.PMC4632135.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/c0/b3/iranjradiol-12-03-16063.PMC4632136.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ce/12/iranjradiol-12-03-16059.PMC4632137.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/c6/d9/iranjradiol-12-03-16753.PMC4632138.pdf
doi:10.1136/rmdopen-2015- 000064 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ rmdopen-2015-000064).,Non-OADS,/arxiv_data1/oa_pdf/ed/29/rmdopen-2015-000064.PMC4632139.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ rmdopen-2015-000056).,Non-OADS,/arxiv_data1/oa_pdf/9d/ab/rmdopen-2015-000056.PMC4632140.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ rmdopen-2015-000051).,Non-OADS,/arxiv_data1/oa_pdf/bf/8a/rmdopen-2015-000051.PMC4632141.pdf
28. http://www.mercknewsroom.com/; last visited April 06 201529.,Non-OADS,/arxiv_data1/oa_pdf/bf/8a/rmdopen-2015-000051.PMC4632141.pdf
53. http://www.clinicaltrialsregister.eu Geusens P. RMD Open 2015; 1(Suppl 1) :e000051.,Non-OADS,/arxiv_data1/oa_pdf/bf/8a/rmdopen-2015-000051.PMC4632141.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ rmdopen-2015-000061).,Non-OADS,/arxiv_data1/oa_pdf/ef/51/rmdopen-2015-000061.PMC4632142.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ rmdopen-2015-000053).,Non-OADS,/arxiv_data1/oa_pdf/e7/db/rmdopen-2015-000053.PMC4632143.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e7/db/rmdopen-2015-000053.PMC4632143.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/rmdopen-2015-000062).,Non-OADS,/arxiv_data1/oa_pdf/b7/fc/rmdopen-2015-000062.PMC4632144.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ rmdopen-2015-000069).,Non-OADS,/arxiv_data1/oa_pdf/19/17/rmdopen-2015-000069.PMC4632145.pdf
http://www.shef.ac.uk/NOGG Updated March 2014.,Non-OADS,/arxiv_data1/oa_pdf/19/17/rmdopen-2015-000069.PMC4632145.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ rmdopen-2015-000048).,Non-OADS,/arxiv_data1/oa_pdf/1b/ca/rmdopen-2015-000048.PMC4632146.pdf
2012. http://labels.fda.gov/ingredientname.cfm36.,Non-OADS,/arxiv_data1/oa_pdf/1b/ca/rmdopen-2015-000048.PMC4632146.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ rmdopen-2015-000083).,Non-OADS,/arxiv_data1/oa_pdf/77/2e/rmdopen-2015-000083.PMC4632147.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/rmdopen-2015-000049).,Non-OADS,/arxiv_data1/oa_pdf/ad/c4/rmdopen-2015-000049.PMC4632148.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ rmdopen-2015-000065).,Non-OADS,/arxiv_data1/oa_pdf/43/7a/rmdopen-2015-000065.PMC4632149.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ rmdopen-2015-000046).,Non-OADS,/arxiv_data1/oa_pdf/19/7b/rmdopen-2015-000046.PMC4632150.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ rmdopen-2015-000054).,Non-OADS,/arxiv_data1/oa_pdf/60/0a/rmdopen-2015-000054.PMC4632151.pdf
68. http://ir.celgene.com/releasedetail.cfm?releaseid=858785 (last accessed 15 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/60/0a/rmdopen-2015-000054.PMC4632151.pdf
doi:10.1136/ rmdopen-2015-000057 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ rmdopen-2015-000057).,Non-OADS,/arxiv_data1/oa_pdf/8f/29/rmdopen-2015-000057.PMC4632152.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/rmdopen-2015-000050).,Non-OADS,/arxiv_data1/oa_pdf/95/1e/rmdopen-2015-000050.PMC4632153.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/20/f5/iranjradiol-12-03-17353.PMC4632154.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/61/f2/iranjradiol-12-03-17507.PMC4632155.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/22/main.PMC4632173.pdf
"Received July 20, 2015 /C15Revision received August 26, 2015 /C15Accepted September 2, 2015 /C15Available online 11 September 2015 http://dx.doi.org/10.1016/j.molmet.2015.09.001 Original article MOLECULAR METABOLISM 4 (2015) 857 e866/C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/bf/22/main.PMC4632173.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/22/main.PMC4632173.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/22/main.PMC4632173.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/22/main.PMC4632173.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/22/main.PMC4632173.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/22/main.PMC4632173.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/22/main.PMC4632173.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/22/main.PMC4632173.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/22/main.PMC4632173.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bf/22/main.PMC4632173.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/22/main.PMC4632173.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/22/main.PMC4632173.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/65/main.PMC4632174.pdf
"Received August 19, 2015 /C15Revision received August 28, 2015 /C15Accepted September 3, 2015 /C15Available online 18 September 2015 http://dx.doi.org/10.1016/j.molmet.2015.09.002 Original article 758MOLECULAR METABOLISM 4 (2015) 758 e770/C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/5b/65/main.PMC4632174.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/65/main.PMC4632174.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/65/main.PMC4632174.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/65/main.PMC4632174.pdf
The stained cells were observed using a Nikon de- convolution wide- ﬁeld Epi ﬂuorescence system and images were pro- cessed using NIH ImageJ software ( http://imagej.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/5b/65/main.PMC4632174.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/65/main.PMC4632174.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/65/main.PMC4632174.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/65/main.PMC4632174.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/65/main.PMC4632174.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/65/main.PMC4632174.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/65/main.PMC4632174.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/65/main.PMC4632174.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/65/main.PMC4632174.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5b/65/main.PMC4632174.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/65/main.PMC4632174.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/65/main.PMC4632174.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/95/main.PMC4632175.pdf
"Abbreviations: BAC, bacterial arti ﬁcial chromosome; T2DM, type 2 diabetes mellitus; HCD, high-caloric diet; IPGTT, intraperitoneal glucose tolerance test; IPPTT, intra- peritoneal pyruvate tolerance test; R g, tissue-speci ﬁc glucose uptake rate; GIR, glucose infusion rate; EndoR a, endogenous glucose appearance rate; Rd, glucose disposal rate Received June 7, 2014 /C15Revision received September 14, 2015 /C15Accepted September 15, 2015 /C15Available online 25 September 2015 http://dx.doi.org/10.1016/j.molmet.2015.09.003 Original article 846MOLECULAR METABOLISM 4 (2015) 846 e856/C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3f/95/main.PMC4632175.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/95/main.PMC4632175.pdf
According to the World Health Organization T2DM and/orobesity are estimated to affect hundreds of millions worldwide ( http:// www.who.int/mediacentre/factsheets/fs311/en/ and http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/3f/95/main.PMC4632175.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/95/main.PMC4632175.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/95/main.PMC4632175.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/95/main.PMC4632175.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/95/main.PMC4632175.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/95/main.PMC4632175.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/95/main.PMC4632175.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/95/main.PMC4632175.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/95/main.PMC4632175.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3f/95/main.PMC4632175.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/95/main.PMC4632175.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/95/main.PMC4632175.pdf
"”,http://dx.doi.org/10.1016/j.molmet.2015.08.005 .",OADS,/arxiv_data1/oa_pdf/60/b0/main.PMC4632176.pdf
"Received September 18, 2015 /C15Accepted September 22, 2015 /C15Available online 3 October 2015 http://dx.doi.org/10.1016/j.molmet.2015.09.009 Commentary MOLECULAR METABOLISM 4 (2015) 755 e757/C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/60/b0/main.PMC4632176.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/b0/main.PMC4632176.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/b0/main.PMC4632176.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/b0/main.PMC4632176.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/78/main.PMC4632177.pdf
"Received September 4, 2015 /C15Accepted September 15, 2015 /C15Available online 25 September 2015 http://dx.doi.org/10.1016/j.molmet.2015.09.004 Original article MOLECULAR METABOLISM 4 (2015) 823 e833/C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/86/78/main.PMC4632177.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/78/main.PMC4632177.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/78/main.PMC4632177.pdf
Over-representation analysis was performed using Gene Set Enrich- ment Analysis software (GSEA; http://www.broadinstitute.org/gsea/ index.jsp )[51] and genesets from the TRANSFAC database.,OADS,/arxiv_data1/oa_pdf/86/78/main.PMC4632177.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/78/main.PMC4632177.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/78/main.PMC4632177.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/78/main.PMC4632177.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/78/main.PMC4632177.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/78/main.PMC4632177.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/78/main.PMC4632177.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/78/main.PMC4632177.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/86/78/main.PMC4632177.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/78/main.PMC4632177.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/78/main.PMC4632177.pdf
"Since 2005, funding bodies such as The Bill & Melinda Gates  Foundation ( http://www.gatesfoundation.org/ ), the United States National Institutes of  Health ( http://grants1.nih.gov/grants/index.cfm ), The Wellcome Trust in the UK ( http:// www.wellcome.ac.uk/funding/ ) and others have been increasing funding for research on  diseases that affect poorer countries, in an attempt to address the infamous 90/10 gap in  global health research.",Non-OADS,/arxiv_data1/oa_pdf/e2/82/emss-64918.PMC4632193.pdf
"This initiative prompted a new interest in diseases such as malaria  and tuberculosis, and genomics projects that are looking into these diseases, such as  MalariaGEN ( http://www.malariagen.net/ ), emerged from it.",Non-OADS,/arxiv_data1/oa_pdf/e2/82/emss-64918.PMC4632193.pdf
2014 http://www.mrc.ac.uk/Newspublications/News/MRC009788 7.,Non-OADS,/arxiv_data1/oa_pdf/e2/82/emss-64918.PMC4632193.pdf
"2014. http://wmra.org/post/blood-victory-medical- research-dispute Mello MM, Wolf LE.",Non-OADS,/arxiv_data1/oa_pdf/e2/82/emss-64918.PMC4632193.pdf
[Accessed 11 Aug 2014] http://www.mikekujawski.ca/2012/05/30/finally-some-2012-statistics-for- the-african-mobile-phone-market/ 37.,Non-OADS,/arxiv_data1/oa_pdf/e2/82/emss-64918.PMC4632193.pdf
"Geneva, Switzerland: 2013. http://scholar.google.com/scholar?",Non-OADS,/arxiv_data1/oa_pdf/fe/46/nihms732884.PMC4632202.pdf
"Geneva,  Switzerland: 2013. http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf 5.",Non-OADS,/arxiv_data1/oa_pdf/fe/46/nihms732884.PMC4632202.pdf
"Lilongwe, Malawi: 2014. http://cms.medcol.mw/ cms_uploaded_resources/18381_16.pdf 11.",Non-OADS,/arxiv_data1/oa_pdf/fe/46/nihms732884.PMC4632202.pdf
Ministry of Health; Kenya: 2014. http://aidsinfo.nih.gov/contentfiles/lvguidelines/ adultandadolescentgl.pdf 12.,Non-OADS,/arxiv_data1/oa_pdf/fe/46/nihms732884.PMC4632202.pdf
http://www.sahivsoc.org/upload/documents/Circular- ChangesinthePrescriptionofProgestinSubdermalImplants.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/fe/46/nihms732884.PMC4632202.pdf
"Nairobi, Kenya: 2011. http://healthservices.uonbi.ac.ke/sites/default/files/centraladmin/ healthservices/KenyaTreatmentGuidelines2011.pdf 26.",Non-OADS,/arxiv_data1/oa_pdf/fe/46/nihms732884.PMC4632202.pdf
Ministry of Health; Kenya:  2014. http://healthservices.uonbi.ac.ke/sites/default/files/centraladmin/healthservices/Rapid %20Advice%20Booklet%202014%2024%20June%2012%20noon_0.pdf 37.,Non-OADS,/arxiv_data1/oa_pdf/fe/46/nihms732884.PMC4632202.pdf
http://ghr.nlm.nih.gov/gene/ PTCH1  Reviewed- October 2012.,OADS,/arxiv_data1/oa_pdf/e8/13/CCD-6-192.PMC4632223.pdf
Available from: http://www.journalgateway.com/ijphd/ article/view/446.,Non-OADS,/arxiv_data1/oa_pdf/e4/05/CCD-6-235.PMC4632228.pdf
Available from: http://www.censusindia.gov.in/Census_And_You/ scheduled_castes_and_sceduled_tribes.aspx.,Non-OADS,/arxiv_data1/oa_pdf/e4/05/CCD-6-235.PMC4632228.pdf
Available from:  http://www.en.wikipedia.org/w/index.php?title=Paniya_people &  oldid=587822746.,Non-OADS,/arxiv_data1/oa_pdf/e4/05/CCD-6-235.PMC4632228.pdf
Available from: http://www.districtwayanad.com/ demographics/index.aspx.,OADS,/arxiv_data1/oa_pdf/e4/05/CCD-6-235.PMC4632228.pdf
Available from: http://www.who.int/bulletin/volumes/83/9/editorial30905html/en/.,Non-OADS,/arxiv_data1/oa_pdf/e4/05/CCD-6-235.PMC4632228.pdf
Available form: http://optn.transplant.hrsa.gov/PublicComment/ pubcommentPropSub_288.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/94/SJG-21-267.PMC4632249.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/9a/22/iranjradiol-12-03-20269.PMC4632555.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/df/84/iranjradiol-12-03-22383.PMC4632556.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/7b/60/iranjradiol-12-03-18801.PMC4632557.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/10/21/iranjradiol-12-03-25518.PMC4632558.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/cd/03/atr-04-03-19280.PMC4632559.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/c3/cf/iranjradiol-12-03-17853.PMC4632560.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/10/16/iranjradiol-12-03-18290.PMC4632561.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ad/5d/iranjradiol-12-03-17832.PMC4632562.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/aa/09/iranjradiol-12-03-17757.PMC4632563.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e4/2e/iranjradiol-12-03-11656.PMC4632564.pdf
More than 2500 DDSM data sets were available  at http://marathon.csee.usf/edu/Mammography/DDSM  (15).,OADS,/arxiv_data1/oa_pdf/e4/2e/iranjradiol-12-03-11656.PMC4632564.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/",Non-OADS,/arxiv_data1/oa_pdf/27/d0/mtm201543.PMC4632835.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/",Non-OADS,/arxiv_data1/oa_pdf/10/91/mtm201540.PMC4632836.pdf
"The source code and the executable binaries are freelyavailable at https://github.com/jhhung/Tailor .INTRODUCTION Over the past decade, small silencing RNAs, including mi- croRNAs (miRNAs), endogenous small silencing RNAs (endo-siRNAs)andPiwi-interactingRNAs(piRNAs)havebeen shown to play indispensable roles in regulating gene expression, protecting against viral infection and prevent- ing mobilization of transposable elements ( 1–4).",Non-OADS,/arxiv_data1/oa_pdf/b9/f0/gkv537.PMC4632877.pdf
"Mismatches, if allowed (−v), will be reported in the ‘MD’ tag (see Supplemen- taryMaterialsformoredetails).Tailorisfreelyavailableon GitHub( http://jhhung.github.io/Tailor/ )underGNUGen- eral Public License 2.",Non-OADS,/arxiv_data1/oa_pdf/b9/f0/gkv537.PMC4632877.pdf
Available from: http://guidance.nice.,Non-OADS,/arxiv_data1/oa_pdf/a5/ff/cm-88-258.PMC4632880.pdf
Available from: http://www.acgs.uk.com/ media/908997/frx_bpg_final_nov_2014.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/c6/ef/cm-88-288.PMC4632884.pdf
Available from: http://legeaz.net/noul-cod- procedura-penala-ncpp / / The New-Revised Romanian Criminal  Procedure Code - adopted by Law no.,Non-OADS,/arxiv_data1/oa_pdf/3e/a3/cm-88-314.PMC4632889.pdf
"Raport de activitate al Administratiei Nationale a  Penitenciarelor pe anul 2014, available from URL: http://anp.gov.",Non-OADS,/arxiv_data1/oa_pdf/3e/a3/cm-88-314.PMC4632889.pdf
Available from: http://wp.unil.ch/ space/files/2015/02/SPACE-I-2013-English.pdf .,Non-OADS,/arxiv_data1/oa_pdf/3e/a3/cm-88-314.PMC4632889.pdf
Available from: http://anp.gov.ro/web/ penitenciarul-spital-dej.,Non-OADS,/arxiv_data1/oa_pdf/3e/a3/cm-88-314.PMC4632889.pdf
Available from: http://string-db.org/ 23.,Non-OADS,/arxiv_data1/oa_pdf/3f/d8/cm-88-333.PMC4632892.pdf
Available from http://www.mental-health-today.com/rx/testos.htm  18.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/cm-88-381.PMC4632899.pdf
Available from: http://livertox.nih.gov/ Sertraline.htm  21.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/cm-88-381.PMC4632899.pdf
Available from: http://livertox.nih.gov/ Paroxetine.htm  22.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/cm-88-381.PMC4632899.pdf
"N2 were divided into“clinical” and “bulky.” Bulky disease was deﬁned as LNs>2 cm in the short-axis diameter on chest CT, disease in a group of LNs, or involvement of more than two LN stations[http://www.cancernetwork.com/oncology-journal/managing-patient-borderline-resectable-lung-cance].",Non-OADS,/arxiv_data1/oa_pdf/21/cc/tca0006-0731.PMC4632925.pdf
"Simi-larly, the rate of pathologic CR improved very slowly, and veryfew prospective clinical trials evaluating ICT have recentlybeen conducted (http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/21/cc/tca0006-0731.PMC4632925.pdf
"Available from URL: http://apps.who.int/gho/data/view.main.680 25 Slatore CG, Baumann C, Pappas M, Humphrey LL.",OADS,/arxiv_data1/oa_pdf/19/0c/tca0006-0812.PMC4632939.pdf
Available	at:<http://www.britannica.com/biography/Avicenna>.,Non-OADS,/arxiv_data1/oa_pdf/8f/fc/IJBMS-18-721.PMC4633453.pdf
"It was ﬁrst described by Open AccessA Deeb and others 17-hydroxylase/17,20-lyase deﬁciencyID: 15-0069; November 2015 DOI: 10.1530/EDM-15-0069 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2015 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd",Non-OADS,/arxiv_data1/oa_pdf/22/92/edmcr-2015-150069.PMC4633651.pdf
"A Deeb and others 17-hydroxylase/17,20-lyase deﬁciencyID: 15-0069; November 2015 DOI: 10.1530/EDM-15-0069 http://www.edmcasereports.com 2",Non-OADS,/arxiv_data1/oa_pdf/22/92/edmcr-2015-150069.PMC4633651.pdf
"Index case Presenting featureAge at presentation (years) KaryotypeInitial blood pressureInitial potassium level (mmol/l) (NR 4.0–4.8)Initial ACTH level (mcg/l) (NR 3–11)Testosterone level DHEAS level17 OHP level (nmol/l) (NR 0.9–8.8) Patient (1) Abdominal pain (retroperitoneal germ cell tumor)17 46 XX 170/96 2.5 21 Undetectable Undetectable Undetectable Patient (2) Hypertension on routine check 14 46 XX 163/117 3.8 55.7 Undetectable Undetectable 1.8 Patient (3) Headache Hypertension 14 46 XX 155/110 3.3 35 Undetectable Undetectable Undetectable Patient (4) Hypertension on routine check 8 46 XX 153/85 3.3 198 Undetectable Undetectable Undetectable A Deeb and others 17-hydroxylase/17,20-lyase deﬁciencyID: 15-0069; November 2015 DOI: 10.1530/EDM-15-0069 http://www.edmcasereports.com 3",Non-OADS,/arxiv_data1/oa_pdf/22/92/edmcr-2015-150069.PMC4633651.pdf
"A Deeb and others 17-hydroxylase/17,20-lyase deﬁciencyID: 15-0069; November 2015 DOI: 10.1530/EDM-15-0069 http://www.edmcasereports.com 4",Non-OADS,/arxiv_data1/oa_pdf/22/92/edmcr-2015-150069.PMC4633651.pdf
"(doi:10.1159/000348301 ) Received in ﬁnal form 18 September 2015 Accepted 5 October 2015 A Deeb and others 17-hydroxylase/17,20-lyase deﬁciencyID: 15-0069; November 2015 DOI: 10.1530/EDM-15-0069 http://www.edmcasereports.com 5",Non-OADS,/arxiv_data1/oa_pdf/22/92/edmcr-2015-150069.PMC4633651.pdf
"Primers and probes were from the Centers for Disease Control and Prevention (CDC) In ﬂuen- za Virus Real-Time RT-PCR In ﬂuenza A (H1/H3/H1pdm09) Subtyping Panel and the CDC In ﬂuenza B Lineage Genotyping Panel, obtained from the In ﬂuenza Reagent Resource (available at:http://www.in ﬂuenzareagentresource.org/ ).",OADS,/arxiv_data1/oa_pdf/1a/ce/jiv260.PMC4633756.pdf
"Geneva, Switzerland: World Health Organisation, 2014 .http://www.who.int/csr/disease/ ebola/situation-reports/en/ .",Non-OADS,/arxiv_data1/oa_pdf/db/81/jiv304.PMC4633764.pdf
"Geneva, Switzerland: World Health Organisation, 2014 .http://www.who.int/csr/resources/publications/ ebola/response-roadmap/en/ .",Non-OADS,/arxiv_data1/oa_pdf/db/81/jiv304.PMC4633764.pdf
"Geneva, Switzerland: World Health Organization, 2014 .http://www.who.int/countries/sle/en/ .",Non-OADS,/arxiv_data1/oa_pdf/db/81/jiv304.PMC4633764.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercialreproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/c4/jiv308.PMC4633765.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/6d/main.PMC4633837.pdf
http://dx.doi.org/10.1016/j.nicl.2015.10.007 2213-1582/© 2015 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/4b/6d/main.PMC4633837.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/6d/main.PMC4633837.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4b/6d/main.PMC4633837.pdf
http://dx.doi.org/10.1001/jamaneurol.2014.4144 (PubMed PMID: WOS: 000352157200008).,OADS,/arxiv_data1/oa_pdf/4b/6d/main.PMC4633837.pdf
http://dx.doi.org/10.1037/h0031619 (PubMed PMID: WOS: A1971K852700006).,OADS,/arxiv_data1/oa_pdf/4b/6d/main.PMC4633837.pdf
"Heart J. http://dx.doi.org/10.1093/eurheartj/ehs003 (Epub 2012/03/13, PubMed PMID: 22408037).",OADS,/arxiv_data1/oa_pdf/4b/6d/main.PMC4633837.pdf
"http://dx.doi.org/10.1002/ana.22068 (Epub 2010/08/06, PubMed PMID: 20687209).",OADS,/arxiv_data1/oa_pdf/4b/6d/main.PMC4633837.pdf
http://dx.doi.org/10.1002/jlcr.854 (PubMed PMID: WOS:000224594000006).,OADS,/arxiv_data1/oa_pdf/4b/6d/main.PMC4633837.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).NeuroImage: Clinical 9 (2015) 581 –591 Abbreviations: ACC, anterior cingulate cortex; ANT, Attentional Network Test; BLS, Bavarian Longitudinal Study; BW, birth weight; CSF, cerebrospinal ﬂuid; DLPFC, dorsolateral prefrontal cortex; DNTI, duration of neonatal intensive treatment; EHI, Edinburgh Handedness Inventory; ELBW, extremely low birth weight; EP, extremely preterm; fMRI, functional magnetic resonance imaging; FWE, familywise error; GA, gestational age; GM, gray matter; ICV, intracranial volume; IVH, intraventricular hemorrhage; INTI, intensity of neonatal intensive treatment; PFC, prefrontal cortex; VLBW, very low birth weight; VP, very preterm; WM, white matter.",Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
"1Present address: Department of Child and Family StudiesCollege of Education, Health & Human SciencesThe University of Tennessee Knoxville1215 W. Cumberland AvenueJessie Harris BuildingKnoxville, TN 37996-1912, USA http://dx.doi.org/10.1016/j.nicl.2015.09.0022213-1582/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
"The presentation orderof the different trial types was pseudorandomized, using OptSeq2 (http://surfer.nmr.mgh.harvard.edu/optseq ).",OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
"Anatomical labels for activation maxima were identi ﬁed with Talairach Cl ient 2.4.3 ( http://www.talairach.org/daemon.html ), after converting the original MNI (Montreal Neurological Institute) coordinates in SPM to Talairach space using icbm2tal ( Lancaster et al., 2007 ).",OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
"NeuroImage 105, 76 –83.http://dx.doi.org/10.1016/j.neuroimage.2014.10.02325451477 .",OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
"54 (3), 247– 253. http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1007/S10802-009- 9327-Z19488851 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
"19, 90 –96.http://dx.doi.org/10.1016/J.Siny.2013.11.012 .",OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
"36 (1), 57 –73.http://dx.doi.org/10.1080/87565641.2011.",Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.02.01815955494 .,OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1007/s00406-011-0264- 921959916 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
Cortex http://dx.doi.org/10.1093/ cercor/bhu13324935776 .,OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1001/jama.288.6.,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1037/ 0033-295X.108.3.62411488380 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
"NeuroImage 16, 497. http://dx.doi.org/10.1016/S1053- 81 19(02)90013-3.",OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
"48, 22– 34.http://dx.doi.org/10.1016/ j.neubiorev.2014.11.00325446951 .",OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1002/hbm.2269125413496 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1371/journal.pone.007010423936149 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1016/j.neuropsychologia.2011.04.03321601584 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1111/j.0924- 2708.2004.00087.x .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
"30 (2), 92 –98.http://dx.doi.org/10.1016/S0887- 8994(03)00402-814984899 .",Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1111/jcpp.,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1016/j.earlhumdev.2015.01.00425617863 .,OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1002/hbm.460020402 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
"NeuroImage 25 (2), 561 –569.http://dx.doi.org/10.1016/j.neuroimage.2004.10.04615784435 .",OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1038/pr.2013.7923823155 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1136/fn.82.3.F20810794788 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1097/DBP.0b013e31819e6a1619322106 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1016/j.tics.2014.02.,OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
"PLOS One 8 (5), e65219.http://dx.doi.org/10.1371/journal.pone.006521923717694 .",Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1017/ S003329171200103122608065 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
"69 (5 Pt 2), 11R –18R.http://dx.doi.org/10.1203/PDR.0b013e318212faa021289534 .",Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.3758/CABN.7.3.15317993204 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1371/journal.pone.003485822532832 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1016/j.brainres.2011.02.02321329677 .,OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
"Psychiatry59 (7), 643 –651.http://dx.doi.org/10.101 6/j.biopsych.2005.08.01316197925 .",Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1212/WNL.,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1002/hbm.2056418412112 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/ 10.1523/JNEUROSCI.0619-12.201223035097 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1080/8756564090296452420183707 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/ 10.3233/JAD-2011-10215421422523 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1017/S135561770707072517521479 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1016/j.neuroimage.2009.04.04119376243 .,OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1016/0028-3932(71)90067- 45146491 .,OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
843 –850http://dx.doi.org/10.1016/B978-012264841-0/50044-5 .,OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/ 10.1542/peds.110.6.115312456913.,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1017/ S135561770999103219849881 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1002/(SICI)1097-0193(1999)8:2/ 3b102::AID-HBM6 N3.,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1007/s00431-012-1906-223247616 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1111/j.1365-2214.2010.01201.x21299592 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1017/S146114570999068X19793402 .,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1016/j.nicl.2014.01.00524567907 .,OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
"19 (10), 1097– 1108. http://dx.doi.org/10.1017/ S135561771300105724050646.",Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
http://dx.doi.org/10.1111/j.1469-8749.,Non-OADS,/arxiv_data1/oa_pdf/f9/74/main.PMC4633838.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/f8/main.PMC4633839.pdf
"Indeed, the epithelia covering endometriotic cysts contain a high level of oxidative DNA damage compared with other ovarian tumors [17,18], which may be a major pathology for carcinogenesis [19,20].Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.10.001 2213-2317/ &2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/02/f8/main.PMC4633839.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: ESCs, endometrial(-otic) stromal cells; ecESCs, ectopic ESCs (im- mortalized); e-euESCs, eutopic ESCs with endometriosis (immortalized); n-euESCs, eutopic ESCs without endometriosis (in controls, immortalized); EpCs, epithelial cells; Fe-NTA, ferric nitrilotriacetate; IRP, iron regulatory protein or iron-responsiveelement binding protein; TfR1, transferrin receptor 1 nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/02/f8/main.PMC4633839.pdf
Supplementary Information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2015.10.001 .,OADS,/arxiv_data1/oa_pdf/02/f8/main.PMC4633839.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/4c/main.PMC4633888.pdf
http://dx.doi.org/10.1016/j.bbacli.2014.11.001 2214-6474/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/4c/main.PMC4633888.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/4c/main.PMC4633888.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/f8/4c/main.PMC4633888.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/d0/main.PMC4633918.pdf
http://dx.doi.org/10.1016/j.bbacli.2014.06.002 2214-6474/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/77/d0/main.PMC4633918.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/d0/main.PMC4633918.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/77/d0/main.PMC4633918.pdf
"Gene expres- sion analysis was performed by reverse-transcription and real time polymerase chain reaction with the use of a SYBR Green-based cells- to-threshold cycle (C T) kit (Life Technologies) for small cell samples, as previously described [10].S p e c i ﬁc primers for the target geneCOL1A1, encoding the pro- α1 chain of COL1 ( http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/77/d0/main.PMC4633918.pdf
"References [1] Global Initiative for Asthma (GINA), Global strategy for asthma management and prevention, Updated 2012, Available at: http://www.ginasthma.com (last accessed on 06 March 2013).",Non-OADS,/arxiv_data1/oa_pdf/77/d0/main.PMC4633918.pdf
6 (2013) 1 –10.http://dx.doi.org/10.2174/1875044301306010001 .,Non-OADS,/arxiv_data1/oa_pdf/77/d0/main.PMC4633918.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/5f/main.PMC4633919.pdf
http://dx.doi.org/10.1016/j.bbacli.2014.08.002 2214-6474/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/5f/main.PMC4633919.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/5f/main.PMC4633919.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/9d/5f/main.PMC4633919.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/d4/main.PMC4633920.pdf
http://dx.doi.org/10.1016/j.bbacli.2014.08.004 2214-6474/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/59/d4/main.PMC4633920.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/d4/main.PMC4633920.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/59/d4/main.PMC4633920.pdf
"November 2013 Jeffrey N. Keller Executive Editor Pennington Biomedical Research Center/Louisiana State University System, Baton Rouge, LA, USA E-mail address: Jeffrey.Keller@pbrc.edu .BBA Clinical 1 (2014) 1 2214-6474/$ –see front matter © 2013 Published by Elsevier B.V. http://dx.doi.org/10.1016/j.bbacli.2013.10.001 Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/",Non-OADS,/arxiv_data1/oa_pdf/a1/25/main.PMC4633923.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/19/nov049.PMC4633924.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/6b/main.PMC4633940.pdf
http://dx.doi.org/10.1016/j.bbacli.2014.05.0032214-6474/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/6b/main.PMC4633940.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/6b/main.PMC4633940.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/79/6b/main.PMC4633940.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/37/main.PMC4633941.pdf
http://dx.doi.org/10.1016/j.bbacli.2014.07.001 2214-6474/© 2014 Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/e9/37/main.PMC4633941.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/37/main.PMC4633941.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/e9/37/main.PMC4633941.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/88/main.PMC4633942.pdf
http://dx.doi.org/10.1016/j.bbacli.2014.09.006 2214-6474/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/88/main.PMC4633942.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/88/main.PMC4633942.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/67/88/main.PMC4633942.pdf
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/c4/main.PMC4633944.pdf
http://dx.doi.org/10.1016/j.bbacli.2014.09.003 2214-6474/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/c4/main.PMC4633944.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/c4/main.PMC4633944.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/f0/c4/main.PMC4633944.pdf
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/ff/main.PMC4633945.pdf
http://dx.doi.org/10.1016/j.bbacli.2014.06.0032214-6474/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/ff/main.PMC4633945.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/ff/main.PMC4633945.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/a1/ff/main.PMC4633945.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/04/main.PMC4633946.pdf
http://dx.doi.org/10.1016/j.bbacli.2013.12.0012214-6474/© 2013 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/04/main.PMC4633946.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/04/main.PMC4633946.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/d0/04/main.PMC4633946.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/a7/main.PMC4633947.pdf
http://dx.doi.org/10.1016/j.bbacli.2014.09.005 2214-6474/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/49/a7/main.PMC4633947.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/a7/main.PMC4633947.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/49/a7/main.PMC4633947.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/2c/main.PMC4633968.pdf
: +374 10650832. http://dx.doi.org/10.1016/j.bbacli.2014.05.0012214-6474/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/2c/main.PMC4633968.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/2c/main.PMC4633968.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/be/2c/main.PMC4633968.pdf
"Selection of SNPs for NGF and NGFR genes In total, ﬁve SNPs within the NGF and NGFR genes were selected based on either their functionality according to the National Center of Biotechnology Information (NCBI) databases [ http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/be/2c/main.PMC4633968.pdf
"The sequences of speci ﬁc primers were designed based on relevant DNA sequences available inthe NCBI GenBank database ( http://www.ncbi.nlm.nih.gov/genbank/ ; Gene IDs: 4803, 4804).",OADS,/arxiv_data1/oa_pdf/be/2c/main.PMC4633968.pdf
"11 (2012) 5, http://dx.doi.org/10.1186/1477-5751-11-5 .29 R .",Non-OADS,/arxiv_data1/oa_pdf/be/2c/main.PMC4633968.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/4d/main.PMC4633972.pdf
http://dx.doi.org/10.1016/j.bbacli.2014.10.001 2214-6474/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/4d/main.PMC4633972.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/4d/main.PMC4633972.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/ce/4d/main.PMC4633972.pdf
"proteomic data as raw ﬁles, total proteins and peptides identi ﬁed with relative intensities and search parameters were loaded on Peptide Atlas repository (accession number http://www.peptideatlas.org/ PASS/PASS00383) .",OADS,/arxiv_data1/oa_pdf/ce/4d/main.PMC4633972.pdf
Bioinformatics and statistical analysis Biological Networks Gene Ontology (BiNGO) program package (v 2.44) [25]with the Cytoscape plugin (v 2.8.0) were used to ﬁnd statis- tically over-represented Gene Ontology (GO) categories [26].K y o t oE n c y - clopedia of Genes and Genomes (KEGG) pathway analysis was performed with the KEGG pathway mapper tool ( http://www.genome.jp/kegg/tool/ map_pathway2.html ) using the Uniprot ID of the modulated proteins.,OADS,/arxiv_data1/oa_pdf/ce/4d/main.PMC4633972.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/6f/main.PMC4633973.pdf
http://dx.doi.org/10.1016/j.bbacli.2014.09.002 2214-6474/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/83/6f/main.PMC4633973.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/6f/main.PMC4633973.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/83/6f/main.PMC4633973.pdf
"Available at: http://www.asahq.org/Home/For-Members/Clinical-Informa- tion/ASA-Physical-Status-Classi ﬁcation-System Accessed on Dec 12, 2012.",Non-OADS,/arxiv_data1/oa_pdf/83/6f/main.PMC4633973.pdf
"(Available at: http://www.horizonscanning.gov.au/internet/horizon/ publishing.nsf/Content/58685F8B48CC9EE7CA2575AD0080F340/$File/HSR%20-% 20USCOM%20Final.pdf Accessed on Nov 26, 2010).",Non-OADS,/arxiv_data1/oa_pdf/83/6f/main.PMC4633973.pdf
"[29] OECD: Obesity Update 2012, Available at: http://www.oecd.org/health/49716427.",Non-OADS,/arxiv_data1/oa_pdf/83/6f/main.PMC4633973.pdf
"2013 Revision 005, Available at: http://www.uscom.com.au/dist/train/educa- tion/The_USCOM_and_Haemodynamics.pdf (Accessed on Sep 12, 2013).",Non-OADS,/arxiv_data1/oa_pdf/83/6f/main.PMC4633973.pdf
"[38] The United Nations Department of Economic and Social Affairs (UN DESA), Population Division, released World Population Prospects, 2010 Revision, Available at: http://esa.un.org/unpd/wpp/Documentation/pdf/WPP2010_ Highlights.pdf (Accessed on Jan 4, 2013).55 C.P.",Non-OADS,/arxiv_data1/oa_pdf/83/6f/main.PMC4633973.pdf
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/a0/main.PMC4633975.pdf
http://dx.doi.org/10.1016/j.bbacli.2014.09.004 2214-6474/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/59/a0/main.PMC4633975.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/a0/main.PMC4633975.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/59/a0/main.PMC4633975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f9/26/main.PMC4633976.pdf
http://dx.doi.org/10.1016/j.bbacli.2014.08.003 2214-6474/© 2014 Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/f9/26/main.PMC4633976.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f9/26/main.PMC4633976.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/f9/26/main.PMC4633976.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/ee/main.PMC4633978.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 10 (2015) 5 e8 http://dx.doi.org/10.1016/j.radcr.2015.06.001 1930-0433/Copyright ©2015, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/89/ee/main.PMC4633978.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/ee/main.PMC4633978.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/6e/main.PMC4633979.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 10 (2015) 9 e11 http://dx.doi.org/10.1016/j.radcr.2015.06.003 1930-0433/Copyright ©2015, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/18/6e/main.PMC4633979.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/6e/main.PMC4633979.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e6/5e/main.PMC4633980.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 10 (2015) 18 e21 http://dx.doi.org/10.1016/j.radcr.2015.06.005 1930-0433/Copyright ©2015, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/e6/5e/main.PMC4633980.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e6/5e/main.PMC4633980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/1c/main.PMC4633981.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 10 (2015) 22 e26 http://dx.doi.org/10.1016/j.radcr.2015.06.011 1930-0433/Copyright ©2015, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/8c/1c/main.PMC4633981.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/1c/main.PMC4633981.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/8f/main.PMC4633982.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 10 (2015) 1 e4 http://dx.doi.org/10.1016/j.radcr.2015.06.007 1930-0433/Copyright ©2015, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/52/8f/main.PMC4633982.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/8f/main.PMC4633982.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/52/main.PMC4633983.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 10 (2015) 12 e17 http://dx.doi.org/10.1016/j.radcr.2015.05.001 1930-0433/Copyright ©2015, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/9b/52/main.PMC4633983.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/52/main.PMC4633983.pdf
Available at: https://www.aan.,Non-OADS,/arxiv_data1/oa_pdf/bf/f9/NEURCLINPRACT2015009621.PMC4634157.pdf
com/Guidelines/ and https://www.aan.com/practice/quality-measures/.,Non-OADS,/arxiv_data1/oa_pdf/bf/f9/NEURCLINPRACT2015009621.PMC4634157.pdf
Available at: http://www.commondataelements.ninds.nih.gov/.,OADS,/arxiv_data1/oa_pdf/bf/f9/NEURCLINPRACT2015009621.PMC4634157.pdf
Available at: http://www.heart.org/ HEARTORG/HealthcareResearch/GetWithTheGuidelines/Get-With-The-Guidelines-Stroke_UCM_ 306098_SubHomePage.jsp.,Non-OADS,/arxiv_data1/oa_pdf/bf/f9/NEURCLINPRACT2015009621.PMC4634157.pdf
Available at: https://www.aan.,Non-OADS,/arxiv_data1/oa_pdf/bf/f9/NEURCLINPRACT2015009621.PMC4634157.pdf
Available at: https://www.aan.com/practice/axon- registry/.,Non-OADS,/arxiv_data1/oa_pdf/bf/f9/NEURCLINPRACT2015009621.PMC4634157.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/17/main.PMC4634195.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.07.024 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/77/17/main.PMC4634195.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/17/main.PMC4634195.pdf
"Persons Living with an HIV or AIDS Diagnosis, 2010. http://aidsvu.org (accessed 12/5/2014 2014).",Non-OADS,/arxiv_data1/oa_pdf/77/17/main.PMC4634195.pdf
"http://transborder.bts.gov/programs/international/transborder/TBDR_ BC/TBDR_BCQ.html (accessed November 5, 2013 2013).",OADS,/arxiv_data1/oa_pdf/77/17/main.PMC4634195.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/2a/main.PMC4634198.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.07.034 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/2a/main.PMC4634198.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/2a/main.PMC4634198.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/d6/main.PMC4634200.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.08.014 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/d6/main.PMC4634200.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/d6/main.PMC4634200.pdf
"Rep. 3, 3209. http://dx.doi.org/10.1038/srep03209 .",Non-OADS,/arxiv_data1/oa_pdf/c9/d6/main.PMC4634200.pdf
http://dx.doi.org/10.1364/ OE.18.012960 .,Non-OADS,/arxiv_data1/oa_pdf/c9/d6/main.PMC4634200.pdf
http://dx.doi.org/10.1364/OPEX.13.006296 .,Non-OADS,/arxiv_data1/oa_pdf/c9/d6/main.PMC4634200.pdf
"Express 18, 16890. http://dx.doi.org/10.1364/OE.",Non-OADS,/arxiv_data1/oa_pdf/c9/d6/main.PMC4634200.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/7c/main.PMC4634201.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.07.040 2352-3964/Crown Copyright © 2015 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/e4/7c/main.PMC4634201.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/7c/main.PMC4634201.pdf
Cre ated using  Servier Medical Art by Servier which is licensed under a Creative Commons Attribution 3.0 Unported License http://www.servier.c om/  slidekit.,Non-OADS,/arxiv_data1/oa_pdf/33/d8/MRMC-16-19.PMC4634222.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/7b/main.PMC4634318.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.08.041 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/7b/main.PMC4634318.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/7b/main.PMC4634318.pdf
"Notes 2, 221. http://dx.doi.org/ 10.1186/1756 –0500 –2–221(2009).",Non-OADS,/arxiv_data1/oa_pdf/e8/7b/main.PMC4634318.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/a1/main.PMC4634351.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 10 (2015) 27 e29 http://dx.doi.org/10.1016/j.radcr.2015.06.006 1930-0433/Copyright ©2015, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/f7/a1/main.PMC4634351.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/a1/main.PMC4634351.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/17/main.PMC4634352.pdf
http://dx.doi.org/10.1016/j.mgene.2015.09.002 2214-5400/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/49/17/main.PMC4634352.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/17/main.PMC4634352.pdf
"Statistical analysis POPGENE ( http://www.ualberta.ca/fyeh/ ) version 1.32 was used to calculate genotypic and allelic frequencies of each variation and Hardy Weinberg Equilibrium (HWE) was also tested by calculating Chi2 (Tables 3, 4 and 5 ).",OADS,/arxiv_data1/oa_pdf/49/17/main.PMC4634352.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/0c/main.PMC4634353.pdf
http://dx.doi.org/10.1016/j.mgene.2015.08.008 2214-5400/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/0c/main.PMC4634353.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/0c/main.PMC4634353.pdf
"ncbi.nlm.nih.gov/pubmed ), Google Scholar ( http://scholar.google.com), and Springer Link ( http://link.springer.com ) databases using the keywords “breast cancer ”,“C677T ”,“methylenetetrahydrofolate reduc- tase ”and “MTHFR ”published up to March 31, 2015.",Non-OADS,/arxiv_data1/oa_pdf/bd/0c/main.PMC4634353.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/2b/main.PMC4634354.pdf
http://dx.doi.org/10.1016/j.mgene.2015.09.005 2214-5400/© 2015 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/3d/2b/main.PMC4634354.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/2b/main.PMC4634354.pdf
http://dx.doi.org/10.1002/cncr.27455 (Oct 1).,OADS,/arxiv_data1/oa_pdf/3d/2b/main.PMC4634354.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/ed/main.PMC4634355.pdf
http://dx.doi.org/10.1016/j.mgene.2015.09.004 2214-5400/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/ed/main.PMC4634355.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/ed/main.PMC4634355.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/e8/main.PMC4634356.pdf
http://dx.doi.org/10.1016/j.mgene.2015.09.003 2214-5400/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/df/e8/main.PMC4634356.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/e8/main.PMC4634356.pdf
"All the initial data, from which we extracted this novel analysis, were deposited in NCBI's Gene Expression Omnibus ( Edgar et al., 2002 ) with the GEO series accession number GSE15582 ( http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc= GSE15582 ).",OADS,/arxiv_data1/oa_pdf/df/e8/main.PMC4634356.pdf
Functional and cellular localization annotations were evaluated by using the DAVID NIAID/NIH online annotation tool ( http://david.niaid.,OADS,/arxiv_data1/oa_pdf/df/e8/main.PMC4634356.pdf
pantherdb.org /) and the KEGG database ( http://www.genome.jp/ kegg/ ).,OADS,/arxiv_data1/oa_pdf/df/e8/main.PMC4634356.pdf
Chromosomal enrichment Chromosomal enrichment was performed using the DAVID NIAID/ NIH online annotation tool ( http://david.niaid.nih.gov/david/ ) for chro- mosome localization.,OADS,/arxiv_data1/oa_pdf/df/e8/main.PMC4634356.pdf
"Chromosomal loci for insulin dependent diabetes identi ﬁed by genetic analysis in mouse ( Idd), in rat ( Iddm ) and in human ( IDDM ) were retrieved by search of the literature and from the T1D Database (http://www.t1dbase.org /) (Burren et al., 2011 ).",OADS,/arxiv_data1/oa_pdf/df/e8/main.PMC4634356.pdf
"SNPs identi ﬁcation We searched for SNPs, their genomic positions and associated genes when applied, between the NOD/ ShiLtJ strain and strains C57Bl/6, C3H, DBA/2, SJL and NON in the public data made available in the Mouse Ge- nome Informatics web site ( Blake et al., 2014 )(http://www.informatics.",OADS,/arxiv_data1/oa_pdf/df/e8/main.PMC4634356.pdf
"Indeed several QTLs were identi- ﬁed within or nearby the loci de ﬁned by the E-IAA genes (Table S3) (http://www.t1dbase.org /), (Burren et al., 2011 ).",OADS,/arxiv_data1/oa_pdf/df/e8/main.PMC4634356.pdf
"Data are retrieved from MGI bioinformaticsand see Table S3 ( http://www.informatics.jax.org/strains_SNPs.shtml ).100 B. Regnault, E. Melanitou / Meta Gene 6 (2015) 96 –104",OADS,/arxiv_data1/oa_pdf/df/e8/main.PMC4634356.pdf
"Br J Anaesth 111 (1), 52 –58.EBioMedicine 2 (2015) 1280 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.08.001 .",OADS,/arxiv_data1/oa_pdf/dc/33/main.PMC4634357.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.08.038 2352-3964/© 2015 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/dc/33/main.PMC4634357.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/33/main.PMC4634357.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/71/main.PMC4634358.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.08.036 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/71/main.PMC4634358.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/71/main.PMC4634358.pdf
Local institutional ethics committee approved the study andparticipants gave their written informed consent according to the ethical declaration of Helsinki ( http://www.wma.net/en/30publications ).,Non-OADS,/arxiv_data1/oa_pdf/74/71/main.PMC4634358.pdf
http://dx.doi.org/10.1038/mp.2015.48 (Epub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/74/71/main.PMC4634358.pdf
"This initiative aims to have 90% of people living with HIV diagnosed, 90% of diagnosed people receiving antiretroviral therapy (ART) and 90% of people receiving ART under viral suppression by 2020 ( http://www.unaids.org/sites/default/ ﬁles/media_asset/90-90- 90_en_0.pdf, n.d. ).",Non-OADS,/arxiv_data1/oa_pdf/bd/67/main.PMC4634359.pdf
"In Mexico, a middle-income country with a strong ART programme, it is estimated that more than half of HIV-infected individuals are unaware of their serologic status ( http://www.censida.salud.gob.mx/descargas/ 2009/VIHSIDAenMexico2009.pdf, n.d. ).",Non-OADS,/arxiv_data1/oa_pdf/bd/67/main.PMC4634359.pdf
"Moreover, albeit with considerable overlap in both directions, a shift in viral migration from Tijuana to San Diego was observed comparing 2014 to the 1990s, when theEBioMedicine 2 (2015) 1296 –1297 DOI of original article: http://dx.doi.org//10.1016/j.ebiom.2015.07.024 ⁎Corresponding authors.",Non-OADS,/arxiv_data1/oa_pdf/bd/67/main.PMC4634359.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.08.039 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/67/main.PMC4634359.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/67/main.PMC4634359.pdf
El VIH/SIDA en México 2009. http://www.censida.salud.gob.mx/descargas/ 2009/VIHSIDAenMexico2009.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bd/67/main.PMC4634359.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/ce/main.PMC4634360.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.08.0262352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/94/ce/main.PMC4634360.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/ce/main.PMC4634360.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/9f/ddv380.PMC4634377.pdf
The GO enrichments were calculated in the DAVID website (http://david.abcc.ncifcrf.gov/) and in the Bingo tools for Cytos-cape (http://apps.cytoscape.org/apps/bingo) and by performinga standard hypergeometric test on the Mus musculus GO annota- tions (updated to version 22/02/2015).,OADS,/arxiv_data1/oa_pdf/fe/9f/ddv380.PMC4634377.pdf
Funding This work was supported by the EU funded project ‘Genetic and Epigenetic Networks in Cognitive Dysfunction ’(GENCODYS) con- sortium (http://www.gencodys.eu/) (FP7-COLLABORATION PRO- JECT-2009-2.1.1 ‐1/241995 to A.S. and Y.H.,Non-OADS,/arxiv_data1/oa_pdf/fe/9f/ddv380.PMC4634377.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/08/ddv382.PMC4634379.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/d5/ddv386.PMC4634381.pdf
The quanti ﬁcation of ABCA4 bands detected by Western blot was performed using ImageJ software (free download available athttp://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/19/d5/ddv386.PMC4634381.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f3/77/main.PMC4634618.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.08.034 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/77/main.PMC4634618.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f3/77/main.PMC4634618.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/74/main.PMC4634619.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.08.021 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/74/main.PMC4634619.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/74/main.PMC4634619.pdf
http://dx.doi.org/10.4161/ 2162402X.2014.985924 .,Non-OADS,/arxiv_data1/oa_pdf/d0/74/main.PMC4634619.pdf
Oncoimmunology 3. http://dx.doi.org/10.4161/ 21624011.2014.948705 .,Non-OADS,/arxiv_data1/oa_pdf/d0/74/main.PMC4634619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.001 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1146/annurev-immunol-030409-101256 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.2174/ 157016207782418533 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1016/j.cell.2014.01.052 .,OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1089/vim.2010.0108 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1371/journal.ppat.1002890.s004 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/ 10.1002/eji.201344305 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1038/nature06106 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/ 10.1038/nm.1974 .,OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
"Immunology 142, 46 –57.http://dx.doi.org/10.1111/imm.12232 .",Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1128/JVI.00313-11 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1128/JVI.00326-11 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1016/j.cell.2014.08.023 .,OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
"http://dx.doi.org/10.1086/425,582 .",OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1089/vim.2011.0025 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1111/ imm.12016 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1371/journal.pone.0074855 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1097/QAI.0b013e31822c62b9 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.10 16/j.chom.2015.03.002 .,OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1371/journal.ppat.1002739.s004 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.4049/ jimmunol.177.6.4028 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.4049/jimmunol.,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1128/JVI.00410-10 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
"Nature 482, 89 –93.http://dx.doi.org/10.1038/nature10766 .",Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.4049/jimmunol.178.10.6596 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1056/NEJMoa1113425 .,OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
"2012, 637208. http://dx.doi.org/10.1155/2012/637,208 .",Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.4049/jimmunol.0900419 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1128/JVI.75.22.11096-11105.2001 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/ 10.1128/JVI.02194-14 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10 .1128/JVI.00171-11 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1128/JVI.01023-12 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1097/QAD.,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1128/JVI.01149-09 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
"35, 77 –81.http://dx.doi.org/10.1086/340862 .",Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1097/QAI.,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/ 10.1016/j.jim.2007.09.017 .,OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1126/science.1207227 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1126/science.1207532 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1126/science.1233989 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/ 10.1128/JVI.75.24.12161-12168.2001 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
"Methods 384, 51 –61.http://dx.doi.org/10.1016/j.jim.2012.",OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/ 10.1126/science.1205669 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1089/08892220151126661 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.4049/ jimmunol.0803115 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1128/JVI.77.1.642-658.2003 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1126/science.1187659 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
"http://dx.doi.org/10.1371/journal.pone.0072054 .Thali, M., Moore, J.P., Furman, C., Charles, M., Ho, D.D., Robinson, J., et al., 1993.",Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1126/science.1178746 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1371/journal.ppat.1000433 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1128/JVI.01687-09 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1016/j.str.2004.01.003 .,OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1146/annurev-immunol-032712-095916 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1128/JVI.80.5.2515-2528.2006 .,OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1128/JVI.01145-13 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1128/JVI.03048-13 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1128/JVI.77.1.353-365.2003 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1126/ science.1070441 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1038/nature01188 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1128/JVI.01232-15 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1371/journal.ppat.1004772 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
http://dx.doi.org/10.1038/nature10373 .,Non-OADS,/arxiv_data1/oa_pdf/2d/44/main.PMC4634620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/33/main.PMC4634621.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.08.018 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/33/main.PMC4634621.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/33/main.PMC4634621.pdf
"Drugbank, k. Cysteamine http://www.drugbank.ca/drugs/DB00847 (accessed July 2015).",Non-OADS,/arxiv_data1/oa_pdf/f7/33/main.PMC4634621.pdf
Annual data report 2013. http://www.cystic ﬁbrosis.org.uk/media/ 598466/annual-data-report-2013-jul14.pdf (accessed June 2015).,OADS,/arxiv_data1/oa_pdf/f7/33/main.PMC4634621.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/9e/main.PMC4634622.pdf
"Among them,186 MERS-CoV infection cases, including 36 deaths, had been reported by the Republic of Korea ( http://www.who .int/csr/don/12-august-2015- mers-saudi-arabia/en/ ).",Non-OADS,/arxiv_data1/oa_pdf/b0/9e/main.PMC4634622.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.08.0312352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/9e/main.PMC4634622.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/9e/main.PMC4634622.pdf
http://dx.doi.org/10.1038/cmi.,Non-OADS,/arxiv_data1/oa_pdf/b0/9e/main.PMC4634622.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/53/main.PMC4634623.pdf
http://dx.doi.org/10.1038/sj.bjc.6604509 .,Non-OADS,/arxiv_data1/oa_pdf/07/53/main.PMC4634623.pdf
http://dx.doi.org/10.1038/ nrg2843 .,Non-OADS,/arxiv_data1/oa_pdf/07/53/main.PMC4634623.pdf
"Mitchell, P.S., Parkin, R.K., Kroh, E.M., Fritz, B.R., Wyman, S.K., Pogosova-Agadjanyan, E.L., Peterson, A., Noteboom, J., O'Briant, K.C., Allen, A., Lin, D.W., Urban, N., Drescher, C.W.,EBioMedicine 2 (2015) 1278 –1279 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.07.034 .",Non-OADS,/arxiv_data1/oa_pdf/07/53/main.PMC4634623.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.08.0322352-3964/© 2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/07/53/main.PMC4634623.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/53/main.PMC4634623.pdf
http://dx.doi.org/10.1073/ pnas.0804549105 (0804549105 [pii]).,OADS,/arxiv_data1/oa_pdf/07/53/main.PMC4634623.pdf
http://dx.doi.org/10.1093/jnci/djv063 .,OADS,/arxiv_data1/oa_pdf/07/53/main.PMC4634623.pdf
http://dx.doi.org/10.1038/ 469156a .,Non-OADS,/arxiv_data1/oa_pdf/07/53/main.PMC4634623.pdf
http://dx.doi.org/10.1200/JCO.2013.50.4357 .,Non-OADS,/arxiv_data1/oa_pdf/07/53/main.PMC4634623.pdf
http://dx.doi.org/10.1371/ journal.pone.0125026.1279 F. Bianchi / EBioMedicine 2 (2015) 1278 –1279,Non-OADS,/arxiv_data1/oa_pdf/07/53/main.PMC4634623.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/19/main.PMC4634630.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.08.017 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/19/main.PMC4634630.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/19/main.PMC4634630.pdf
"ECDC, Stockholm ( http://ecdc.europa.",Non-OADS,/arxiv_data1/oa_pdf/ef/19/main.PMC4634630.pdf
"Co llege voor Zorgverzekeringen, Diemen (Dutch http://www.zorginstituutnederland.nl/binaries/content/documents/ zinl-www/documenten/publicaties/overige-publicaties/1007-handleiding- voor-kostenonderzoek/Handlei ding+voor+kostenonderzoek.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/ef/19/main.PMC4634630.pdf
"Alternatively, functional compensation for structural damage is a possi- ble explanation (as much as other explanations may be plausible as well, such as compensation for aberrant neural transmission), yet this possibility has not been addressed so far in a theoretically convincingEBioMedicine 2 (2015) 1288 –1289 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.08.002 .",Non-OADS,/arxiv_data1/oa_pdf/41/fb/main.PMC4634675.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.10.005 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/41/fb/main.PMC4634675.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/fb/main.PMC4634675.pdf
"6, 27. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/41/fb/main.PMC4634675.pdf
"40, 140246. http://dx.doi.org/10.1503/jpn.140246 .1289 R.C.",Non-OADS,/arxiv_data1/oa_pdf/41/fb/main.PMC4634675.pdf
The best type of therapy wouldEBioMedicine 2 (2015) 1272 –1273 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.09.002 .,Non-OADS,/arxiv_data1/oa_pdf/db/fa/main.PMC4634676.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.020 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/db/fa/main.PMC4634676.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/fa/main.PMC4634676.pdf
"As genetic ﬁndings are translated into intervention, genetic research focused solely on European populations threatens to widen the existing http://dx.doi.org/10.1016/j.ebiom.2015.10.002 2352-3964/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dc/e0/main.PMC4634677.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/e0/main.PMC4634677.pdf
"For example, the Drakenstein Child Health Study ( http://www.paediatrics.uct.ac.za/ scah/dclhs ) is a multidisciplinary South African birth cohort study in- vestigating genetic and environmental risk factors for common mental disorders.",Non-OADS,/arxiv_data1/oa_pdf/dc/e0/main.PMC4634677.pdf
The post-traumatic stress disorder (PTSD) subgroup of the multi-national Psychiatric Genomics Consortium (PGC) ( http://www.med.unc.edu/ pgc) aims to carry out large-scale GWASs and has included South African samples in their analyses.,Non-OADS,/arxiv_data1/oa_pdf/dc/e0/main.PMC4634677.pdf
"The Enhancing Neuro Imaging Genetics through Meta-Analysis (ENIGMA) Network (http://enigma.ini.usc.edu/about-2/ ), a consortium investigating brain structure, function and disease using brain imaging and genomics, has also included samples from South Africa.",Non-OADS,/arxiv_data1/oa_pdf/dc/e0/main.PMC4634677.pdf
"Lastly, the Human Heredity and Health in Africa (H3Africa) (http://h3africa.org /) initiative seeks to improve health in African populations by investigating genomic and environmental factors contributing to common disease.",Non-OADS,/arxiv_data1/oa_pdf/dc/e0/main.PMC4634677.pdf
"(b) Proportion investigated in PGC-PTSD studies (total N = 20,468).World population data from http://en.wikipedia.org/w/index.php?title=World_ population&oldid=648649676 .1260 S. Dalvie et al.",OADS,/arxiv_data1/oa_pdf/dc/e0/main.PMC4634677.pdf
"Finally, the key messages to take into account are: 1) humoral immunity has a major role in healing DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.09.005 .",Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC4634678.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.039 2352-3964/© 2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC4634678.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/main.PMC4634678.pdf
"There might not be a unitary in ﬂuence of GABA-ergic dysfunction on all cognitive domains with the same impact, but with differingEBioMedicine 2 (2015) 1290 –1291 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.08.036 .",Non-OADS,/arxiv_data1/oa_pdf/2c/7b/main.PMC4634689.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.013 2352-3964/© 2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/2c/7b/main.PMC4634689.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/7b/main.PMC4634689.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.005 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1371/ journal.pone.0054375 .,Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1016/j.vaccine.2007.04.086 .,OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1111/bju.12244 .,Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1093/infdis/ 174.5.927 .,Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1093/infdis/jiq116 .,OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1001/jama.2014.12274 .,Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1016/j.ejogrb.,OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1016/j.chom.2010.08.003 .,OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1016/j.ejca.2009.07.019 .,OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1097/OLQ.0b013e31820bc880 .,Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1371/journal.pone.0061825 .,Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1111/ andr.284.,Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
"Vaccine 30 (Suppl 5), F12 –F23.http://dx.doi.org/10.1016/j.vaccine.2012.07.055 .",Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
"100 (1), 20 –29.http://dx.doi.org/10.1016/j.jri.2013.03.004 .",OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1093/ humrep/des009 .,Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1097/GCO.,Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1006/exmp.,OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
"2), 15 –19.http://dx.doi.org/10.1016/j.ygyno.2010.",OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
"2014, 956901. http://dx.doi.org/10.1155/2014/956901 .",Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1128/CVI.,Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/ 10.1007/s00345-012-0997-8 .,Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1093/humrep/det453 .,OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1016/ S1473-3099(12)70187-1 .,OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
"6, 95. http://dx.doi.org/10.1186/1471-2334-6-95 .",Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1086/604729 .,Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/ 10.1016/j.fertnstert.2003.08.020 .,OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1086/314934 .,Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1016/S0140-6736(09)61248-4 .,OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
"3), 11–25.http://dx.doi.org/10.1016/j.vaccine.2006.05.111 .",OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
"doi: http://dx.doi.org/10.5306/wjco.v5.i5.1002 Rositch, A.F., Poole, C., Hudgens, M.G., Agot, K., Nyagaya, E., Moses, S., et al., 2012.",OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
"205 (1),72–81.http://dx.doi.org/10.1093/infdis/jir709 .",Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1016/S0140- 6736(07)61416-0 .,OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
"Agents Cancer 4, 8. http://dx.doi.org/10.1186/1750-9378-4-8 .",Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1016/j.vaccine.2005.09.002 .,OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1016/j.vaccine.2012.,OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1016/S0140-6736(14)61261-7 .,OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1093/cid/cir1036 .,OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1016/j.canlet.2014.,OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1016/S1473-3099(10)70190-0 .,OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.1001/jamaoto.2013.5460 .,Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
"Cancer 7 (1), 11 –22.http://dx.doi.org/10.1038/ nrc2050 .",Non-OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
http://dx.doi.org/10.4161/hv.27619 .1493 C. Foresta et al.,OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC4634690.pdf
(c) The use of suitable phantoms to establish the technical re- quirements for applying the methodology to larger diameter objects (ultimately the adult torso –although the breast and peripheral limb would be a very good start) to address ques- tions such as (i) what is the role of x-ray photon energy andEBioMedicine 2 (2015) 1304 –1305 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.08.014 .,Non-OADS,/arxiv_data1/oa_pdf/f1/7b/main.PMC4634695.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.008 2352-3964/© 2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/f1/7b/main.PMC4634695.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/7b/main.PMC4634695.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non- Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ) which permits unrestricted, non-commercial use, distribution  and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/8e/nihms-718349.PMC4634705.pdf
"As such, the cell line models described in this manuscript substantially augment the current toolbox of patient derived xenograft models and existing GSC lines ( SarkariaEBioMedicine 2 (2015) 1274 –1275 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.08.026 .",Non-OADS,/arxiv_data1/oa_pdf/46/b5/main.PMC4634746.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.033 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/b5/main.PMC4634746.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/b5/main.PMC4634746.pdf
"With the introduction of new drug combinations and regimens, and patients with potentially more complex resistance pro ﬁles, it is imperative to understand SNPs and genotypic information, and their correlation with phenotypic resistance, in order to allow for the imple- mentation of correct, personalized therapies in a rapid, individual http://dx.doi.org/10.1016/j.ebiom.2015.10.008 2352-3964/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/14/78/main.PMC4634747.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/78/main.PMC4634747.pdf
(Mar 16) http://dx.doi.org/10.1111/cbdd.12549 .,Non-OADS,/arxiv_data1/oa_pdf/14/78/main.PMC4634747.pdf
"As we know, most patients with PSC have a colitis, which is classi ﬁed as UC ( Navaneethan and Shen, 2010; Loftus et al., 2005; Navaneethan, DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.08.041 .",Non-OADS,/arxiv_data1/oa_pdf/bb/b7/main.PMC4634748.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.046 2352-3964/© 2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/bb/b7/main.PMC4634748.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/b7/main.PMC4634748.pdf
"This may be especially true for RANKL, where previous studies reported elevated levels of RANKL in the cells of the bone microenvironment in postmenopausal women, and while this increase was reversedin women receiving hormone replacement therapy in bone cells, no changes in serum RANKL were observed between the groups (Eghbali-Fatourechi et al., 2003 ).EBioMedicine 2 (2015) 1270 –1271 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.08.037 .",Non-OADS,/arxiv_data1/oa_pdf/07/2b/main.PMC4634749.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.035 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/07/2b/main.PMC4634749.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/2b/main.PMC4634749.pdf
"Especially, the comparison between elderly with burns http://dx.doi.org/10.1016/j.ebiom.2015.09.009 2352-3964/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/5f/c2/main.PMC4634750.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/c2/main.PMC4634750.pdf
It will be very interesting to determine if transplantations of non-mutant mammary epithelium and/or Müllerian derivatives into mice carryingEBioMedicine 2 (2015) 1268 –1269 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.08.034 .,Non-OADS,/arxiv_data1/oa_pdf/65/14/main.PMC4634751.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.017 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/14/main.PMC4634751.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/14/main.PMC4634751.pdf
"5, 208ra145.DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.08.021 .",OADS,/arxiv_data1/oa_pdf/04/2b/main.PMC4634752.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.028 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/2b/main.PMC4634752.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/2b/main.PMC4634752.pdf
"This study suggested the allele rs12075 *G, which is linked to lower serum levels of CCL2/MCP-1, as a genetic risk factor for prosthesis failure (especially AL).EBioMedicine 2 (2015) 1266 –1267 http://dx.doi.org/10.1016/j.ebiom.2015.10.006 2352-3964/© 2015 The Author.",Non-OADS,/arxiv_data1/oa_pdf/63/4f/main.PMC4634769.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/63/4f/main.PMC4634769.pdf
"This implies that recognition is not the main reason why alcohol dependence is having a low treatment r a t e .O n ep r o b l e mh e r es e e m st ob et h a tm o s tc o u n t r i e ss e en or o l ef o r treatment at the primary health care level; the leading paradigm recom- mends screening, brief advice/interventions for alcohol problems and re- ferral to specialized treatment for alcohol dependence ( Babor et al., 2007 ; http://pathways.nice.org.uk/pathways/alcohol-usedisorders/brief- interventions-for-alcohol-use-disorders ).",Non-OADS,/arxiv_data1/oa_pdf/a2/3a/main.PMC4634770.pdf
"Euro Psych (in press).EBioMedicine 2 (2015) 1283 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.09.023 , http://dx.doi.org/10.1016/j.ebiom.2015.08.040 .",Non-OADS,/arxiv_data1/oa_pdf/a2/3a/main.PMC4634770.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.0322352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/3a/main.PMC4634770.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/3a/main.PMC4634770.pdf
"9, 189. http://dx.doi.org/10.1186/s13023-014-0189-2 .",Non-OADS,/arxiv_data1/oa_pdf/31/ee/main.PMC4634771.pdf
"Autophagy 10, 2053 –2074.EBioMedicine 2 (2015) 1306 –1307 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.08.018 .",Non-OADS,/arxiv_data1/oa_pdf/31/ee/main.PMC4634771.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.0382352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/31/ee/main.PMC4634771.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/ee/main.PMC4634771.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.015 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/8d/main.PMC4634772.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c2/8d/main.PMC4634772.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c2/8d/main.PMC4634772.pdf
http://dx.doi.org/10.1093/gerona/ glt153 .,OADS,/arxiv_data1/oa_pdf/c2/8d/main.PMC4634772.pdf
http://dx.doi.org/10.1093/ije/dyt267 .,OADS,/arxiv_data1/oa_pdf/c2/8d/main.PMC4634772.pdf
http://dx.doi.org/10.1016/j.devcel.,OADS,/arxiv_data1/oa_pdf/c2/8d/main.PMC4634772.pdf
"1), S4 –S9.http://dx.doi.org/10.1093/gerona/glu057 .",OADS,/arxiv_data1/oa_pdf/c2/8d/main.PMC4634772.pdf
http://dx.doi.org/10.1111/j.1532-5415.2011.,Non-OADS,/arxiv_data1/oa_pdf/c2/8d/main.PMC4634772.pdf
http://dx.doi.org/10.1093/gerona/ glt023 .,OADS,/arxiv_data1/oa_pdf/c2/8d/main.PMC4634772.pdf
Aging Cell http://dx.doi.org/10.1111/acel.12344 (Mar 9).1317 R. Giacconi et al.,OADS,/arxiv_data1/oa_pdf/c2/8d/main.PMC4634772.pdf
This ﬁnding is similar to a pre- vious systematic review of the association between all alcohol use disor- ders and mortality which found that mortality risk was 3 times higher in men and over 4 times higher in women with alcohol use disordersEBioMedicine 2 (2015) 1281 –1282 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.08.040 .,Non-OADS,/arxiv_data1/oa_pdf/e2/0e/main.PMC4634782.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.023 2352-3964/© 2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/e2/0e/main.PMC4634782.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/0e/main.PMC4634782.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/73/main.PMC4634783.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.003 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/73/main.PMC4634783.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/73/main.PMC4634783.pdf
"Therefore, testing the efﬁcacy of any vaccine in aged and immune compromised populations DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.08.031 .",Non-OADS,/arxiv_data1/oa_pdf/cf/61/main.PMC4634784.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.037 2352-3964/© 2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/cf/61/main.PMC4634784.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/61/main.PMC4634784.pdf
"http://dx.doi.org/10.1128/JVI.06048-11 .van Doremalen, N., Munster, V.J., 2015.",Non-OADS,/arxiv_data1/oa_pdf/cf/61/main.PMC4634784.pdf
"122, 28 –38.http://dx.doi.org/10.1016/j.antiviral.",OADS,/arxiv_data1/oa_pdf/cf/61/main.PMC4634784.pdf
http://dx.doi.org/10.1371/journal.ppat.,Non-OADS,/arxiv_data1/oa_pdf/cf/61/main.PMC4634784.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cf/61/main.PMC4634784.pdf
http://dx.doi.org/ 10.1128/JVI.03445-14 .,Non-OADS,/arxiv_data1/oa_pdf/cf/61/main.PMC4634784.pdf
http://dx.doi.org/10.1016/j.vaccine.2005.08.055 .,OADS,/arxiv_data1/oa_pdf/cf/61/main.PMC4634784.pdf
http://dx.doi.org/10.1371/journal.pone.0037019 .,Non-OADS,/arxiv_data1/oa_pdf/cf/61/main.PMC4634784.pdf
http://www.who.int/csr/don/17-september-2015-mers-saudi-arabia/en/ .,Non-OADS,/arxiv_data1/oa_pdf/cf/61/main.PMC4634784.pdf
http://dx.doi.org/10.1016/S0140-6736(15)60454-8 .1293 V.D.,OADS,/arxiv_data1/oa_pdf/cf/61/main.PMC4634784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/6f/main.PMC4634820.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.004 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/6f/main.PMC4634820.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/6f/main.PMC4634820.pdf
"Nevertheless, Nabavi and associates' study leaves both researchers and clinicians with a very clear take-home message –that the very com- mon occurrence of anxiety disorders in people with bipolar disorder contributes in an important fashion to challenges faced by those striving to accurately assess neurobiology and diagnosis and to provide effective treatment for individuals struggling with both conditions.EBioMedicine 2 (2015) 1284 –1285 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.09.006 .",Non-OADS,/arxiv_data1/oa_pdf/46/55/main.PMC4634821.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.022 2352-3964/© 2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/46/55/main.PMC4634821.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/55/main.PMC4634821.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fa/e1/dddt-9-5793.PMC4634822.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 5793–5803Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5793Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S6992 6Empagliflozin in the treatment of type 2 diabetes:  evidence to date Jay H Shubrook1 Babak Baradar Bokaie2 Sarah E Adkins3 1Primary Care Department, Clinical  Research and Diabetes Services,   Touro University College of  Osteopathic Medicine, vallejo, CA,   USA; 2The Diabetes Institute at Ohio  University, Ohio University, Athens,   OH, USA; 3Pharmacy Practice and  Administration, College of Pharmacy,   Ohio State University, Athens, OH,   USAAbstract:  In the last decade, researchers have gained a greater understanding of the  pathophysiologic mechanisms of type 2 diabetes as a chronic and progressive disease.",Non-OADS,/arxiv_data1/oa_pdf/fa/e1/dddt-9-5793.PMC4634822.pdf
"One  of the newly discovered pathophysiologic processes that can be treated is increased  renal glucose reabsorption that occurs in diabetes.4 This treatment is novel because Correspondence: Jay H Shubrook Primary Care Department, Clinical  Research and Diabetes Services, Touro  University College of Osteopathic  Medicine, 1310 Club Drive, Mare Island,  vallejo, CA 94592, USA email jay.shubrook@tu.ed u Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Shubrook et al Running head recto: Empagliflozin update DOI: http://dx.doi.org/10.2147/DDDT.S69926",Non-OADS,/arxiv_data1/oa_pdf/fa/e1/dddt-9-5793.PMC4634822.pdf
"Available from:  http://www.idf.org/diabetesatla s. Accessed January 3 , 2015.",Non-OADS,/arxiv_data1/oa_pdf/fa/e1/dddt-9-5793.PMC4634822.pdf
Avail - able from: http://www.who.int/diabetes/facts/en /.,Non-OADS,/arxiv_data1/oa_pdf/fa/e1/dddt-9-5793.PMC4634822.pdf
"Available from: http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm345848.ht m. Accessed October 3, 2015.",Non-OADS,/arxiv_data1/oa_pdf/fa/e1/dddt-9-5793.PMC4634822.pdf
"Silver Spring, MD: U.S. Department of Health and Human  Services, Food and Drug Administration; 2014 [August 1]s. Available  from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnounce - ments/ucm407637.ht m. Accessed April 12, 2015.",Non-OADS,/arxiv_data1/oa_pdf/fa/e1/dddt-9-5793.PMC4634822.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/fa/e1/dddt-9-5793.PMC4634822.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/e1/dddt-9-5793.PMC4634822.pdf
"Available  from: https://www.aace.com/publications/algorith m. Accessed April 4,   2015.",Non-OADS,/arxiv_data1/oa_pdf/fa/e1/dddt-9-5793.PMC4634822.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a0/0b/ijgm-8-355.PMC4634823.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2015:8 355–360International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  355OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S8192 0Impact of inpatient caseload, emergency  department duties, and online learning resource  on General Medicine In-Training examination  scores in Japan Kensuke Kinoshita1 Yusuke Tsugawa2 Taro shimizu3 Yusuke Tanoue4 ryota Konishi5 Yuji nishizaki6 T oshiaki shiojiri7 Yasuharu T okuda8 1Department of Medicine, Mito  Kyodo General hospital, University  of Tsukuba, Mito city, Ibaraki, Japan;   2Department of health Policy and  Management, harvard T. h. chan  school of Public health, Boston, M a,   Usa; 3T okyo Joto hospital, Koto-ku,   T okyo, 4Good Medicine Japan, Miyagi,   5Department of General Internal  Medicine, Kanto rosai hospital,   Kawasaki, Kanagawa, 6Department  of cardiology, Juntendo University  Graduate school of Medicine, T okyo,   7Department of General Internal  Medicine, asahi General hospital,   asahi, chiba, 8Japan community  healthcare Organization, Minato-ku,   T okyo, Japan correspondence: Kensuke Kinoshita   Department of Medicine,   Mito Kyodo General hospital,   University of Tsukuba, 3-2-7 Miya-Machi,  Mito, Ibaraki 310-0015, Japan   Tel +81 29 231 2371   Fax +81 29 221 5137   email kensuke.kinoshita@nifty.ne.j pBackground:  Both clinical workload and access to learning resource are important components  of educational environment and may have effects on clinical knowledge of residents.",Non-OADS,/arxiv_data1/oa_pdf/a0/0b/ijgm-8-355.PMC4634823.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/a0/0b/ijgm-8-355.PMC4634823.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/0b/ijgm-8-355.PMC4634823.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ca/65/rmhp-8-175.PMC4634824.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pRisk Management and Healthcare Policy 2015:8 175–183Risk Management and Healthcare Policy Dove press submit your manuscript | www.dovepress.co m Dove press  175Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RMHP .S7017 3Barriers to health care for undocumented  immigrants: a literature review Karen Hacker1,2 Maria Anies2 Barbara L Folb2,3 Leah Zallman4–6 1Allegheny County Health  Department, Pittsburgh, PA,   USA; 2Graduate School of Public  Health, 3Health Sciences Library  System, University of Pittsburgh,   Pittsburgh, PA, USA; 4institute for  Community Health, Cambridge, MA,   USA; 5Cambridge Health Alliance,   Cambridge, MA, USA; 6Harvard School  of Medicine, Boston, MA, USA Correspondence: Karen Hacker   Allegheny County Health Department,  542 4th Street, Pittsburgh,   PA 15219, USA   Tel +1 412 578 8008   Fax +1 412 578 8325   email khacker@achd.ne tAbstract:  With the unprecedented international migration seen in recent years, policies that  limit health care access have become prevalent.",Non-OADS,/arxiv_data1/oa_pdf/ca/65/rmhp-8-175.PMC4634824.pdf
"Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/risk-management-and-healthcare-policy-journa lRisk Management and Healthcare Policy is an international, peer- reviewed, open access journal focusing on all aspects of public health,  policy, and preventative measures to promote good health and improve  morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/ca/65/rmhp-8-175.PMC4634824.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/65/rmhp-8-175.PMC4634824.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b6/c7/dmso-8-535.PMC4634825.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 535–542Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  535Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S8848 9relationship between chronic complications,  hypertension, and health-related quality of life   in Portuguese patients with type 2 diabetes eduardo Sepúlveda1,2 rui Poínhos2,3 Miguel constante4,5 José Pais-ribeiro1,2 Paula Freitas6–8 Davide carvalho6–8 1Faculty of Psychology and  educational Sciences, University of  Porto, Porto, Portugal; 2associação  de Prevenção e apoio à Diabetes,   Porto, Portugal; 3Faculty of nutrition  and Food Sciences, University of  Porto, Porto, Portugal; 4institute of  Psychiatry, King’s college london,   london, UK; 5Department of  Psychiatry, hospital Beatriz Ângelo,   loures, Portugal; 6Department  of endocrinology, Diabetes and  Metabolism, centro hospitalar São  João, Porto, Portugal; 7Faculty of  Medicine, University of Porto, Porto,   Portugal; 8instituto de investigação e  inovação em Saúde, Universidade do  Porto, Porto, Portugal correspondence: eduardo Sepúlveda   Faculty of Psychology and educational   Sciences, University of Porto, Porto,   Portugal, rua alfredo allen, s/n,   4200-135 Porto, Portugal   Tel +351 916 714 084   email edusepulvedamoura@gmail.co mBackground:  The aim of this study was to assess the relationship between health-related  quality  of life (HRQoL) and the presence or absence of hypertension and diabetes-related chronic  complications in type 2 diabetes, and also the association between HRQoL and the number of  chronic complications.",Non-OADS,/arxiv_data1/oa_pdf/b6/c7/dmso-8-535.PMC4634825.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/b6/c7/dmso-8-535.PMC4634825.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/c7/dmso-8-535.PMC4634825.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2015:8 367–378Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  367RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S6835 1New developments in the treatment of   drug-resistant tuberculosis: clinical utility   of bedaquiline and delamanid Grania Brigden1 Cathy Hewison2 Francis varaine2 1Access Campaign, Médecins Sans  Frontières, Geneva, Switzerland;   2Medical Department, Médecins Sans  Frontières, Paris, France Correspondence: Grania Brigden   Access Campaign, Médecins Sans  Frontières, 78 Rue de Lausanne, Geneva,  Switzerland   T el +41 78 742 4025   email g rania.brigden@geneva.msf.or gAbstract:  The current treatment for drug-resistant tuberculosis (TB) is long, complex, and  associated with severe and life-threatening side effects and poor outcomes.",Non-OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
Available from: http://www.who.int/tb/post2015_ strategy/en /.,Non-OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
Available from: http://www.ema.europa.eu/ema/index.,Non-OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
Available from: http://www.ema.europa.eu/ema/index.,Non-OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
Available from: http://clinicaltrials.gov/show/NCT0185992 3.,Non-OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
Available from: http://www.who.int/mediacentre/news/notes/2013/ bedaquiline_mdr_tb_20130613/en /.,Non-OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
Available from: http://apps.who.int/iris/ bitstream/10665/137334/1/WHO_HTM_TB_2014.23_eng.pdf?ua =1.,OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
Available from: http://apps.who.int/iris/bitstream/10665/130918 /1/97 89241548809_eng.pdf?ua =1&ua=1.,OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
Available from: http://apps.who.int/prequal/query/Product- Registry.aspx?list =all.,OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
Available from:  http://www.trialsjournal.com/content/15/1/35 3.,Non-OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
Available from: http://www.nejm.org/doi/ full/10.1056/NEJMoa120196 4.,OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
Available from: https://www.msfaccess.org/sites/ default/files/MSF_assets/TB/Docs/MSF_IssueBrief_DRTB_ReadySet  Slowdown.,OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
Available at: http://www.tb-symposium.org/documents/ en/presentations/Lusine_Y eghiazaryan_BDQ_ practical_use_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
Available from:  http://www.ncbi.nlm.nih.gov/pubmed/1667013 4.,Non-OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
Available from: http://erj.ersjournals.com/ content/42/Suppl_57/190.short.,Non-OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
Available from: http://www.ema.europa.eu/ema/index.,Non-OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
Available from: http://www.who.int/tb/publications/ WHO_BDQ implementati onplan.pdf.,OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
A vailable  from: https://www.tbconsilium.org /.,Non-OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
Available from: http://www.usaid.gov/news-information/press-releases/ dec-11-2014-usaid-and-johnson-johnson-tackle-antibiotic-resistant- tuberculosis.,Non-OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
Available from: http://www.who.int/tb/ features_archive/otsuka_2015/en /.,OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
Available from: http://www.resisttb.org/?page_id =1602.,Non-OADS,/arxiv_data1/oa_pdf/aa/6a/idr-8-367.PMC4634826.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2a/74/cia-10-1771.PMC4634827.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1771–1777Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1771OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S9500 7elderly women who received Helicobacter pylori - eradicating therapy have reduced risk of low  skeletal muscle mass Myong Ki Baeg Myung-gyu Choi sun-hye Ko Chul-hyun lim Jin su Kim Yu Kyung Cho Jae Myung Park Y oung-seok Cho Bo-In lee In-seok lee Department of Internal Medicine,   The Catholic University of Korea  College of Medicine, seoul,   republic of KoreaBackground:  Sarcopenia is associated with adverse outcomes such as physical disability, poorer  quality of life, and death.",Non-OADS,/arxiv_data1/oa_pdf/2a/74/cia-10-1771.PMC4634827.pdf
"H. pylori  eradication has been reported to increase Correspondence: Myung-gyu Choi Department of Internal Medicine, The  Catholic University of Korea College of  Medicine, 222 Banpodaero, seocho-gu,  seoul 137-701, republic of Korea Tel +82 2 2258 6017 Fax +82 2 2258 2055 email choim@catholic.ac.k r Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Baeg et al Running head recto: H. pylori  eradication and low muscle mass DOI: http://dx.doi.org/10.2147/CIA.S95007",Non-OADS,/arxiv_data1/oa_pdf/2a/74/cia-10-1771.PMC4634827.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/2a/74/cia-10-1771.PMC4634827.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/2a/74/cia-10-1771.PMC4634827.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e2/41/dmso-8-525.PMC4634828.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 525–533Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  525Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S8531 8red cell distribution width in type 2   diabetic patients aml Mohamed nada Department of internal Medicine,   Unit of endocrinology, Diabetes and  Metabolism, Faculty of Medicine,   Mansoura University, Mansoura, egypt correspondence: aml Mohamed nada   Department of internal Medicine,   Unit of endocrinology, Diabetes and   Metabolism, Faculty of Medicine,  Mansoura University, 19 hassan  ibraheem Street, Mokram Obaid,  nasar city, cairo, egypt   Tel +20 10 2741 3981   email aml_nadanoha@yahoo.co mObjective:  To study the indices of some elements of the complete blood count, in type 2 diabetic  patients, in comparison with nondiabetic healthy controls; and to find out the effects of glycemic  control and different medications on these indices.",Non-OADS,/arxiv_data1/oa_pdf/e2/41/dmso-8-525.PMC4634828.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/e2/41/dmso-8-525.PMC4634828.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/41/dmso-8-525.PMC4634828.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/40/d8/dddt-9-5851.PMC4634829.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 5851–5862Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5851Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9294 3Arsenic sulfide combined with JQ1, chemotherapy  agents, or celecoxib inhibit gastric and colon  cancer cell growth lian Zhang1 Yingying T ong1 Xiuli Zhang1 Minggui Pan2,3 siyu chen1 1Department of Oncology, Xin hua  Hospital Affiliated to Shanghai Jiao  T ong University school of Medicine,   Shanghai, People’s Republic of  china; 2Department of Oncology  and hematology, Kaiser Permanente  Medical center, santa clara, 3Division  of research, Kaiser Permanente,   Oakland, ca, UsaBackground:  Arsenic compounds have modest cytotoxic activity in solid tumors.",Non-OADS,/arxiv_data1/oa_pdf/40/d8/dddt-9-5851.PMC4634829.pdf
"The exact mechanism of such syn - ergistic effect on APL remains incompletely understood, though it was discovered that  their combined effect on inducing the degradation of promyelocytic leukemia protein  most likely mediates the induction of cell differentiation and apoptosis.6,7 In chronic  myelocytic leukemia, As4S4 seems to use a different mechanism by activating c-CBL,  preventing its self-ubiquitination, therefore increasing its protein degradation activity  against several oncogene products including some receptor tyrosine kinases.8 In our previous studies, we explored the anticancer effect and mechanism of  As4S4 on a series of solid tumor cell lines, and showed that As4S4 possessed potent  antitumor activities in solid tumors by inducing apoptosis.9,10 Meanwhile, we carried correspondence: siyu chen Department of Oncology, Xin hua  Hospital Affiliated to Shanghai Jiao  Tong University school of Medicine,  1665 Kongjiang road, shanghai 200092,  People’s Republic of China Tel +86 21 2507 7642 email siyu.chen@shsmu.edu.c n  Minggui Pan Department of Oncology and  hematology, Kaiser Permanente Medical  center, 710 lawrence expressway,  santa clara, ca 95051, Usa Tel +1 408 851 4306 email minggui.pan@kp.or gJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Zhang et al Running head recto: As4S4 combined therapy in gastric and colon cancer DOI: http://dx.doi.org/10.2147/DDDT.S92943",Non-OADS,/arxiv_data1/oa_pdf/40/d8/dddt-9-5851.PMC4634829.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/40/d8/dddt-9-5851.PMC4634829.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/40/d8/dddt-9-5851.PMC4634829.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/53/2c/jpr-8-735.PMC4634830.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 735–740Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  735COMMENTARYopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S8939 3Reflections on osteopathic fascia treatment in the  peripheral nervous system Bruno Bordoni1–3 Giovanni Bordoni4 1Department of Cardiology, Santa  Maria Nascente Institute IRCCS  –  Hospitalization and Care with  Scientific Address, Don Carlo  Gnocchi Foundation, 2School TCIO  Milano – Osteopathy Institute,    3Edi-Ermes, Milan, 4CRESO School,   Osteopathic Centre for Research   and Studies, Falconara Marittima,   Ancona, Italy Correspondence: Bruno Bordoni   Department of Cardiology, Santa  Maria Nascente Institute IRCCS –  Hospitalization and Care with Scientific  Address, Don Carlo Gnocchi Foundation,  via Capecelatro 66, Milan 20142, Italy   Tel +39 02 349 630 0617   Email bordonibruno@hotmail.co mAbstract:  The peripheral nerve is composed of several layers of fascia tissue, which can become  a source of pain if the way they slide is impeded.",Non-OADS,/arxiv_data1/oa_pdf/53/2c/jpr-8-735.PMC4634830.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/53/2c/jpr-8-735.PMC4634830.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/53/2c/jpr-8-735.PMC4634830.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/84/0f/tcrm-11-1649.PMC4634831.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pTherapeutics and Clinical Risk Management 2015:11 1649–1656Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1649Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S6668 0Managing gastroesophageal reflux disease –  comparative efficacy and outcomes of  dexlansoprazole MR Jeanetta W Frye David A Peura Division of Gastroenterology  and Hepatology, University of  Virginia Health Sciences Center,   Charlottesville, VA, USAAbstract:  The management of gastroesophageal reflux disease (GERD) has been revolutionized  with the development of proton pump inhibitors (PPIs).",Non-OADS,/arxiv_data1/oa_pdf/84/0f/tcrm-11-1649.PMC4634831.pdf
"Interestingly, Correspondence: Jeanetta W Frye Division of Gastroenterology and  Hepatology, University of Virginia Health  Sciences Center, PO Box 800708,  Charlottesville, VA 22908, USA Tel +1 434 924 1623 Fax +1 434 244 9463 email jwf5v@virginia.ed u Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Frye and Peura Running head recto: Managing gastroesophageal reflux disease with dexlansoprazole MR DOI: http://dx.doi.org/10.2147/TCRM.S66680",Non-OADS,/arxiv_data1/oa_pdf/84/0f/tcrm-11-1649.PMC4634831.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/84/0f/tcrm-11-1649.PMC4634831.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/0f/tcrm-11-1649.PMC4634831.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ab/bc/tacg-8-245.PMC4634832.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pThe Application of Clinical Genetics 2015:8 245–255The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  245Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S6865 0Diagnostic and treatment strategies in  mucopolysaccharidosis vi Filippo vairo1–3 Andressa Federhen1,3,4 Guilherme Baldo1,2,5–7 Mariluce Riegel1,6 Maira Burin1 Sandra Leistner-Segal1,8 Roberto Giugliani1–5,6,8 1Medical Genetics Service, Hospital  de Clínicas de Porto Alegre, Porto  Alegre, Brazil; 2Department of  Genetics, Universidade Federal do  Rio Grande do Sul, Porto Alegre,   Brazil; 3Clinical Research Group on  Medical Genetics, Hospital de Clínicas  de Porto Alegre, Porto Alegre, Brazil;   4Post-Graduate Program in Child  and Adolescent Health, Universidade  Federal do Rio Grande do Sul, Porto  Alegre, Brazil; 5Gene Therapy Center,   Hospital de Clínicas de Porto Alegre,   Porto Alegre, Brazil; 6Post-Graduate  Program in Genetics and Molecular  Biology, Universidade Federal do  Rio Grande do Sul, Porto Alegre,   Brazil; 7Department of Physiology,   Universidade Federal do Rio Grande  do Sul, Porto Alegre, Brazil; 8Post- Graduate Program in Medical  Sciences, Universidade Federal do Rio  Grande do Sul, Porto Alegre, Brazil Correspondence: Roberto Giugliani   Medical Genetics Service, Hospital de  Clínicas de Porto Alegre, Rua Ramiro  Barcelos 2350, Porto Alegre,   RS 90035-903, Brazil   Tel +55 51 3359 6342   Fax +55 51 3359 7564   email rgiugliani@hcpa.edu.b rAbstract:  Mucopolysaccharidosis VI (MPS VI) is a very rare autosomal recessive disorder  caused by mutations in the ARSB  gene, which lead to deficient activity of the lysosomal enzyme  ASB.",Non-OADS,/arxiv_data1/oa_pdf/ab/bc/tacg-8-245.PMC4634832.pdf
"Available from: http://www.hgmd.cf.ac.uk/ac/index.ph p.  Accessed September 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ab/bc/tacg-8-245.PMC4634832.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/ab/bc/tacg-8-245.PMC4634832.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/bc/tacg-8-245.PMC4634832.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c5/18/copd-10-2347.PMC4634833.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 2347–2356International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2347RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S8824 6Combined bronchodilators (tiotropium plus  olodaterol) for patients with chronic  obstructive pulmonary disease wijdan H Ramadan1 wissam K Kabbara1 Ghada M el Khoury1 Sarah A Al Assir2 1Department of Pharmacy Practice,   School of Pharmacy, Lebanese  American University, Byblos, Lebanon;   2School of Pharmacy, Lebanese  American University, Byblos, LebanonAbstract:  Chronic obstructive pulmonary disease (COPD), a respiratory disease characterized  by a progressive decline in lung function, is considered to be a leading cause of morbidity and  mortality.",Non-OADS,/arxiv_data1/oa_pdf/c5/18/copd-10-2347.PMC4634833.pdf
"Keywords:  chronic obstructive pulmonary disease, bronchodilators, long-acting β2 agonists,  long-acting muscarinic antagonist, olodaterol, tiotropium Introduction Chronic obstructive pulmonary disease (COPD) is a progressive yet controllable  disease characterized by persistent airway obstruction triggered by an inflammatory  response to several noxious stimuli, mainly cigarette smoke.1 The chronic inflam - matory response may eventually stimulate the development of parenchymal tissue  destruction (emphysema) and chronic bronchitis, which in turn contribute to most of  the symptoms of the disease, mainly dyspnea and chronic cough.1,2 COPD is a leading cause of morbidity and mortality, with data supporting future  predictions of it becoming the third leading cause of death, resulting in a substantial  and increasing worldwide economic and social burden mainly driven by disease  exacerbations and hospitalizations.1,2 As a result, management of COPD is primarily aimed at relieving and reducing  symptoms as well as reducing the risk of future exacerbations.1,2Correspondence: wijdan H Ramadan Department of Pharmacy Practice,  School of Pharmacy, Lebanese American  University, PO Box 36-F 53, Byblos,  Lebanon Tel +961 9 547 249 ext 2267 Fax +961 9 547 256 ext 2897 email wramadan@lau.edu.l b Journal name: International Journal of COPD Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Ramadan et al Running head recto: Combined bronchodilators (tiotropium plus olodaterol) DOI: http://dx.doi.org/10.2147/COPD.S88246",Non-OADS,/arxiv_data1/oa_pdf/c5/18/copd-10-2347.PMC4634833.pdf
Available from:  http://www.goldcopd.org/uploads/users/files/GOLD_Report_2015.pdf.,OADS,/arxiv_data1/oa_pdf/c5/18/copd-10-2347.PMC4634833.pdf
"Available from: http://www.medicines.org.uk/ EMC/medicine/10039/SPC/Spiriva +18+microgram +inhalation +pow der%2c +hard+capsul e. Accessed April 7, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c5/18/copd-10-2347.PMC4634833.pdf
Available from: http://www.drugs.com/newdrugs/fda- approves-stiolto-respimat-tiotropium-bromide-olodaterol-inhalation- copd-4216.html.,Non-OADS,/arxiv_data1/oa_pdf/c5/18/copd-10-2347.PMC4634833.pdf
Available from: http://us.boehringer-ingelheim.com/news_events/ press_releases/press_release_archive/2015/6-30-2015-stiolto-respimat- available-united-states-treatment-copd.html.,Non-OADS,/arxiv_data1/oa_pdf/c5/18/copd-10-2347.PMC4634833.pdf
Avail - able from: http://bidocs.boehringeringelheim.com/BIWebAccess/View   Servlet.ser?docBase=renetnt&folderPath=/Prescribing+Information/PIs/ Stiolto+Respimat/stiolto.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c5/18/copd-10-2347.PMC4634833.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/c5/18/copd-10-2347.PMC4634833.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/18/copd-10-2347.PMC4634833.pdf
Avail - able from: https://www.clinicaltrials.gov/ct2/show/NCT01559116?,Non-OADS,/arxiv_data1/oa_pdf/c5/18/copd-10-2347.PMC4634833.pdf
"Available from: http://www.pharma.us.novartis.com/ product /pi/ pdf/arcapta.pd f. Accessed April 7, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c5/18/copd-10-2347.PMC4634833.pdf
"Available from: http://www.pbm.va.gov/ PBM/clinicalguidance/drugmonographs/Olodaterol_Monograph.pd f.  Accessed April 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c5/18/copd-10-2347.PMC4634833.pdf
Available  from: https://www.clinicaltrials.gov/ct2/show/NCT02296138?term =  NCT02296138&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/c5/18/copd-10-2347.PMC4634833.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/tcrm-11-1641.PMC4634834.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1641–1648Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1641ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9501 7The relationships between blood pressure, blood  glucose, and bone mineral density in postmenopausal  T urkish women huseyin altug Cakmak1 Burcu Dincgez Cakmak2 ayse ender Yumru3 serkan aslan4 asim enhos1 ali Kemal Kalkan4 ebru inci Coskun5 abdullah serdar acikgoz6 suat Karatas3 1Department of Cardiology,   Mustafakemalpasa government  hospital, Bursa, 2Department of  Obstetric and gynecology, Rize  Kackar government hospital, Rize,   3Department of Obstetric and  gynecology, sisli hamidiye etfal  Training and Research hospital,   4Department of Cardiology,   Mehmet akif ersoy Thoracic and  Cardiovascular surgery Training  and Research hospital, istanbul,   5Department of Obstetric and  gynecology, inonu University,   Malatya, 6Department of Obstetric  and gynecology, Cerrahpasa  Medical Faculty, istanbul University,   istanbul, T urkeyBackground:  Hypertension, diabetes mellitus, and osteoporosis are important comorbidities  commonly seen in postmenopausal women.",Non-OADS,/arxiv_data1/oa_pdf/90/2d/tcrm-11-1641.PMC4634834.pdf
"Keywords:  hypertension, type 2 diabetes mellitus, postmenopausal, bone mineral density Introduction Menopause is a physiological period of a woman’s life during which she lacks  menstruation continuously for 12 months.1 Lives have been extended with improved  diagnosis and treatment modalities, and women spend 20–30  years in the postmenopausal  period.2 One of the most important health problems in the postmenopausal period, in  addition to flushing and irritability, is impairment of bone mineral density (BMD),  leading to osteopenia or osteoporosis.Correspondence: huseyin altug Cakmak Department of Cardiology,  Mustafakemalpasa government hospital,  Tatkavakli Village, Kiryolu street, no 6,  Mustafakemalpasa, Bursa, Turkey Tel +90 53 3328 6329 email altugcakmak@hotmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Cakmak et al Running head recto: Blood pressure, blood glucose, and bone mineral density after menopause DOI: http://dx.doi.org/10.2147/TCRM.S95017",Non-OADS,/arxiv_data1/oa_pdf/90/2d/tcrm-11-1641.PMC4634834.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/90/2d/tcrm-11-1641.PMC4634834.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/tcrm-11-1641.PMC4634834.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/90/prbm-8-259.PMC4634835.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPsychology Research and Behavior Management 2015:8 259–262Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  259CoMMentaR yopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/PRBM.S9177 4Beyond expectation: a case for nonpersonal  contextual factors in a more comprehensive  approach to the placebo effect and the  contribution of environmental psychology Stefan Sütterlin1,2 Lars e egner1 Ricardo G Lugo1 Slawomir Wojniusz2,3 1Section of Psychology, Lillehammer  University College, Lillehammer,   2Department of Psychosomatic  Medicine, Division of Surgery  and Clinical neuroscience, oslo  University Hospital – Rikshospitalet,   oslo, 3Department of Physiotherapy,   Faculty of Health Sciences, oslo  and akershus University College of  applied Sciences, oslo, n orway Correspondence: Stefan Sütterlin   Section of Psychology,  Lillehammer University College,  Gudbrandsdalsvegen 350,   2624 Lillehammer, Lillehammer, norway   tel +47 9807 6685   email stefan.sutterlin@hil.n oAbstract:  Creating an optimized health care environment to maximize the probability and  magnitude of placebo effects draws on a number of well-researched mechanisms such as the  patient’ s positive expectation toward treatment outcome.",Non-OADS,/arxiv_data1/oa_pdf/bc/90/prbm-8-259.PMC4634835.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/bc/90/prbm-8-259.PMC4634835.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/bc/90/prbm-8-259.PMC4634835.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/29/cd/jmdh-8-489.PMC4634836.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 489–494Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  489HypotHesisopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/JMDH.S9470 2the fascial system and exercise intolerance in  patients with chronic heart failure: hypothesis of  osteopathic treatment Bruno Bordoni1–3 F Marelli2,3 1Don Carlo Gnocchi Foundation,   Department of Cardiology,  iRCC s  santa Maria Nascente, Milan, italy;   2school CR eso, osteopathic Centre  for Research and studies, Falconara  Marittima, AN, italy; 3school CReso ,   osteopathic Centre for Research and  studies, Castellanza, VA, italy Correspondence: Bruno Bordoni   Foundation Don Carlo Gnocchi iRCCs,  Department of Cardiology, institute  of Hospitalization and Care with  Scientific Address, S Maria Nascente, Via  Capecelatro 66, Milan 20100, italy   tel +39 02 34963 00617   email bordonibruno@hotmail.co mAbstract:  Chronic heart failure is a progressive, debilitating disease, resulting in a decline in  the quality of life of the patient and incurring very high social economic costs.",Non-OADS,/arxiv_data1/oa_pdf/29/cd/jmdh-8-489.PMC4634836.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/29/cd/jmdh-8-489.PMC4634836.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/cd/jmdh-8-489.PMC4634836.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/62/76/jpr-8-771.PMC4634837.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 771–780Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  771ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S8820 3analysis of opioid-mediated analgesia in   Phase iii studies of methylnaltrexone for   opioid-induced constipation in patients with  chronic noncancer pain lynn R Webster1 Darren M Brenner2 andrew c Barrett3 craig Paterson3 enoch Bortey3 William P Forbes3 1PRa health sciences, salt lake  city, UT, 2Department of Medicine,   northwestern University Feinberg  school of Medicine, chicago, il, 3salix,   a Division of Valeant Pharmaceuticals  north america llc, Bridgewater, nJ,   Usa correspondence: lynn R Webster   PRa health sciences,  3838 s  700 e #202,  salt lake city, UT  84106, Usa   Tel +1 801 269 8200  Fax +1 801 261 3341  email lrwebstermd@gmail.co mBackground:  Subcutaneous methylnaltrexone is efficacious and well tolerated for opioid- induced constipation (OIC) but may theoretically disrupt opioid-mediated analgesia.",Non-OADS,/arxiv_data1/oa_pdf/62/76/jpr-8-771.PMC4634837.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/62/76/jpr-8-771.PMC4634837.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/62/76/jpr-8-771.PMC4634837.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/53/jpr-8-781.PMC4634838.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 781–789Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  781ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S8542 4The safety of liposome bupivacaine following  various routes of administration in animals Girish P Joshi1 Gary Patou2 Vladimir Kharitonov2 1Department of Anesthesiology and  Pain Management, University of Texas  Southwestern Medical School, Dallas,   TX, 2Pacira Pharmaceuticals, Inc.,   Parsippany, NJ, USA Correspondence: Girish P Joshi   Department of Anesthesiology and  Pain Management, University of Texas  Southwestern Medical School, 5323  Harry Hines Boulevard, Dallas, TX  75390-9068, USA   Tel +1 214 590 7259   Fax +1 214 590 6945   Email G irish.Joshi@ UTSouthwestern.ed uBackground:  This report presents results from four preclinical studies evaluating safety and  pharmacokinetics (PKs) of liposome bupivacaine following intravascular (intravenous [IV],  intra-arterial [IA]), epidural, and intrathecal administration in dogs.",Non-OADS,/arxiv_data1/oa_pdf/31/53/jpr-8-781.PMC4634838.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/31/53/jpr-8-781.PMC4634838.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/53/jpr-8-781.PMC4634838.pdf
It just means that further studies should be performed to identify which speci ﬁc aberrant and abnormal embryo populations can be recognized by mir661 overexpression.Subsequently larger double-blinded studies with an appropriate N should be performed to test the accuracy of this marker as a predictorEBioMedicine 2 (2015) 1312 –1313 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.09.003 .,Non-OADS,/arxiv_data1/oa_pdf/11/5a/main.PMC4634840.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.043 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/11/5a/main.PMC4634840.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/5a/main.PMC4634840.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/99/main.PMC4634842.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.002 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/99/main.PMC4634842.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/99/main.PMC4634842.pdf
"After conﬁrming a satisfactory quality, alignment of the ﬁles to the mm10 ref- erence genome, obtained from the UCSC browser ( http://genome.ucsc.",OADS,/arxiv_data1/oa_pdf/9b/99/main.PMC4634842.pdf
"These founder lines were named as: Tg(SPC-DNMT Δ3B/DG)1lm, Tg(SPC-DNMT Δ3B/DG)3lm, Tg(SPC-DNMT Δ3B/DG)25lm and Tg(SPC- DNMT Δ3B/DG)27lm according to MGI-Guidelines for Nomenclature of Gene, Genetic Markers, Alleles, and Mutations in Mouse and Rat: http://www.informatics.jax.org/mgihome/nomen/gene.shtml .",Non-OADS,/arxiv_data1/oa_pdf/9b/99/main.PMC4634842.pdf
The raw data has been deposited in NCBI database and can be access through: http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/9b/99/main.PMC4634842.pdf
Is it really a characteristic of the right hemisphere as the results ofEBioMedicine 2 (2015) 1286 –1287 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.08.002 .,Non-OADS,/arxiv_data1/oa_pdf/c3/15/main.PMC4634843.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.024 2352-3964/© 2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/c3/15/main.PMC4634843.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/15/main.PMC4634843.pdf
This debate is ongoing andEBioMedicine 2 (2015) 1257 –1258 http://dx.doi.org/10.1016/j.ebiom.2015.10.003 2352-3964/© 2015 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/13/6a/main.PMC4634846.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/6a/main.PMC4634846.pdf
DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.09.004 .,OADS,/arxiv_data1/oa_pdf/26/61/main.PMC4634871.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.052 2352-3964/© 2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/26/61/main.PMC4634871.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/26/61/main.PMC4634871.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/main.PMC4634892.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.09.006 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/main.PMC4634892.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/main.PMC4634892.pdf
Analysis of hyperinvasive complexes such as the ST-11 clonal complex will continue to be important both from a historicalEBioMedicine 2 (2015) 1294 –1295 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.09.007 .,Non-OADS,/arxiv_data1/oa_pdf/f1/9b/main.PMC4634895.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.10.011 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/9b/main.PMC4634895.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/9b/main.PMC4634895.pdf
http://dx.doi.org/10.1016/j.jinf.2015.07.007 .,OADS,/arxiv_data1/oa_pdf/f1/9b/main.PMC4634895.pdf
ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37132015000500001J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/3e/74/1806-3713-jbpneu-41-05-00397.PMC4635077.pdf
ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37132015000500002J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/75/79/1806-3713-jbpneu-41-05-00398.PMC4635078.pdf
ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37132015000500003J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/3f/8c/1806-3713-jbpneu-41-05-00399.PMC4635079.pdf
ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37132015000500004J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/7d/bb/1806-3713-jbpneu-41-05-00400.PMC4635080.pdf
ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37132015000500005J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/98/2a/1806-3713-jbpneu-41-05-00401.PMC4635081.pdf
ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37132015000500006J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/ec/de/1806-3713-jbpneu-41-05-00402.PMC4635082.pdf
ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37132015000500007J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/85/c5/1806-3713-jbpneu-41-05-00403.PMC4635083.pdf
ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37132015000500008The next 40 years Rogério Souza1  Current Editor-in-Chief of the JBP.,Non-OADS,/arxiv_data1/oa_pdf/5c/c4/1806-3713-jbpneu-41-05-00404.PMC4635084.pdf
2014;40(4):325-6. http://dx.doi.org/10.1590/S1806-37132014000400001 2.,Non-OADS,/arxiv_data1/oa_pdf/5c/c4/1806-3713-jbpneu-41-05-00404.PMC4635084.pdf
2014;40(5):458-86. http://dx.doi.org/10.1590/S1806-37132014000500003 3.,Non-OADS,/arxiv_data1/oa_pdf/5c/c4/1806-3713-jbpneu-41-05-00404.PMC4635084.pdf
2013;39(2):190-7. http://dx.doi.org/10.1590/S1806-37132013000200010 4.,Non-OADS,/arxiv_data1/oa_pdf/5c/c4/1806-3713-jbpneu-41-05-00404.PMC4635084.pdf
2014;20(6):285-6. http://dx.doi.org/10.1016/j.rppneu.2014.11.001 5.,OADS,/arxiv_data1/oa_pdf/5c/c4/1806-3713-jbpneu-41-05-00404.PMC4635084.pdf
2014;40(6):589-90. http://dx.doi.org/10.1590/S1806- 37132014000600001J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/5c/c4/1806-3713-jbpneu-41-05-00404.PMC4635084.pdf
2015;41(5):405-409 http://dx.doi.org/10.1590/S1806-3713201500000014 405IntroductIon Inhaler technique comprises a set of procedures  for drug delivery to the respiratory system.,Non-OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
2014;108(7):968-75. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
2000;36(1):34-43. http://dx.doi.org/10.1016/S0300-2896(15)30231-3 4.,Non-OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
"Sawston, Cambridge, UK: Woodhead Publishing Limited; 2013. p. 13-27. http://dx.doi.org/10.1533/9780857098696.1.13 5.",Non-OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
Available from: http://www.medwave.cl/link.cgi/Medwave/Reuniones/1791?tab=metrica 6.,OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
http://dx.doi.org/10.1016/j.rmed.2011.01.005 7.,OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
2014;10(1):1-9. http://dx.doi.org/10.1016/j.nurpra.2013.11.009 9.,OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
2006;100(9):1479-94. http://dx.doi.org/10.1016/j.rmed.2006.01.008 12.,OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
2003;32(5):269-74. http://dx.doi.org/10.1016/S0212- 6567(03)79273-7 13.,Non-OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
2013;49(Suppl.1):2-14. http://dx.doi.org/10.1016/S0300-2896(13)70068-1 14.,OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
2010;104(9):1237-45. http://dx.doi.org/10.1016/j.rmed.2010.04.012 15.,OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
2011;377(9770):1032-45. http://dx.doi.org/10.1016/S0140-6736(10)60926-9 16.,Non-OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
2013;107(9):1346-55. http://dx.doi.org/10.1016/j.rmed.2013.05.014 18.,OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
2013;107(1):37-46. http://dx.doi.org/10.1016/j.rmed.2012.09.017 408 J Bras Pneumol.,OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
2013;39(3):287-95. http://dx.doi.org/10.1590/S1806-37132013000300005 20.,Non-OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
Available from: http://web.minsal.cl/portal/url/item/ bcb03d7bc28b64dfe040010165012d23.pdf 21.,Non-OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
2008;102(12):1681-93. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
2013;107(12):1817-21.  http://dx.doi.org/10.1016/j.rmed.2013.09.013 23.,OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
2008;102(1):10-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
2010;80(3):393-8. http://dx.doi.org/10.1016/j.pec.2010.07.011 25.,OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
2014;108(5):694-700. http://dx.doi.org/10.1016/j.rmed.2014.02.013 409 J Bras Pneumol.,OADS,/arxiv_data1/oa_pdf/15/4e/1806-3713-jbpneu-41-05-00405.PMC4635085.pdf
2015;41(5):410-414 http://dx.doi.org/10.1590/S1806-37132015000004493 410 Original article,Non-OADS,/arxiv_data1/oa_pdf/7b/b2/1806-3713-jbpneu-41-05-00410.PMC4635086.pdf
2003;123(2):458-62. http://dx.doi.org/10.1378/ chest.123.2.458 3.,Non-OADS,/arxiv_data1/oa_pdf/7b/b2/1806-3713-jbpneu-41-05-00410.PMC4635086.pdf
2010; 304(20): 2245-52. http://dx.doi.org/10.1001/jama.2010.1705 5.,Non-OADS,/arxiv_data1/oa_pdf/7b/b2/1806-3713-jbpneu-41-05-00410.PMC4635086.pdf
http://dx.doi.org/10.1016/j.jtcvs.2011.08.037 6.,OADS,/arxiv_data1/oa_pdf/7b/b2/1806-3713-jbpneu-41-05-00410.PMC4635086.pdf
2012;106(6):883-92. http://dx.doi.org/10.1016/j.rmed.2012.02.014 7.,OADS,/arxiv_data1/oa_pdf/7b/b2/1806-3713-jbpneu-41-05-00410.PMC4635086.pdf
2013;28(6):660-7. http://dx.doi.org/10.3904/kjim.2013.28.6.660 9.,OADS,/arxiv_data1/oa_pdf/7b/b2/1806-3713-jbpneu-41-05-00410.PMC4635086.pdf
2010;4(4):491-8. http://dx.doi.org/10.1586/ ers.10.39 10.,Non-OADS,/arxiv_data1/oa_pdf/7b/b2/1806-3713-jbpneu-41-05-00410.PMC4635086.pdf
2004;126(1):122-8. http://dx.doi.org/10.1378/chest.126.1.122 11.,Non-OADS,/arxiv_data1/oa_pdf/7b/b2/1806-3713-jbpneu-41-05-00410.PMC4635086.pdf
2011;16(3):467-72. http://dx.doi.org/10.1111/j.1440-1843.2011.01933.x 13.,Non-OADS,/arxiv_data1/oa_pdf/7b/b2/1806-3713-jbpneu-41-05-00410.PMC4635086.pdf
2011;6(2):77-81. http://dx.doi.org/10.4103/1817-1737.78422 14.,Non-OADS,/arxiv_data1/oa_pdf/7b/b2/1806-3713-jbpneu-41-05-00410.PMC4635086.pdf
2004; 125(2):527-31. http://dx.doi.org/10.1378/chest.125.2.527 15.,Non-OADS,/arxiv_data1/oa_pdf/7b/b2/1806-3713-jbpneu-41-05-00410.PMC4635086.pdf
2014;148(2):662-7. http://dx.doi.org/10.1016/j.jtcvs.2014.01.028 17.,OADS,/arxiv_data1/oa_pdf/7b/b2/1806-3713-jbpneu-41-05-00410.PMC4635086.pdf
2011;140(6):1550-6. http://dx.doi.org/10.1378/chest.11-0252 18.,Non-OADS,/arxiv_data1/oa_pdf/7b/b2/1806-3713-jbpneu-41-05-00410.PMC4635086.pdf
2013;191(1):109-15. http://dx.doi.org/10.1007/s00408-012-9439-z 19.,Non-OADS,/arxiv_data1/oa_pdf/7b/b2/1806-3713-jbpneu-41-05-00410.PMC4635086.pdf
2014;20(2):106-12. http://dx.doi.org/10.5761/atcs.,Non-OADS,/arxiv_data1/oa_pdf/7b/b2/1806-3713-jbpneu-41-05-00410.PMC4635086.pdf
2012;6(1):3-8. http://dx.doi.org/10.1111/j.1752-699X.2010.00232.x 22.,Non-OADS,/arxiv_data1/oa_pdf/7b/b2/1806-3713-jbpneu-41-05-00410.PMC4635086.pdf
2009;33(5):1156-64. http://dx.doi.org/10.1183/09031936.00097908 23.,Non-OADS,/arxiv_data1/oa_pdf/7b/b2/1806-3713-jbpneu-41-05-00410.PMC4635086.pdf
2009;45(8):1389-96. http://dx.doi.org/10.1016/j.ejca.2008.11.043 414 J Bras Pneumol.,OADS,/arxiv_data1/oa_pdf/7b/b2/1806-3713-jbpneu-41-05-00410.PMC4635086.pdf
ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37132015000000040J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2010;36(5):1027-33. http://dx.doi.org/10.1183/09031936.00194209 2.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2014;18(1):3-4. http://dx.doi.org/10.5588/ ijtld.13.0868 3.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2010;104(12):1896-902. http://dx.doi.org/10.1016/j.rmed.2010.05.001 4.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2005;82(1): 53-9. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2002;166(6):809-13. http://dx.doi.org/10.1164/rccm.2107031 6.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2006;6(2):190-6. http://dx.doi.org/10.7861/clinmedicine.6-2-190 7.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2009;33(4):947. http://dx.doi.org/10.1183/09031936.00014008 9.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
Available from: http://www.goldcopd.org/uploads/ users/files/GOLD_Report_2011_Feb21.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2009;34(3):648-54. http://dx.doi.org/10.1183/09031936.00102509 13.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2004;350(10):1005-12. http://dx.doi.org/10.1056/NEJMoa021322 15.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
1998;147(8):755-63. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2003;51(11):1602-9.  http://dx.doi.org/10.1046/j.1532-5415.2003.51534.x 18.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2007;55(5):769-74. http://dx.doi.org/10.1111/j.1532-5415.2007.01140.x 19.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2013;24(2):595-603. http://dx.doi.org/10.1007/s00198-012-2002-1 20.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2014;25(2):589-96. http://dx.doi.org/10.1007/s00198-013-2455-x 21.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2010;39(4):412-23. http://dx.doi.org/10.1093/ageing/afq034 22.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2008;31(3):492-501. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2012;41(2):237-41. http://dx.doi.org/10.1093/ageing/afr167 24.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2004;170(12):1286-93. http://dx.doi.org/10.1164/rccm.200406-754OC 25.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2006;173(1):79-83. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2012;13:48.  http://dx.doi.org/10.1186/1465-9921-13-48 28.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2000;67(1):68-74. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2013;63(3):239-47. http://dx.doi.org/10.1159/000353211 31.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2011;30(3):332-8. http://dx.doi.org/10.1016/j.clnu.2010.09.013 32.,OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2013;20(1):1-10. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2013;188(12):1396-406. http://dx.doi.org/10.1164/rccm.201308-1404PP 34.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2007;8:25. http://dx.doi.org/10.1186/1465-9921-8-25 35.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2002;50(12):1947-54. http://dx.doi.org/10.1046/j.1532-5415.2002.50605.x 36.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2007;132(1):164-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
2014;43(4):548-53. http://dx.doi.org/10.1093/ ageing/aft196 38.,Non-OADS,/arxiv_data1/oa_pdf/08/0e/1806-3713-jbpneu-41-05-00415.PMC4635087.pdf
ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37132015000004517J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
Available from:  http://www.who.int/mediacentre/factsheets/fs311/en/index.html 2.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
2009;9:88.  http://dx.doi.org/10.1186/1471-2458-9-88 3.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
2012;17 (1):43-9. http://dx.doi.org/10.1111/j.1440-1843.2011.02096.x 4.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
1993;103(5):1470-6. http://dx.doi.org/10.1378/chest.103.5.1470 6.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
2008;63(7):649-54. http://dx.doi.org/10.1136/thx.2007.086801 7.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
2005;25(5):896-901. http://dx.doi.org/10.1183/09031936.05.00104504 8.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
2008;63(11):1018-23. http://dx.doi.org/10.1136/ thx.2007.086819 9.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
1956;35(3):327-35. http://dx.doi.org/10.1172/JCI103282 10.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
2001;18(3):564-70. http://dx.doi.org/10.1183/09031936.01.00046401 12.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
2009;168(3):198-202. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
2005;26(2):319-38.  http://dx.doi.org/10.1183/09031936.05.00034805 15.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
2003;22(6):1026-41. http://dx.doi.org/10.1183/09031936.03.000894 03 17.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
2001;321(4):249-79. http://dx.doi.org/10.1097/00000441-200104000- 00006 19.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
2004;58(6):573-80. http://dx.doi.org/10.1111/j.1368- 5031.2004.00166.x 20.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
2006;130(3):827-33. http://dx.doi.org/10.1378/chest.130.3.827 22.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
2006;129(4):853-62. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
2001;95(4):281-6. http://dx.doi.org/10.1053/rmed.2001.1035 24.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
2014;116(9):1175-81. http://dx.doi.org/10.1152/ japplphysiol.01339.2013 25.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
2001;14(5):341-50. http://dx.doi.org/10.1006/pupt.2001.0310 26.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
2006;100(7):1180-5. http://dx.doi.org/10.1016/j.rmed.2005.10.025 27.,OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
2011;189(2):121-9. http://dx.doi.org/10.1007/s00408-010-9275-y 28.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
2011;184(5):582-9. http://dx.doi.org/10.1164/rccm.201011- 1909OC 29.,Non-OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
2009;22(4):326-32. http://dx.doi.org/10.1016/j.pupt.2009.01.005 30.,OADS,/arxiv_data1/oa_pdf/72/b1/1806-3713-jbpneu-41-05-00422.PMC4635088.pdf
ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37132015000000031J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
2006;26(5):968- 76. http://dx.doi.org/10.1161/01.ATV.0000216787.85457.f3 2.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
Heart .2011;97(3):171-2. http://dx.doi.org/10.1136/hrt.2010.207092 3.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
2012;29(2):131-9. http://dx.doi.org/10.1111/j.1540-8175.2011.01550.x 5.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
2013;78(1):27-34. http://dx.doi.org/10.1016/j.anpedi.2012.05.010 6.,OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
2014;37(3):172-7. http://dx.doi.org/10.1002/clc.22242 7.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
2011;19(5):1054-61. http://dx.doi.org/10.1038/oby.2010.240 8.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
2011;54(2):121-4. http://dx.doi.org/10.1016/j.cyto.2011.01.010 9.,OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
http://dx.doi.org/10.1371/ journal.pone.0107480 10.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
2011;140(6):1567-73. http://dx.doi.org/10.1378/chest.11-0258 11.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
2012;13(9):822-33.  http://dx.doi.org/10.1111/j.1467-789X.2012.01008.x 12.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
2007;33(4):397-406. http://dx.doi.org/10.1590/S1806-37132007000400008 15.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
1986;57(6):450-8. http://dx.doi.org/10.1016/0002-9149(86)90771-X 16.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
1992;19(1):130-4. http://dx.doi.org/10.1016/0735-1097(92)90063-S 18.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
2011;97(3):203-8. http://dx.doi.org/10.1136/hrt.2009.185009 19.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
2010;20(5):589-94. http://dx.doi.org/10.1007/s11695-009-9961-0 20.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
2011;21(4):485-91. http://dx.doi.org/10.1007/s11695-010-0306-9 21.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
2004;40(2):62-6. http://dx.doi.org/10.1016/S0300- 2896(04)75474-5 22.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
1990;112(11):828-32. http://dx.doi.org/10.7326/0003-4819-112-11- 828 24.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
2011;111(3):726-34.  http://dx.doi.org/10.1152/japplphysiol.01155.2010 25.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
2011;48(8):818-23. http://dx.doi.org/10.3109/02770903.2011.613508 26.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
2007;88(1):52-8. http://dx.doi.org/10.1590/S0066-782X2007000100009 29.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
2007;15(8):2019-26. http://dx.doi.org/10.1038/oby.2007.241 30.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
2000;44(1):64-71. http://dx.doi.org/10.1590/S0004-27302000000100011 432 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/d5/19/1806-3713-jbpneu-41-05-00427.PMC4635089.pdf
ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37132015000004527J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/33/fb/1806-3713-jbpneu-41-05-00433.PMC4635090.pdf
Available from: http://www.who.int/nmh/publications/ncd_report2010/en/ 2.,Non-OADS,/arxiv_data1/oa_pdf/33/fb/1806-3713-jbpneu-41-05-00433.PMC4635090.pdf
http://dx.doi.org/10.1371/journal.pmed.1001336 3.,Non-OADS,/arxiv_data1/oa_pdf/33/fb/1806-3713-jbpneu-41-05-00433.PMC4635090.pdf
2008;34(10):845-80. http://dx.doi.org/10.1590/S1806-37132008001000014 4.,Non-OADS,/arxiv_data1/oa_pdf/33/fb/1806-3713-jbpneu-41-05-00433.PMC4635090.pdf
2011;106(2):418-27. http://dx.doi.org/10.1111/j.1360-0443.2010.03173.x 5.,Non-OADS,/arxiv_data1/oa_pdf/33/fb/1806-3713-jbpneu-41-05-00433.PMC4635090.pdf
1978;3(3-4):235-41. http://dx.doi.org/10.1016/0306- 4603(78)90024-2 9.,Non-OADS,/arxiv_data1/oa_pdf/33/fb/1806-3713-jbpneu-41-05-00433.PMC4635090.pdf
"Pawlina MMC, Rondina RC, Espinosa MM, Botelho C 1989;26(4):494-503. http://dx.doi.org/10.1037/h0085468 11.",Non-OADS,/arxiv_data1/oa_pdf/33/fb/1806-3713-jbpneu-41-05-00433.PMC4635090.pdf
1988;56(6):893-7. http://dx.doi.org/10.1037/0022-006X.56.6.893 13.,Non-OADS,/arxiv_data1/oa_pdf/33/fb/1806-3713-jbpneu-41-05-00433.PMC4635090.pdf
1961;4:561-71. http://dx.doi.org/10.1001/archpsyc.1961.01710120031004 15.,Non-OADS,/arxiv_data1/oa_pdf/33/fb/1806-3713-jbpneu-41-05-00433.PMC4635090.pdf
2010;36(5):603-11. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/33/fb/1806-3713-jbpneu-41-05-00433.PMC4635090.pdf
1992;47:102-14. http://dx.doi.org/10.1037/0003-066X.47.9.1102 24.,Non-OADS,/arxiv_data1/oa_pdf/33/fb/1806-3713-jbpneu-41-05-00433.PMC4635090.pdf
2013;15(11):1807-15. http://dx.doi.org/10.1093/ntr/ntt036 26.,Non-OADS,/arxiv_data1/oa_pdf/33/fb/1806-3713-jbpneu-41-05-00433.PMC4635090.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/33/fb/1806-3713-jbpneu-41-05-00433.PMC4635090.pdf
2014;44(12):2523-35. http://dx.doi.org/10.1017/ S0033291713003206 28.,Non-OADS,/arxiv_data1/oa_pdf/33/fb/1806-3713-jbpneu-41-05-00433.PMC4635090.pdf
2002;32:489-94.  http://dx.doi.org/10.1016/S0191-8869(01)00050-2 29.,OADS,/arxiv_data1/oa_pdf/33/fb/1806-3713-jbpneu-41-05-00433.PMC4635090.pdf
2010;52(2):120-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/33/fb/1806-3713-jbpneu-41-05-00433.PMC4635090.pdf
J Psychiatr Res 2013;47(11):1673-9. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/33/fb/1806-3713-jbpneu-41-05-00433.PMC4635090.pdf
Available from: ftp://ftp.cve.saude.sp.gpv.,OADS,/arxiv_data1/oa_pdf/33/fb/1806-3713-jbpneu-41-05-00433.PMC4635090.pdf
Available from: http://www.af.mil/ News/ArticleDisplay/tabid/223/Article/113470/using-tobacco-does- not-reduce-stress-researchers-report.aspx 439 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/33/fb/1806-3713-jbpneu-41-05-00433.PMC4635090.pdf
ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37132015000000027J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2002;165(9):1217-39. http://dx.doi.org/10.1164/rccm.2109080 2.,Non-OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2000;284(23):3015-21. http://dx.doi.org/10.1001/jama.284.23.3015 3.,Non-OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2014;311(8):806-14. http://dx.doi.org/10.1001/jama.2014.732 4.,Non-OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2009;30(3):455-65. http://dx.doi.org/10.1016/j.ccm.2009.05.012 5.,OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2010;11(5):441-6. http://dx.doi.org/10.1016/j.sleep.2009.10.005 6.,OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2012;8(5):569-73. http://dx.doi.org/10.1016/j.soard.2011.06.021 7.,OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2012;16(1):163-8. http://dx.doi.org/10.1007/s11325- 010-0468-7 8.,Non-OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2013;23(3):287-91. http://dx.doi.org/10.1007/s11695-012-0806-x9.,Non-OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2010;20(1):30-5. http://dx.doi.org/10.1007/s11695-009-9854-2 10.,Non-OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2013:27(12):4556-63. http://dx.doi.org/10.1007/s00464-013-3122-1 11.,Non-OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2004;14(1):23- 6. http://dx.doi.org/10.1381/096089204772787248 12.,Non-OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2004;292(14):1724-37. http://dx.doi.org/10.1001/jama.292.14.1724 13.,Non-OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2014;24(6):927-35. http://dx.doi.org/10.1007/s11695-014-1196-z 14.,Non-OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2011:38(5):1089-97. http://dx.doi.org/10.1183/09031936.00198810 15.,Non-OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2012;269(7):1865-71. http://dx.doi.org/10.1007/s00405-012-1948-0 16.,Non-OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2009;35(9):877-83.  http://dx.doi.org/10.1590/S1806-37132009000900009 18.,Non-OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2003:13(5):676- 83. http://dx.doi.org/10.1381/096089203322509228 22.,Non-OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2007 Jul;17(7):996. http://dx.doi.org/10.1007/s11695-007- 9147-6 23.,Non-OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2009;10(2):226-32. http://dx.doi.org/10.1016/j.sleep.2008.01.005 26.,OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2007;193(3):364-7; discussion 367. http://dx.doi.org/10.1016/j.amjsurg.2006.09.022 27.,Non-OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2010;20(8):1142-8. http://dx.doi.org/10.1007/s11695-009- 0053-y 28.,Non-OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2011;7(5):605-10. http://dx.doi.org/10.1016/j.soard.2011.04.226 29.,OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2003;123(4):1134-41. http://dx.doi.org/10.1378/chest.123.4.1134 30.,Non-OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
2013;9(4):539-46.  http://dx.doi.org/10.1016/j.soard.2012.01.020 448 J Bras Pneumol.,OADS,/arxiv_data1/oa_pdf/58/09/1806-3713-jbpneu-41-05-00440.PMC4635091.pdf
"ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e TisiologiaBrief CommuniCation http://dx.doi.org/10.1590/S1806-37132015000000073Assessment of contacts is one of the essential steps  in tuberculosis control programs, and its purpose is to  diagnose or rule out latent infection or active tuberculosis  in such individuals.",Non-OADS,/arxiv_data1/oa_pdf/06/5d/1806-3713-jbpneu-41-05-00449.PMC4635092.pdf
2006;32(6):559-65.  http://dx.doi.org/10.1590/S1806-37132006000600014 3.,Non-OADS,/arxiv_data1/oa_pdf/06/5d/1806-3713-jbpneu-41-05-00449.PMC4635092.pdf
2008:34(5):298-303. http://dx.doi.org/10.1590/S1806-37132008000500009 4.,Non-OADS,/arxiv_data1/oa_pdf/06/5d/1806-3713-jbpneu-41-05-00449.PMC4635092.pdf
2012;54(9):1287-95. http://dx.doi.org/10.1093/ cid/cis029 5.,Non-OADS,/arxiv_data1/oa_pdf/06/5d/1806-3713-jbpneu-41-05-00449.PMC4635092.pdf
Available  from: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?ibge/cnv/popmg.def6.,OADS,/arxiv_data1/oa_pdf/06/5d/1806-3713-jbpneu-41-05-00449.PMC4635092.pdf
2012;22(2):177-82. http://dx.doi.org/10.1093/eurpub/ckr017 453 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/06/5d/1806-3713-jbpneu-41-05-00449.PMC4635092.pdf
ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37132015000000152J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2011;183(6):788-824. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2013:39(1):111-2. http://dx.doi.org/10.1590/S1806-37132013000100017 3.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2001;164(7):1171-81. http://dx.doi.org/10.1164/ajrccm.164.7.2003140 5.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2005;142(12 Pt 1):963-7. http://dx.doi.org/10.7326/0003-4819-142-12_Part_1-200506210-00005 6.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
39(6): 641-43. http://dx.doi.org/10.1590/S1806-37132013000600001 8.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2013;1(9):685-94. http://dx.doi.org/10.1016/S2213-2600(13)70191-7 9.,OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2014;40(2):183-7.  http://dx.doi.org/10.1590/S1806-37132014000200013 10.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2014;19(6):900-6.  http://dx.doi.org/10.1111/resp.12322 11.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2012;40(3):519-21. http://dx.doi.org/10.1183/09031936.00001612 12.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2014;40(3):304-12. http://dx.doi.org/10.1590/S1806- 37132014000300014 13.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2001;134(2):136-51. http://dx.doi.org/10.7326/0003-4819-134-2-200101160-00015 14.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
http://dx.doi.org/10.1002/14651858.cd002880 16.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2012;366(21):1968-77. http://dx.doi.org/10.1056/NEJMoa1113354 17.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
1999;341(17):1264-9. http://dx.doi.org/10.1056/NEJM199910213411703 18.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2004;350(2):125- 33. http://dx.doi.org/10.1056/NEJMoa030511 19.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2009;374(9685):222-8. http://dx.doi.org/10.1016/S0140-6736(09)60551-1 20.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2005;353(21):2229-42. http://dx.doi.org/10.1056/NEJMoa042976 21.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2014;370(22):2093-101. http://dx.doi.org/10.1056/NEJMoa1401739 22.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2011;71(13):1721-32. http://dx.doi.org/10.2165/11207710-000000000-00000 24.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
1999;159(4 Pt 1):1061-9. http://dx.doi.org/10.1164/ajrccm.159.4.9805017 25.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2002;41(12):1118-23. http://dx.doi.org/10.2169/internalmedicine.41.1118 26.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2005;171(9):1040-7.  http://dx.doi.org/10.1164/rccm.200404-571OC 27.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2010;35(4):821-9. http://dx.doi.org/10.1183/09031936.00005209 28.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2011;377(9779):1760-9. http://dx.doi.org/10.1016/S0140-6736(11)60405-4 29.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2014;371(12):1172. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2008;68(12):4774-82. http://dx.doi.org/10.1158/0008-5472.CAN-07-6307 31.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2014;15(5):729-39. http://dx.doi.org/10.1517/14656566.2014.897695 32.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2015;45(5):1434-45. http://dx.doi.org/10.1183/09031936.00174914 33.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2015;373(8):782. http://dx.doi.org/10.1056/NEJMoa1402584 35.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2015;372(13):1189-91. http://dx.doi.org/10.1056/NEJMp1500526 36.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
http://dx.doi.org/10.1164/rccm.201506-1063ST 37.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2015;45(5):1382-92. http://dx.doi.org/10.1183/09031936.00198013 38.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
"Baddini-Martinez J, Baldi BG, Costa CH, Jezler S, Lima MS, Rufino R http://dx.doi.org/10.7326/0003-4819-157-6-201209180-00003 39.",Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2013;381(9867):623. http://dx.doi.org/10.1016/S0140-6736(13)60338-4 40.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2012;43(4):771-82. http://dx.doi.org/10.1016/j.jpainsymman.2011.04.026 41.,OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2005;19(2):128-30. http://dx.doi.org/10.1191/0269216305pm998oa 42.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2014;19(8):1215-21. http://dx.doi.org/10.1111/resp.12360 43.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2014;21(2):81-85. http://dx.doi.org/10.1097/CPM.0000000000000031 44.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2006;27(1):136-42. http://dx.doi.org/10.1183/09031936.06.00037005 45.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
1998;158(6):1804-8. http://dx.doi.org/10.1164/ajrccm.158.6.9804105 46.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2006;129(3):794-800. http://dx.doi.org/10.1378/ chest.129.3.794 47.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2006;131(2):438-46. http://dx.doi.org/10.1016/j.jtcvs.2005.10.014 48.,OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2013;1(5):369-76. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2011;184(12):1390-4. http://dx.doi.org/10.1164/rccm.201101- 0138OC 50.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2000;161(1):5-8. http://dx.doi.org/10.1164/ajrccm.161.1.9906062 51.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2009;136(3):772-8. http://dx.doi.org/10.1378/chest.08-2776 53.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2015;19(1):385-91. http://dx.doi.org/10.1007/s11325-014-1033-6 54.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2007;30(4):715-21. http://dx.doi.org/10.1183/09031936.00107206 55.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2010;363(7):620-8. http://dx.doi.org/10.1056/NEJMoa1002110 56.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2014;190(2):208-17. http://dx.doi.org/10.1164/rccm.201403-0446OC 57.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2013;143(6):1699-708. http://dx.doi.org/10.1378/chest.12-1594 58.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2012;33(1):51-7. http://dx.doi.org/10.1016/j.ccm.2011.12.005 59.,OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2009;136(1):10-5. http://dx.doi.org/10.1378/chest.08-2306 60.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2008;178(12):1257-61. http://dx.doi.org/10.1164/rccm.200805-725OC 61.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
http://dx.doi.org/10.1002/14651858.cd006322.pub3 62.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2014;108(1):203-10. http://dx.doi.org/10.1016/j.rmed.2013.11.016 63.,OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2015;34(1):1-15. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2007;176(7):636-43. http://dx.doi.org/10.1164/ rccm.200703-463PP 65.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2008;178(9):948-55. http://dx.doi.org/10.1164/rccm.200709-1446OC 67.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2008;177(1):75-81. http://dx.doi.org/10.1164/rccm.200705-732OC 68.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2010;181(6):604-10. http://dx.doi.org/10.1164/rccm.200906-0964OC 69.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2011;184(1):92-9.  http://dx.doi.org/10.1164/rccm.201011-1874OC 70.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2011;16(5):776-83. http://dx.doi.org/10.1111/j.1440- 1843.2011.01955.x 71.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2012;186(1):88-95.  http://dx.doi.org/10.1164/rccm.201202-0314OC 72.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2013;158(9):641-9. http://dx.doi.org/10.7326/0003-4819-158-9-201305070-00003 73.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2013;42(6):1622-32. http://dx.doi.org/10.1183/09031936.00104612 465 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2013;68(2):155- 62. http://dx.doi.org/10.1136/thoraxjnl-2012-20240375.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
2014;370(22):2093-101. http://dx.doi.org/10.1056/NEJMoa1401739 466 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/c8/13/1806-3713-jbpneu-41-05-00454.PMC4635093.pdf
ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37132015000000108J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/7a/8d/1806-3713-jbpneu-41-05-00473.PMC4635095.pdf
2008;46(3):327-60. http://dx.doi.org/10.1086/525258 2.,Non-OADS,/arxiv_data1/oa_pdf/7a/8d/1806-3713-jbpneu-41-05-00473.PMC4635095.pdf
2015;70(3):270-7. http://dx.doi.org/10.1136/thoraxjnl-2014-206291 3.,Non-OADS,/arxiv_data1/oa_pdf/7a/8d/1806-3713-jbpneu-41-05-00473.PMC4635095.pdf
1966;41(215):34-43. http://dx.doi.org/10.1136/adc.41.215.34 4.,Non-OADS,/arxiv_data1/oa_pdf/7a/8d/1806-3713-jbpneu-41-05-00473.PMC4635095.pdf
1991;143(2):431-6. http://dx.doi.org/10.1164/ajrccm/143.2.431 5.,Non-OADS,/arxiv_data1/oa_pdf/7a/8d/1806-3713-jbpneu-41-05-00473.PMC4635095.pdf
2003;22:357-9. http://dx.doi.org/10.1007/s10096-003-0939-x 6.,Non-OADS,/arxiv_data1/oa_pdf/7a/8d/1806-3713-jbpneu-41-05-00473.PMC4635095.pdf
2006;38(10):945-9.  http://dx.doi.org/10.1080/003655406006065807.,Non-OADS,/arxiv_data1/oa_pdf/7a/8d/1806-3713-jbpneu-41-05-00473.PMC4635095.pdf
2014;48(9):1225-9. http://dx.doi.org/10.1177/1060028014537611 8.,Non-OADS,/arxiv_data1/oa_pdf/7a/8d/1806-3713-jbpneu-41-05-00473.PMC4635095.pdf
2001;10(2):181-3. http://dx.doi.org/10.1136/tc.10.2.181 9.,Non-OADS,/arxiv_data1/oa_pdf/7a/8d/1806-3713-jbpneu-41-05-00473.PMC4635095.pdf
2003;60(8):595-8. http://dx.doi.org/10.1136/ oem.60.8.595 11.,Non-OADS,/arxiv_data1/oa_pdf/7a/8d/1806-3713-jbpneu-41-05-00473.PMC4635095.pdf
2015;53(5):417-39. http://dx.doi.org/10.1093/mmy/myv020 12.,Non-OADS,/arxiv_data1/oa_pdf/7a/8d/1806-3713-jbpneu-41-05-00473.PMC4635095.pdf
2011;52(9):1144-55. http://dx.doi.org/10.1093/cid/cir122 477 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/7a/8d/1806-3713-jbpneu-41-05-00473.PMC4635095.pdf
ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37132015000000150J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/3c/f0/1806-3713-jbpneu-41-05-00478.PMC4635096.pdf
2013;188(6):733-48. http://dx.doi.org/10.1164/rccm.201308-1483ST 2.,Non-OADS,/arxiv_data1/oa_pdf/3c/f0/1806-3713-jbpneu-41-05-00478.PMC4635096.pdf
2004;126(6):2007-13. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/f0/1806-3713-jbpneu-41-05-00478.PMC4635096.pdf
2011;12:111. http://dx.doi.org/10.1186/1465-9921-12- 111 4.,Non-OADS,/arxiv_data1/oa_pdf/3c/f0/1806-3713-jbpneu-41-05-00478.PMC4635096.pdf
2014;44(2):289-96. http://dx.doi.org/10.1183/09031936.00088414 5.,Non-OADS,/arxiv_data1/oa_pdf/3c/f0/1806-3713-jbpneu-41-05-00478.PMC4635096.pdf
2008;21(6):784-7. http://dx.doi.org/10.1038/modpathol.2008.56 479 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/3c/f0/1806-3713-jbpneu-41-05-00478.PMC4635096.pdf
ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37132015000000126J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/30/20/1806-3713-jbpneu-41-05-00480.PMC4635097.pdf
Available from: http://www.revistaavft.com/ avft%202%202009/hoja4.html 2.,Non-OADS,/arxiv_data1/oa_pdf/30/20/1806-3713-jbpneu-41-05-00480.PMC4635097.pdf
2005;24(6):538-41.  http://dx.doi.org/10.1097/01.inf.0000164769.22033.2c 481 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/30/20/1806-3713-jbpneu-41-05-00480.PMC4635097.pdf
ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37132015000000095J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/44/22/1806-3713-jbpneu-41-05-00482.PMC4635098.pdf
Available from:  http://www.esid.org 3.,Non-OADS,/arxiv_data1/oa_pdf/44/22/1806-3713-jbpneu-41-05-00482.PMC4635098.pdf
2004;76(4):707-26. http://dx.doi.org/10.1590/S0001-37652004000400007 5.,Non-OADS,/arxiv_data1/oa_pdf/44/22/1806-3713-jbpneu-41-05-00482.PMC4635098.pdf
1999;92(1):34-48. http://dx.doi.org/10.1006/clim.1999.4725 6.,Non-OADS,/arxiv_data1/oa_pdf/44/22/1806-3713-jbpneu-41-05-00482.PMC4635098.pdf
1999;93(3):190-7. http://dx.doi.org/10.1006/clim.1999.4799 8.,Non-OADS,/arxiv_data1/oa_pdf/44/22/1806-3713-jbpneu-41-05-00482.PMC4635098.pdf
2002;28(3):155-8. http://dx.doi.org/10.1590/S0102-35862002000300008 483 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/44/22/1806-3713-jbpneu-41-05-00482.PMC4635098.pdf
ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37132015000000160J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/82/8d/1806-3713-jbpneu-41-05-00484.PMC4635099.pdf
ISSN 1806-3713 © 2015 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37132015000000215J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/17/93/1806-3713-jbpneu-41-05-00485.PMC4635100.pdf
2015;41(5):486-486 ImagIng In Pulmonary medIcIne http://dx.doi.org/10.1590/S1806-37132015000000066,Non-OADS,/arxiv_data1/oa_pdf/cb/9f/1806-3713-jbpneu-41-05-00486.PMC4635101.pdf
"Journal of Human Genetics (2015) 60,613 –617; doi:10.1038/jhg.2015.82; published online 16 July 2015 INTRODUCTION Inherited diseases are frequently found worldwide and a major group of inherited diseases is autosomal recessive disorders such as non-syndromic hereditary hearing impairment, Fukuyama congenitalmuscular dystrophy, Wilson disease and xeroderma pigmentosum.The carrier frequencies of these diseases are estimated to be 0.9% for Fukuyama congenital muscular dystrophy, 11.1% for Wilson disease2 and 0.9% for xeroderma pigmentosum (see the Japan Intractable Disease Information Center ’s website: http://www.nanbyou.or.jp/ entry/112).",Non-OADS,/arxiv_data1/oa_pdf/1a/a4/jhg201582a.PMC4635169.pdf
The result from our questionnaire are consistent with Japan Trakreport in which 10.8% of the randomly selected 15 036 respondents reportedexperiencing hearing dif ﬁculty (see the Japan Trak website: http://www.atpress.,Non-OADS,/arxiv_data1/oa_pdf/1a/a4/jhg201582a.PMC4635169.pdf
"Cys60 is evolutionarily conserved, while the leucine residue of p.Phe106Leu is found in Xenopus laevis .T o predict the effect of the variants, we carried out computer analysis using the Sorting Intolerant from Tolerant (SIFT: http://sift.jcvi.org/) and Polymorphism Phenotyping (PolyPhen2: http://genetics.bwh.",Non-OADS,/arxiv_data1/oa_pdf/1a/a4/jhg201582a.PMC4635169.pdf
"Analysis of the p.Val63Val (c.189G4T) synonymous variant using the prediction programNNSPLICE (http://www.fruit ﬂy.org/seq_tools/splice.html) indicates that this variant is not expected to be either a donor or an acceptorsite for splicing and is, therefore, likely to be non-pathogenic.",Non-OADS,/arxiv_data1/oa_pdf/1a/a4/jhg201582a.PMC4635169.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/GJB2 carrier frequency in the Japanese population MT a n i g u c h i et al 617 Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/1a/a4/jhg201582a.PMC4635169.pdf
"To view a copy of this license, visit http://creativecom mons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Journal of Human Genetics website (http://www.nature.com/jhg)Whole genome imputation of Japanese individuals Y Kawai et al 587 Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/80/2b/jhg201568a.PMC4635170.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.940 Adv Ther (2015) 32:929–943",Non-OADS,/arxiv_data1/oa_pdf/ac/39/12325_2015_Article_249.PMC4635174.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ee/39/12325_2015_Article_250.PMC4635176.pdf
2015. https://www.nccn.org/store/ login/login.aspx?ReturnURL=http://www.nccn.org/ professionals/physician_gls/pdf/amyloidosis.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ee/39/12325_2015_Article_250.PMC4635176.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/04/3c/12325_2015_Article_254.PMC4635178.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/cb/7f/12325_2015_Article_252.PMC4635180.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/cc/84/12325_2015_Article_244.PMC4635182.pdf
"Brussels, Belgium: InternationalDiabetes Federation; 2013. http://www.idf.org/ diabetesatlas .",Non-OADS,/arxiv_data1/oa_pdf/cc/84/12325_2015_Article_244.PMC4635182.pdf
http://www.ema.europa.eu/ema/ .,Non-OADS,/arxiv_data1/oa_pdf/cc/84/12325_2015_Article_244.PMC4635182.pdf
http://www.medicines.org.uk/emc/ medicine/8591/SPC/NovoMix ?30?Penﬁll ?100?,Non-OADS,/arxiv_data1/oa_pdf/cc/84/12325_2015_Article_244.PMC4635182.pdf
http://www.medicines.org.uk/emc/ medicine/9314/SPC/Humalog ?100U ?ml%2c ?,Non-OADS,/arxiv_data1/oa_pdf/cc/84/12325_2015_Article_244.PMC4635182.pdf
http://www.medicines.,Non-OADS,/arxiv_data1/oa_pdf/cc/84/12325_2015_Article_244.PMC4635182.pdf
http://www.medicines.org.uk/emc/ medicine/25506/SPC/Lantus ?100?units ?ml?,Non-OADS,/arxiv_data1/oa_pdf/cc/84/12325_2015_Article_244.PMC4635182.pdf
http://www.medicines.org.uk/emc/ medicine/14584/SPC/Levemir ?,Non-OADS,/arxiv_data1/oa_pdf/cc/84/12325_2015_Article_244.PMC4635182.pdf
http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/cc/84/12325_2015_Article_244.PMC4635182.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/7b/53/12325_2015_Article_251.PMC4635183.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Journal of Cerebral Blood Flow & Metabolism website (http://www.nature.",Non-OADS,/arxiv_data1/oa_pdf/1a/41/jcbfm2015139a.PMC4635240.pdf
"With the available transmit strength of 1500 Hz, single-voxel PRESS spectroscopic 8 mm3(typically, 2 × 2 × 2 or 2 × 1.8 × 2.2 mm) acquisitions (17 minutes per acquisition) at TE 10 ms and40 ms were performed separately over the left and right hippocampus.Water suppression was performed using a VAPOR prespin echo sequence.LCM (http://s-provencher.com/pages/lcmodel.shtml) 25analysis was per- formed for determination of the metabolite pro ﬁles and taken as a ratio to total creatine.",OADS,/arxiv_data1/oa_pdf/3d/fb/jcbfm2015145a.PMC4635243.pdf
The μPET and μCT images were fused using the landmark tool of the open source image analysis software VINCI (Version: 4.19.0; http://www.nf.mpg.de/vinci3/).,OADS,/arxiv_data1/oa_pdf/fc/af/jcbfm2015149a.PMC4635244.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Journal of Cerebral Blood Flow & Metabolism website (http://www.nature.",Non-OADS,/arxiv_data1/oa_pdf/fc/af/jcbfm2015149a.PMC4635244.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/86/rjv133.PMC4635321.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/2d/55/aps201551a.PMC4635324.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/fb/06/aps201586a.PMC4635333.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)miR-125b-5p exerts anti-myeloma activity E Morelli et al 2183 © 2015 Macmillan Publishers Limited Leukemia (2015) 2173 –2183",Non-OADS,/arxiv_data1/oa_pdf/64/bb/leu2015124a.PMC4635336.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu).Metformin suppresses bortezomib-induced autophagy S Jagannathan et al 2191 © 2015 Macmillan Publishers Limited Leukemia (2015) 2184 –2191",Non-OADS,/arxiv_data1/oa_pdf/24/d8/leu2015157a.PMC4635337.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/OPEN",Non-OADS,/arxiv_data1/oa_pdf/b9/48/srep15938.PMC4635402.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/6b/main.PMC4635408.pdf
"For example, isolated mitochondria can generate ROS via ETCContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.09.003 2213-2317/ &2015 The Authors.",OADS,/arxiv_data1/oa_pdf/b9/6b/main.PMC4635408.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: AA, antimycin A; CI, complex I or NADH: Ubiquinone oxidoreductase; CIII, complex III or Ubiquinol-cytochrome c oxidoreductase; Δψ, mitochondrial membrane potential; ETC, electron transport chain; FCCP, carbonyl cyanide-p-tri ﬂuoromethoxyphenylhydrazone; HEt, hydroethidine; [H 2O2]c, cytosolic hydrogen peroxide concentration; [H 2O2]ext, extracellular hydrogen peroxide concentration; [H 2O2]m, mitochondrial hydrogen peroxide concentration; IMS, intermembrane space; MIM, mi- tochondrial inner membrane; MOM, mitochondrial outer membrane; OXPHOS, oxidative phosphorylation; PMF, proton motive force; RET, reverse electr on transfer; ROS, reactive oxygen species; ROT, rotenone nCorrespondence to: 286 Biochemistry, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Centre (RUMC), P.O.",Non-OADS,/arxiv_data1/oa_pdf/b9/6b/main.PMC4635408.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs204/en/.,Non-OADS,/arxiv_data1/oa_pdf/09/a7/IJPVM-5-200.PMC4635410.pdf
Available from: http://www.cdc.govNCIDOD/DISEASE/ HEPATITIS/b/faqb.htm.,Non-OADS,/arxiv_data1/oa_pdf/09/a7/IJPVM-5-200.PMC4635410.pdf
Available from:  http://www.utdol.com.,Non-OADS,/arxiv_data1/oa_pdf/09/a7/IJPVM-5-200.PMC4635410.pdf
Available  from: http://www.who.int/entity/wer/2009/wer8440.pdf.,OADS,/arxiv_data1/oa_pdf/ba/fd/IJPVM-5-213.PMC4635415.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/d0/3a/IJPVM-5-231.PMC4635416.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ 526 Pediatric ReSeARCH       Volume 78  |  N umber 5  |  November 2015",Non-OADS,/arxiv_data1/oa_pdf/03/f4/pr2015145a.PMC4635434.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/23/43/main.PMC4635435.pdf
"These changes likely involve the production of reactive oxygen species (ROS) and their scavenging by CoQ [18,19].T h e r e - fore, CoQ plays an important role in homeostasis and disease states.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.10.004 2213-2317/ &2015 The Authors.",OADS,/arxiv_data1/oa_pdf/23/43/main.PMC4635435.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/23/43/main.PMC4635435.pdf
"161 Copyright © 2015 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286 Welcoming a global microbiome  initiative proposal for precision  dentistry Tae-Il Kim  Department of Periodontology, Seoul National University School of Dentistry, Seoul, Korea Editorial J Periodontal Implant Sci 2015;45:161-161 http://dx.doi.org/10.5051/jpis.2015.45.5.161 Received:  Oct. 29, 2015 Accepted:  Oct. 29, 2015 *Correspondence:   Tae-Il Kim (Editor-in-Chief)  Department of Periodontology, Seoul National  University School of Dentistry, 101 Daehak-ro,  Jongno-gu, Seoul 03080, Korea  E-mail: periopf@snu.ac.kr  Tel: +82-2-2072-2642  Fax: +82-2-744-1349Periodontal diseases are the outcome of the interactions among microbes, hosts, and en - vironments, in which the microbial factor is implicated in inducing inflammatory responses  leading to tissue destruction.",Non-OADS,/arxiv_data1/oa_pdf/6b/ad/jpis-45-161.PMC4635436.pdf
ORCID Tae-Il Kim http://orcid.org/0000-0003-4087-8021 This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/6b/ad/jpis-45-161.PMC4635436.pdf
"162 Copyright © 2015 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286 Assessment of buccal bone thickness  of aesthetic maxillary region: a cone- beam computed tomography study Ramón Fuentes1,*, Tania Flores1,  Pablo Navarro1, Carlos Salamanca1,   Víctor Beltrán1, Eduardo Borie1,2 1Research Centre in Dental Sciences (CICO), Universidad de La Frontera Dental School, Temuco, Chile 2Department of Dental Materials and Prosthodontics, University of São Paulo Dental School of    Ribeirão Preto, Ribeirão Preto, Brazil Research Article J Periodontal Implant Sci 2015;45:162-168 http://dx.doi.org/10.5051/jpis.2015.45.5.162 Purpose:  The aim of this study was to analyze the anatomical dimensions of the buccal  bone walls of the aesthetic maxillary region for immediate implant placement, based upon  cone-beam computed tomography (CBCT) scans in a sample of adult patients.",Non-OADS,/arxiv_data1/oa_pdf/3e/5c/jpis-45-162.PMC4635437.pdf
"Therefore, efforts must be made to preserve bone and soft tis - sues using minimally invasive surgical techniques in accordance with clinical conditions  This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/3e/5c/jpis-45-162.PMC4635437.pdf
ORCID Ramón Fuentes http://orcid.org/0000-0002-5895-024X Tania Flores http://orcid.org/0000-0001-7582-6278 Pablo Navarro http://orcid.org/0000-0002-5467-5009 Carlos Salamanca http://orcid.org/0000-0003-0135-3599 Víctor Beltrán http://orcid.org/0000-0001-6046-821X Eduardo Borie http://orcid.org/0000-0001-6175-6221  REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/3e/5c/jpis-45-162.PMC4635437.pdf
"169 Copyright © 2015 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286 Peri-implant crevicular fluid levels of  cathepsin-K, RANKL, and OPG around  standard, short, and mini dental  implants after prosthodontic loading   Raif Alan1,*, İsmail Marako ğlu2, Seyfullah Halilo ğlu3   1Department of Periodontology, Necmettin Erbakan University Faculty of Dentistry, Konya, Turkey 2Department of Periodontology, Selcuk University Faculty of Dentistry, Konya, Turkey 3Department of Biochemistry, Selcuk University Faculty of Dentistry, Konya, Turkey Research Article J Periodontal Implant Sci 2015;45:169-177 http://dx.doi.org/10.5051/jpis.2015.45.5.169 Purpose:  Despite the high success rates of endosseous dental implants, their placement is  restricted according to the height and volume of bone available.",Non-OADS,/arxiv_data1/oa_pdf/69/17/jpis-45-169.PMC4635438.pdf
"In fact, in the presence of a thin ridge and narrow gaps between two natural teeth,  This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/69/17/jpis-45-169.PMC4635438.pdf
ORCID Raif Alan http://orcid.org/0000-0003-2602-3481 İsmail Marako ğlu http://orcid.org/0000-0002-9869-7883 Seyfullah Halilo ğlu http://orcid.org/0000-0001-8269-9668 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/69/17/jpis-45-169.PMC4635438.pdf
"178 Copyright © 2015 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286 Humoral immune responses to  periodontal pathogens in the elderly Uttom Shet1, Hee-Kyun Oh1, Hyun-Ju Chung2, Young-Joon Kim2, Ok-Su Kim2,  Hoi-Jeong Lim3, Min-Ho Shin4, Seok-Woo Lee2,5,* 1Department of Oral & Maxillofacial Surgery, Chonnam National University School of Dentistry, Gwangju, Korea 2Department of Periodontology, Chonnam National University School of Dentistry, Gwangju, Korea 3Department of Orthodontics, Chonnam National University School of Dentistry, Gwangju, Korea 4Department of Preventive Medicine, Chonnam National University Medical School, Gwangju, Korea 5Department of Dental Education, Dental Science Research Institute, Chonnam National University School    of Dentistry, Gwangju, Korea Research Article J Periodontal Implant Sci 2015;45:178-183 http://dx.doi.org/10.5051/jpis.2015.45.5.178 Purpose:  Elderly people are thought to be more susceptible to periodontal disease due to  reduced immune function associated with aging.",Non-OADS,/arxiv_data1/oa_pdf/14/fb/jpis-45-178.PMC4635439.pdf
"Chronic diseases with multiple etiologies, such as cancer, cardiovas - cular disease, respiratory disease, diabetes, and oral infection are thought to be more prev - This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/14/fb/jpis-45-178.PMC4635439.pdf
ORCID Uttom Shet http://orcid.org/0000-0001-6369-7835 Hee-Kyun Oh http://orcid.org/0000-0003-0391-7095 Hyun-Ju Chung http://orcid.org/0000-0001-8461-5093 Young-Joon Kim http://orcid.org/0000-0003-1397-8166 Ok-Su Kim http://orcid.org/0000-0001-8528-9314 Hoi-Jeong Lim http://orcid.org/0000-0002-0795-8305 Min-Ho Shin http://orcid.org/0000-0002-2217-5624 Seok-Woo Lee http://orcid.org/0000-0002-7589-282X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/14/fb/jpis-45-178.PMC4635439.pdf
"184 Copyright © 2015 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286 Effect of root planing on the  reduction of probing depth and the  gain of clinical attachment depending  on the mode of interproximal bone  resorption Yoon Mi Choi1, Ju-Youn Lee1,2, Jeomil Choi1,2, Ji-Young Joo1,* 1Department of Periodontology, Pusan National University Dental Hospital, Dental Research Institute,    Yangsan, Korea 2Department of Periodontology, Pusan National University School of Dentistry, Yangsan, Korea Research Article J Periodontal Implant Sci 2015;45:184-189 http://dx.doi.org/10.5051/jpis.2015.45.5.184 Purpose:  The purpose of the present study was to evaluate the effect of root planing on  the reduction of probing pocket depth and the gain of clinical attachment depending on  the pattern of bone resorption (vertical versus horizontal bone loss) in the interproximal  aspect of premolar teeth that showed an initial probing pocket depth of 4–6 mm.",Non-OADS,/arxiv_data1/oa_pdf/e9/01/jpis-45-184.PMC4635440.pdf
A long-term observational study reported that attachment loss increased by 0.05–0.3 mm  This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e9/01/jpis-45-184.PMC4635440.pdf
ORCID Yoon Mi Choi http://orcid.org/0000-0002-2925-2565 Ju-Youn Lee http://orcid.org/0000-0002-0772-033X Jeomil Choi http://orcid.org/0000-0002-7491-6711 Ji-Young Joo http://orcid.org/0000-0002-4050-5797REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e9/01/jpis-45-184.PMC4635440.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/12/main.PMC4635481.pdf
http://dx.doi.org/10.1016/j.pmedr.2015.09.011 2211-3355/© 2015 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/44/12/main.PMC4635481.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/12/main.PMC4635481.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/44/12/main.PMC4635481.pdf
Information on how to obtain the Add Health data ﬁles is available on the Add Health website ( http://www.cpc.unc.edu/addhealth ).,OADS,/arxiv_data1/oa_pdf/44/12/main.PMC4635481.pdf
"Glossary: Chronic Pain Accessed June 8, 2015 from http://www.theacpa.org/Glossary .",Non-OADS,/arxiv_data1/oa_pdf/44/12/main.PMC4635481.pdf
"The National Longitudinal Study of Adolescent to Adult Health: Research Design Accessed January30, 2015 from http://www.cpc.unc.edu/projects/addhealth/design .",Non-OADS,/arxiv_data1/oa_pdf/44/12/main.PMC4635481.pdf
"The National Academies Press (Accessed June 8, 2015 from http://www.nap.edu/openbook.php?record_id=13172 ).",Non-OADS,/arxiv_data1/oa_pdf/44/12/main.PMC4635481.pdf
"IASP Taxonomy, Pain Terms Accessed June 8, 2015 from http://www.iasp-pain.org/Taxonomy?navItemNumber=576#Pain .",OADS,/arxiv_data1/oa_pdf/44/12/main.PMC4635481.pdf
"7-10In parallel to these recent functional studies, unprecedentedamounts of molecular-level data have beencollected on primary human tumorsthrough the efforts of The CancerGenome Atlas (http://cancergenome.nih.gov).",OADS,/arxiv_data1/oa_pdf/ad/62/kmco-02-04-996418.PMC4635483.pdf
"© Mahya Mehrmohamadi and Jason W Locasale *Correspondence to: Jason W Locasale; Email: Locasale@cornell.eduSubmitted: 12/03/2014; Revised: 12/04/2014; Accepted: 12/05/2014 http://dx.doi.org/10.1080/23723556.2014.996418 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/62/kmco-02-04-996418.PMC4635483.pdf
Cell Rep 2014; 9:1507-1519; PMID:25456139; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ad/62/kmco-02-04-996418.PMC4635483.pdf
Nat Revi Cancer 2013; 13:572-583; PMID:23822983; http://dx.doi.org/ 10.1038/nrc3557 3.,Non-OADS,/arxiv_data1/oa_pdf/ad/62/kmco-02-04-996418.PMC4635483.pdf
Science 2012; 336:1040-1044; PMID:22628656; http://dx.doi.org/10.1126/science.1218595 4.,Non-OADS,/arxiv_data1/oa_pdf/ad/62/kmco-02-04-996418.PMC4635483.pdf
Nature 2013; 493:542-546;PMID:23242140; http://dx.doi.org/10.1038/ nature11743 5.,Non-OADS,/arxiv_data1/oa_pdf/ad/62/kmco-02-04-996418.PMC4635483.pdf
Nat Genet 2011; 43:869-874; PMID:21804546; http://dx.doi.org/10.1038/ng.890 6.,OADS,/arxiv_data1/oa_pdf/ad/62/kmco-02-04-996418.PMC4635483.pdf
Nature 2014; 510:298-302; PMID:24805240; http://dx.doi.org/ 10.1038/nature132368.,OADS,/arxiv_data1/oa_pdf/ad/62/kmco-02-04-996418.PMC4635483.pdf
Mol Cell 2014; 55:253-263; PMID:24882210; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ad/62/kmco-02-04-996418.PMC4635483.pdf
Cancer Discov 2014; 4(12):1406-17;PMID:25186948; http://dx.doi.org/10.1158/2159- 8290 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/ad/62/kmco-02-04-996418.PMC4635483.pdf
"This is an Open Access article, distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/e2/S0007114515003578a.PMC4635606.pdf
"Supplementary material For supplementary material/s referred to in this article, please visit http://dx.doi.org/doi:10.1017/S0007114515003578 References 1.",Non-OADS,/arxiv_data1/oa_pdf/9a/e2/S0007114515003578a.PMC4635606.pdf
http://www.framinghamheartstudy.org/ (accessed February 2012).,Non-OADS,/arxiv_data1/oa_pdf/9a/e2/S0007114515003578a.PMC4635606.pdf
"Agricultural Research Service, United States Department of Agriculture (2013) National Nutrient Database for StandardReference, Release 26. http://ndb.nal.usda.gov/ndb/search/ list (accessed December 2013).",OADS,/arxiv_data1/oa_pdf/9a/e2/S0007114515003578a.PMC4635606.pdf
http://www.choosemyplate.gov/dairy.,Non-OADS,/arxiv_data1/oa_pdf/9a/e2/S0007114515003578a.PMC4635606.pdf
Released 31 January 2011. http://www.cnpp.usda.gov/Publications/ DietaryGuidelines/2010/PolicyDoc/PolicyDoc.pdf (accessedSeptember 2012).,Non-OADS,/arxiv_data1/oa_pdf/9a/e2/S0007114515003578a.PMC4635606.pdf
"2Moreover, early treat- ment with cART rest rains the level of immune activation and facilitatesKeywords: antiretroviral therapy, func- tional cure, HIV-1, immunotherapy, ret-roviral persistence, T-cell responses,therapeutic vaccines © Nesrina Imami and Anna A Herasimtschuk *Correspondence to: Nesrina Imami;Email: n.imami@imperial.ac.uk Submitted: 02/03/2015Accepted: 02/15/2015 http://dx.doi.org/10.1080/21645515.2015.1021523 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Clin Infect Dis 2014; 59 Suppl 1:S3-6; PMID:24926030; http://dx.doi.org/ 10.1093/cid/ciu321 2.,OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
JAcquir Immune Deﬁc Syndr 2004; 36:783-90; PMID:15213561; http://dx.doi.org/10.1097/ 00126334-200407010-00004 3.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Future HIV Therapy 2007; 1:171-79; http://dx.doi.org/ 10.2217/17469600.1.2.171 4.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Nat Med 2003; 9:727-8; PMID:12754504; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Clin Exp Immunol 2005; 142:354-61; PMID:16232224; http://dx.doi.org/10.1111/j.1365-2249.2005.02918.x 6.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
N Engl J Med2006; 355:2283-96; PMID:17135583; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Science 2009; 323:1304-7; PMID:19265012; http://dx.doi.org/10.1126/science.1165706 8.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Front Immunol2013; 4:58; PMID:23459797; http://dx.doi.org/ 10.3389/ﬁmmu.2013.00058 10.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Immunity 2013; 39:633-45; PMID:24138880; http://dx.doi.org/10.1016/j.immuni.2013.10.001 11.,OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
PLoS One 2011; 6:e18164; PMID:21483676; http://dx.doi.org/ 10.1371/journal.pone.0018164 13.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Clin Immunol 2002; 102:154-61; PMID:11846457;http://dx.doi.org/10.1006/clim.2001.5164 15.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
J Immune Based Ther Vaccines 2007; 5:6;PMID:17428345; http://dx.doi.org/10.1186/1476- 8518-5-6 16.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
AIDS 2003; 17:1121-6; PMID:12819512; http://dx.doi.org/10.1097/00002030-200305230-00002 17.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Vaccine 2014; 32:7005-13; PMID:25454870; http://dx.doi.org/10.1016/j.vaccine.2014.09.072 18.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
PLoS One 2012; 7:e33948; PMID:22479485; http://dx.doi.org/10.1371/journal.pone.0033948 19.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Curr Opin HIV AIDS 2015; 10:18-28; PMID:25415421; http://dx.doi.org/ 10.1097/COH.0000000000000122 20.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Front Immunol 2014; 5:417; PMID:25250026; http://dx.doi.org/10.3389/ ﬁmmu.2014.00417 21.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Vaccine 2011; 29:5558-66; PMID:21300092; http://dx.doi.org/10.1016/j.vaccine.2011.01.064 22.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
PLoS One 2011; 6:e19252; PMID:21603651; http://dx.doi.org/10.1371/journal.pone.0019252 23.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Clin Vaccine Immunol 2011; 18:1577-81; PMID:21752954; http://dx.doi.org/10.1128/CVI.05045-1124.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Vaccine 2012; 30:4046-54; PMID:22549090; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Cytokine Growth Factor Rev 2012; 23:207-14; PMID:22738931; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
N Engl J Med 2009; 361:1548-59; PMID:19828532; http://dx.doi.org/10.1056/NEJMoa0903175 27.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Nat Med 1999; 5:651-5; PMID:10371503; http://dx.doi.org/10.1038/9498 28.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
AIDS 2003; 17:628-9; PMID:12598786; http://dx.doi.org/10.1097/00002030-200303070-00020 29.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Nat Med 2003; 9:540-7; PMID:12692546; http://dx.doi.org/ 10.1038/nm866 31.,OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
J Immunol 2005; 174:1913-21; PMID:15699118; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
J Infect Dis 2003; 187:320-5; PMID:12552459; http://dx.doi.org/10.1086/346056 34.,OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
AIDS 2004; 18:2199-202; PMID:15577655; http://dx.doi.org/10.1097/ 00002030-200411050-00014 35.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
J Immune Based Ther Vaccines 2005; 3:3; PMID:15904525; http://dx.doi.org/10.1186/1476-8518-3-3 36.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Vaccine 2007; 25:5882-91; PMID:17602804; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
J Acquir Immune Deﬁc Syndr 2004; 35:367-75; PMID:15097153; http://dx.doi.org/ 10.1097/00126334-200404010-00006 40.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
AIDS 2002; 16:1103-11; PMID:12004268; http://dx.doi.org/ 10.1097/00002030-200205240-00003 41.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
AIDS 2009; 23:2123-31; PMID:19625946; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
AIDS Res Hum Retroviruses 2010; 26:425-32; PMID:20415638; http://dx.doi.org/10.1089/aid.2009.0052 44.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
J Immune Based Ther Vaccines 2008; 6:7; PMID:18976455; http://dx.doi.org/10.1186/ 1476-8518-6-7 46.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Clin Exp Immunol 2013; 173:444-53; PMID:23701177; http://dx.doi.org/10.1111/cei.12141 47.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
InfectDis Clin North Am 2014; 28:633-50; PMID:25277513; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
J Immune Based Ther Vaccines2005; 3:7; PMID:16181494; http://dx.doi.org/ 10.1186/1476-8518-3-7 50.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
J Immunol 2010; 185:3007-18; PMID:20656923; http://dx.doi.org/10.4049/jimmunol.1000156 51.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
J AcquirImmune Deﬁc Syndr 2011; 56:118-24; PMID:20980914; http://dx.doi.org/10.1097/ QAI.0b013e3181fbab9f 52.,OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
J Exp Med 2008; 205:533-41;PMID:18332180; http://dx.doi.org/10.1084/ jem.20071948 53.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
J Exp Med 2008; 205:543-55; PMID:18332181; http://dx.doi.org/ 10.1084/jem.20071949 54.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Virology 2014; 454- 455:328-39; PMID:24565118; http://dx.doi.org/ 10.1016/j.virol.2014.02.008 57.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
Nat Med 2014; 20:425-9; PMID:24658076; http://dx.doi.org/10.1038/nm.3489 60.,OADS,/arxiv_data1/oa_pdf/5b/95/khvi-11-09-1021523.PMC4635699.pdf
"Exclusion criteria were: studies performed innon-EU/EEA or European overseas countries and territories, notpolio, not in humans, no seroprevalence, clinical trial, outbreak© DRE Nijsten, P Carrillo-Santisteve, A Miglietta, J Ruitenberg, and PL Lopalco *Correspondence to: PL Lopalco; Email: pierluigi.lopalco@ecdc.europa.eu Submitted: 11/24/2014; Revised: 01/15/2015; Accepted: 01/31/2015http://dx.doi.org/10.1080/21645515.2015.1016673 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
Available from: http://www.euro.who.int/en/health-topics/communicable-diseases/ poliomyelitis/publications/pre-2009/certiﬁcation-of- poliomyelitis-eradication.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
Available from: http://www.polioeradication.org/Polioandprevention/Thevirus.aspx 5.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
Available from: http://www.who.int/mediacentre/news/statements/ 2014/polio-20140505/en/.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
Avail- able from: http://ecdc.europa.eu/en/publications/Publications/polio-risk-assessment-transmission-in-Israel.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
eng; PMID:24063976; http://dx.doi.org/10.1016/j.vaccine.2013.09.021 9.,OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
Available from: http://data.euro.who.int/cisid/Default.aspx?TabID=347514.,OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
Available from: http://onlinelibrary.wiley.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
com/o/cochrane/clcentral/articles/036/CN-00141036/frame.html http://jid.oxfordjournals.org/content/175/ Supplement_1/S228.full.pdf; http://dx.doi.org/ 10.1093/infdis/175.Supplement_1.S228 16.,OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
1996; 26(6– 7):714–20; http://dx.doi.org/10.1016/S0399-077X (96)80102-8 22.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
Deut- sche Medizinische Wochenschrift 1995; 120(8):239–44; PMID:7867480; http://dx.doi.org/10.1055/s- 2008-1055339 23.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
2007; 50(5–6):771–4; PMID:17514462; http://dx.doi.org/ 10.1007/s00103-007-0239-1 24.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
eng; PMID: 12005329; http://dx.doi.org/10.1007/s00430–001- 0100-3 26.,OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
1979; 104(30):1065–7; PMID:467253; http://dx.doi.org/ 10.1055/s-0028-1129038 27.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
1986; 111(44):1670–6; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
1999; 17(7– 8):844–50; PMID:10067690; http://dx.doi.org/ 10.1016/S0264-410X(98)00269-2 30.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
2007; 196(3):145– 50; PMID:17273881; http://dx.doi.org/10.1007/ s00430-007-0036-3 32.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
1999; 289(4):475–81; PMID:10603664; http://dx.doi.org/10.1016/S0934-8840(99)80086-3 33.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
J Hyg 1986; 96(3):479–82; PMID:3016076; http://dx.doi.org/10.1017/ S0022172400066274 34.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
2005; 11(1):68–71; PMID:15649308; http://dx.doi.org/ 10.1111/j.1469-0691.2004.00998.x 35.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
Vaccine 1997; 15(6–7):747–50; PMID:9178477; http://dx.doi.org/10.1016/S0264- 410X(96)00208-3 38.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
Eur J Epidemiol 1997; 13(6):725–7; PMID:9324221; http://dx.doi.org/10.1023/A:1007331900645 41.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
Scandinavian J Infect Dis 1994; 26(4):459–67; PMID:7984979; http://dx.doi.org/ 10.3109/00365549409008620 53.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
Am J Epi- demiol 2001; 153(3):207–14; PMID:11157405; http://dx.doi.org/10.1093/aje/153.3.207 54.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
Epidemiol Infect 2002; 129(3):535–41;PMID:12558336; http://dx.doi.org/; http://dx.doi.org/ 10.1017/S0950268802007781 57.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
spa; PMID:17145026; http://dx.doi.org/10.1157/13094418 58.,OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
Int J Epidemiol 1998; 27(5):909–15; PMID:9839752; http://dx.doi.org/10.1093/ije/27.5.909 60.,OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
J Hyg 1975; 74(2):283–7; PMID:164503; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
The Lancet 1969; 294(7624):792–3; PMID:4186037; http://dx.doi.org/ 10.1016/S0140-6736(69)90496-6 68.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
Available from: http://epp.eurostat.ec.europa.eu/portal/page/por tal/population/data/main_tables.,OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
Available from: http://www.eurosurveillance.org/ViewAr ticle.aspx?ArticleId=20156 www.tandfonline.com 2131 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/6e/40/khvi-11-09-1016673.PMC4635704.pdf
"3In addition to being non-live and non-replicating, DNA vaccines are safe and immunogenic.4Vaccination with DNA has © Veronica L Scott, Ami Patel, Daniel O Villarreal, Scott E Hensley, Edwin Ragwan, Jian Yan, Niranjan Y Sardesai, Paul J Rothwell, Jonathan P Extance, L isa J Caproni, and David B Weiner*Correspondence to: David B Weiner; Email: dbweiner@mail.med.upenn.eduSubmitted: 12/01/2014; Revised: 02/05/2015; Accepted: 02/18/2015 http://dx.doi.org/10.1080/21645515.2015.1022008 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/47/khvi-11-08-1022008.PMC4635705.pdf
Sci Am 2010; 303:48-53; PMID:20583666; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/72/47/khvi-11-08-1022008.PMC4635705.pdf
Nat Rev Gen 2008; 9:776-88; PMID:18781156; http://dx.doi.org/10.1038/nrg2432 5.,Non-OADS,/arxiv_data1/oa_pdf/72/47/khvi-11-08-1022008.PMC4635705.pdf
Vaccine 2007; 25:2984-9; PMID:17306909; http://dx.doi.org/ 10.1016/j.vaccine.2007.01.063 6.,Non-OADS,/arxiv_data1/oa_pdf/72/47/khvi-11-08-1022008.PMC4635705.pdf
Vaccine 2014; 32:2833-42; PMID:24631084; http://dx.doi.org/10.1016/j.vaccine.2014.02.038 7.,Non-OADS,/arxiv_data1/oa_pdf/72/47/khvi-11-08-1022008.PMC4635705.pdf
Hum Vaccin 2008; 4:410-9; PMID:18443425; http://dx.doi.org/10.4161/hv.4.6.6177 10.,Non-OADS,/arxiv_data1/oa_pdf/72/47/khvi-11-08-1022008.PMC4635705.pdf
Mol Ther 2013; 21:251-9; PMID:23011030; http://dx.doi.org/ 10.1038/mt.2012.202 11.,OADS,/arxiv_data1/oa_pdf/72/47/khvi-11-08-1022008.PMC4635705.pdf
Nat Rev Immunol 2012; 12:479-91; PMID:22728526; http://dx.doi.org/10.1038/nri3247 12.,Non-OADS,/arxiv_data1/oa_pdf/72/47/khvi-11-08-1022008.PMC4635705.pdf
J Mol Med 2002; 80:648-54; PMID:12395149; http://dx.doi.org/10.1007/s00109-002-0362-2 14.,Non-OADS,/arxiv_data1/oa_pdf/72/47/khvi-11-08-1022008.PMC4635705.pdf
Cell 1982; 31:417-27; PMID:6186384; http://dx.doi.org/10.1016/0092- 8674(82)90135-0 16.,OADS,/arxiv_data1/oa_pdf/72/47/khvi-11-08-1022008.PMC4635705.pdf
J Hyg 1972;70:767-77; PMID:4509641; http://dx.doi.org/ 10.1017/S0022172400022610 18.,Non-OADS,/arxiv_data1/oa_pdf/72/47/khvi-11-08-1022008.PMC4635705.pdf
J Exp Med 1992; 175:1143-5; PMID:1552285; http://dx.doi.org/10.1084/jem.175.4.1143 20.,Non-OADS,/arxiv_data1/oa_pdf/72/47/khvi-11-08-1022008.PMC4635705.pdf
186:2063-8; PMID:9396777; http://dx.doi.org/ 10.1084/jem.186.12.2063 22.,Non-OADS,/arxiv_data1/oa_pdf/72/47/khvi-11-08-1022008.PMC4635705.pdf
J Immunol Methods 1998; 221:35-41; PMID:9894896; http://dx.doi.org/10.1016/S0022-1759(98)00170-724.,Non-OADS,/arxiv_data1/oa_pdf/72/47/khvi-11-08-1022008.PMC4635705.pdf
Cancer Res2014; 74:1789-800; PMID:24448242; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/47/khvi-11-08-1022008.PMC4635705.pdf
"2-4,6,8 © Yiling Jiang, Fr /C19ed/C19eric Gervais, Aline Gauthier, Charles Baptiste, Prescilla Martinon, and Xavier Bresse *Correspondence to: Xavier Bresse; Email: xbresse@spmsd.comSubmitted: 07/24/2014; Revised: 11/17/2014; Accepted: 11/26/2014 http://dx.doi.org/10.1080/21645515.2015.1011957 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
Drugs Aging 1999; 15(Suppl 1):21- 30; PMID:10690792; http://dx.doi.org/10.2165/00002512-199915001-00003 3.,Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
Semin Respir Crit Care Med 2009; 30:189-209; PMID:19296419; http://dx.doi.org/10.1055/s-0029-1202938 4.,Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
Hum Vaccin 2010; 6:918-21; PMID:21045538; http://dx.doi.org/10.4161/ hv.6.11.13352 5.,Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
PLoS One 2013; 8:e60273; PMID:23565216; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
"Available at http://www.inpes.sante.fr/10000/ themes/vaccination/guide-vaccination-2012/pdf/GuideVaccinations2012_Vaccination _contre_les_infection s_invasives_pneumocoque.pdf, accessed 7 April 2014 8.",Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
Eur J Pediatr 2002; 161:188-95;PMID:12014384; http://dx.doi.org/10.1007/s00431- 001-0907-39.,OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
"Avail-able at http://www.ema.europa.eu/docs/en_GB/docu ment_library/EPAR_-_Product_Information/human/ 001104/WC500057247.pdf, accessed 7 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
"Available at http://www.has-sante.fr/ portail/upload/docs/application/pdf/2010-04/preve nar13_-_ct-7346.pdf, accessed 7 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
"Available at http://www.ema.europa.eu/ema/ index.jsp?curl=pages/medicines/human/medicines/001104/human_med_001220.jsp&mid=WC0 b01ac058001d124, accessed 29 October 2014.",Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
Available at http://www.invs.sante.,Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
Lancet Infect Dis 2011; 11:760-8; PMID:21621466; http://dx.doi.org/10.1016/S1473-3099(11)70090-1 18.,Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
J Antimicrob Chemo-ther 2010; 65:634-43; PMID:20118164; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
"Available at http://www.invs.sante.fr/ content/download/48913/21 0452/version/1/ﬁle/Rap port_activites_CNRP2011.pdf, accessed 7 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
J Infect 2012; 65:17-24; PMID:22394683; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
Expert Rev Pharmacoecon Outcomes Res 2012; 12:631-43; PMID:23025421; http://dx.doi.org/10.1586/erp.12.55 24.,Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
Expert Rev Pharmacoecon Outcomes Res 2014; 14(6):901-11; [Epub ahead of print]; PMID:25186657; http://dx.doi.org/10.1586/14737167.2014.953932 25.,Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
"Available at http://isppd.meetingxpert.net/ISPPD_433/poster_90453/program.aspx/anchor90453, accessed 7 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
PLoS Med 2009; 6: e1000081; PMID:19468297; http://dx.doi.org/10.1371/journal.pmed.1000081 27.,Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
Hum Vac-cin Immunother 2014; 10:47-51; PMID:24030320; http://dx.doi.org/10.4161/hv.26422 29.,Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
J Infect 2010; 61:114-24; PMID:20433866; http://dx.doi.org/10.1016/j.jinf.2010.,OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
Thorax 2009; 64(Suppl 3):iii1-55; PMID:19783532; http://dx.doi.org/ 10.1136/thx.2009.121434 33.,Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
"Available at http://www.atih.sante.fr/statistiques- utilisation-des-codes-diagnostics-principaux-ou-actes- classants-dans-les-bases, accessed 7 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
Thorax 2012; 67:71-9;PMID:20729232; http://dx.doi.org/10.1136/thx.2009.,Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
Available at http://www.insee.,Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
"Available at http://www.insee.fr/fr/themes/detail.asp?reg_id=0&ref_id=bilan-demo, accessed 7 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
"Available at http://www.insee.fr/fr/themes/detail.asp?ref_id=ir-proj pop0760, accessed 7 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
"Available at http://www.irdes.fr/Publications/Rap ports2011/rap1820.pdf, accessed 7 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
"Available at http://www.invs.sante.fr/Dossiers-thematiques/Maladies-chroniques-et-traumatismes/ Maladies-cardio-vasculaires/L-insufﬁsance-cardiaque, accessed 7 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
"Available at http://www.agence-biomedecine.fr/ annexes/bilan2011/donnees/cellules/03-greffe/pdf/greffe.pdf, accessed 7 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
"Available at http://www.e-cancer.fr/component/docman/doc_download/9420-situation-de-la-chimiotherapie-des-can cers-en-2011, accessed 7 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
"Available at http://www.unaids.org/en/regionscoun tries/countries/france/, accessed 7 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
"Available athttp://www.ceredih.fr/documents/PrevRegionale.pdf, accessed 7 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
Clin Infect Dis 2008; 46:1093-100; PMID:18444830; http://dx.doi.org/10.1086/529201 56.,Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
Clin Infect Dis 2006; 43:860-8;PMID:16941367; http://dx.doi.org/10.1086/507340 57.,Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
Infect Control Hosp Epidemiol 2008; 29:385-94; PMID:18521990; http://dx.doi.org/10.1086/587155 58.,Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
N Engl J Med 1991; 325:1453-60; PMID:1944423; http://dx.doi.org/10.1056/ NEJM199111213252101 59.,Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
Available at http://www.codage.,Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
"Available at http://www.t2a-conseil.com/blog/ les-tarifs-ghs-2013-publics-et-prives-au-format-excel- avec-dms-bornes-hautes-et-bornes-basses/, accessed 7 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
"Available at http://www.atih.sante.fr/referen tiel-de-couts-mco-2011, accessed 7 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
J Antimi- crob Chemother 2007; 59:977-89; PMID:17395688;http://dx.doi.org/10.1093/jac/dkm033 65.,Non-OADS,/arxiv_data1/oa_pdf/c7/77/khvi-11-09-1011957.PMC4635706.pdf
"Copyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 302 http://j-stroke.orgIdentifying Target Risk Factors Using Population  Attributable Risks of Ischemic Stroke by Age and Sex T ai Hwan Park,a Y oungchai Ko,b Soo Joo Lee,b Kyung Bok Lee,c Jun Lee,d Moon-Ku Han,e   Jong-Moo Park,f Y ong-Jin Cho,g Keun-Sik Hong,g Dae-Hyun Kim,h Jae-Kwan Cha,h Mi-Sun Oh,i   Kyung-Ho Yu,i Byung-Chul Lee,i Byung-Woo Y oon,j Ji Sung Lee,k Juneyoung Lee,l Hee-Joon Baee aDepartment of Neurology, Seoul Medical Center, Seoul, Korea bDepartment of Neurology, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Korea cDepartment of Neurology, Soonchunhyang University College of Medicine, Seoul, Korea dDepartment of Neurology, Y eungnam University Hospital, Daegu, Korea eDepartment of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea fDepartment of Neurology, Eulji General Hospital, Eulji University, Seoul, Korea gDepartment of Neurology, Ilsan Paik Hospital, Inje University, Ilsan, Korea hDepartment of Neurology, Dong-A University Hospital, Pusan, Korea iDepartment of Neurology, Hallym University Sacred Heart Hospital, Anyang, Korea jDepartment of Neurology, Seoul National University Hospital, Seoul, Korea kClinical Research Center, Asan Medical Center, Seoul, Korea lDepartment of Biostatistics, Korea University College of Medicine, Seoul, Korea Correspondence:  Hee-Joon Bae Department of Neurology, Stroke Center,  Seoul National University Bundang  Hospital, 82 Gumi-ro 173beon-gil,  Bundang-gu, Seongnam 13620, Korea Tel: +82-31-787-7467 Fax: +82-31-787-4059 E-mail: braindoc@snu.ac.kr Received: April 24, 2015 Revised: July 24, 2015 Accepted: July 24, 2015 This work was supported by a grant from  the Korea Healthcare Technology R&D  Project, Ministry for Health, Welfare &  Family Affairs, Republic of Korea  (HI10C2020).",Non-OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
Keywords Population attributable risk; Ischemic stroke; Risk factorOriginal ArticleJournal of Stroke  201 5;17(3):302- 311 http://dx.doi.org/10.5853/jos.2015.17.3.302,Non-OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.302Vol.,OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
"3 / September 2015 http://j-stroke.org  303Introduction Stroke is a leading cause of disability and death in most coun - tries.1 Control of modifiable risk factors is the most effective ap - proach to decreasing the burden of stroke.2-4 According to an in - ternational case-controlled study (INTERSTROKE), ten risk  factors account for about 90% of the risk of stroke, and our ef - forts at stroke prevention should be concentrated on reducing  blood pressure (BP) and promoting smoking cessation, physical  activity, and a healthy diet.5  However, the impact of modifiable risk factors on stroke inci - dence is not equal between different ethnic groups, sexes, or age  groups.1,6-9 For example, in the INTERSTROKE study, hyper - tension was more strongly associated with strokes in women than  in men, and in people aged 45 years or younger than in those  aged 45 years or older.5 The recommended strategies for prevent - ing strokes in women with hypertension are different from those  in men with hypertension,7 and the optimal target BP is higher in  people aged 60 years or older than in those less than 60 years.10  Additionally, the risk of strokes in diabetic patients varies with  age8 and sex.9 Therefore, stroke prevention strategies in a specific  populations would be more effective if they were designed based  on knowledge of the population attributable risks (PARs) of in - dividual risk factors in each age- and sex-specific subpopulation  because the PAR indicates the proportion of a disease that could  be prevented by eliminating the risk factor of interest in a specific  population.11  The burden of stroke, as compared to coronary heart disease  (CHD), is disproportionately high in East Asian countries, in - cluding China, Japan, and South Korea.12 Furthermore, these  countries are the world’s fastest aging countries;13 their burden  of stroke is therefore expected to increase substantially in the  near future unless effective prevention strategies are launched.",Non-OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
Identifying Target Risk Factors Using Population Attributable Risks http://dx.doi.org/10.5853/jos.2015.17.3.302 304 http://j-stroke.orgDefinition and selection of vascular risk factors Risk factors of interest were chosen based on their relative im - portance in the primary prevention guidelines4 and the compara - bility of their definitions between the CRCS-5 registry and the  KNHANES.,OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.302Vol.,OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
3 / September 2015 http://j-stroke.org  305Table 1.,Non-OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
Identifying Target Risk Factors Using Population Attributable Risks http://dx.doi.org/10.5853/jos.2015.17.3.302 306 http://j-stroke.orgTable 3.,Non-OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.302Vol.,OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
3 / September 2015 http://j-stroke.org  307lored preventive strategies based on this knowledge may be an  effective approach to stroke prevention at a population level.,Non-OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
"Identifying Target Risk Factors Using Population Attributable Risks http://dx.doi.org/10.5853/jos.2015.17.3.302 308 http://j-stroke.orgrecent cohort study in Japan reported that the PAR of hyperten - sion decreased from 51% to 30% over 27 years.30 However, in or - der to sustain this declining trend we should pay attention to BP  control in the elderly because of the rapid aging of populations  in East Asian countries.",Non-OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.302Vol.,OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
3 / September 2015 http://j-stroke.org  309by a recall bias in the cases.,Non-OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
"Web site http://esa.un.org/wpp/ Accessed  January, 2014.",Non-OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
"Identifying Target Risk Factors Using Population Attributable Risks http://dx.doi.org/10.5853/jos.2015.17.3.302 310 http://j-stroke.orgpertension, smoking and atrial fibrillation.",Non-OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
"Web site http://kosis.kr/  Accessed March, 2015.",Non-OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.302Vol.,OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
3 / September 2015 http://j-stroke.org  31141.,Non-OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
Identifying Target Risk Factors Using Population Attributable Risks http://dx.doi.org/10.5853/jos.2015.17.3.302 http://j-stroke.orgSupplementary Table 1.,Non-OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.302Vol.,OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
3 / September 2015 http://j-stroke.orgSupplementary  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/48/b1/jos-17-3-302.PMC4635707.pdf
"Copyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405268 http://j-stroke.orgEndovascular Recanalization Therapy in Acute  Ischemic Stroke: Updated Meta-analysis of  Randomized Controlled Trials Keun-Sik Hong,a* Sang-Bae Ko,b* Ji Sung Lee,c Kyung-Ho Yu,d Joung-Ho Rhae aDepartment of Neurology, Inje University Ilsan Paik Hospital, Goyang, Korea bDepartment of Neurology, Seoul National University College of Medicine, Seoul, Korea cClinical Research Center, Asan Medical Center, Seoul, Korea dDepartment of Neurology, Hallym University College of Medicine, Anyang, Korea eDepartment of Neurology, Inha University College of Medicine, Incheon, Korea Correspondence:  Keun-Sik Hong Department of Neurology, Stroke Center,  Ilsan Paik Hospital, Inje University, 170  Juhwa-ro, Ilsanseo-gu, Goyang 10380,  Korea  Tel: +82-31-910-7680 Fax: +82-31-910-7368 E-mail: nrhks@paik.ac.kr Co-correspondence:  Joung-Ho Rha Department of Neurology, Inha  University Hospital, Inha University  College of Medicine, 27 Inhang-ro,   Jung-gu, Incheon 22332, Korea Tel: +82-32-890-3668 Fax: +82-32-890-3864 E-mail: jhrha@inha.ac.kr *Keun-Sik Hong and Sang-Bae Ko  contributed equally to the manuscript as  first authors.",Non-OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
"Keywords Acute ischemic stroke; Intra-arterial; Thrombolysis; Thrombectomy; Meta-analysisSystematic Review  Introduction Intravenous tissue plasminogen activator (IV-TPA) adminis - tered within 4.5 hours after stroke onset is the only proven thera - py for improving outcomes in patients with acute ischemic stroke (AIS).1,2 However, acute large artery occlusions are usual - ly resistant to IV-TPA.3,4 Endovascular recanalization therapy  (ERT) has an advantage of a higher recanalization rate, but dis - advantages of longer time required for treatment initiation, the  need for advanced and resource-intensive stroke care system, Journal of Stroke  201 5;17(3):268- 281 http://dx.doi.org/10.5853/jos.2015.17.3.268",Non-OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.268Vol.,OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
3 / September 2015 http://j-stroke.org  269and potential increase in symptomatic intracranial hemorrhage  (SICH).,Non-OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
"Endovascular Recanalization Therapy: Meta-analysis http://dx.doi.org/10.5853/jos.2015.17.3.268 270 http://j-stroke.orgPrimary efficacy outcome: mRS 0-2  Pooling of the results of 13 RCT s comparing ERT versus the  control (1,517 in ERT arms vs. 1,261 in control arms) from the  random-effect model showed that ERT was associated with in - creased mRS 0-2 outcome (43.3% vs. 31.9%; OR [95% CI],  1.79 [1.34, 2.40]; P< 0.001; number needed-to-treat [NNT] =   9).",OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.268Vol.,OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
3 / September 2015 http://j-stroke.org  271Table 1.,Non-OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
Endovascular Recanalization Therapy: Meta-analysis http://dx.doi.org/10.5853/jos.2015.17.3.268 272 http://j-stroke.org Risk of bias graph for all in cluded trials A Risk of bias summary for each trial B Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.268Vol.,OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
3 / September 2015 http://j-stroke.org  273Table 3.,Non-OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
Endovascular Recanalization Therapy: Meta-analysis http://dx.doi.org/10.5853/jos.2015.17.3.268 274 http://j-stroke.org Pooling all RCTs A Pooling stent-retriever RCTs B Pooling RCTs with IV-TPA rate > 75% in control arms C Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.268Vol.,OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
3 / September 2015 http://j-stroke.org  275 Pooling all RCTs A Pooling stent-retriever RCTs B Pooling RCTs with IV-TPA rate > 75% in control arms C Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
Endovascular Recanalization Therapy: Meta-analysis http://dx.doi.org/10.5853/jos.2015.17.3.268 276 http://j-stroke.org Pooling all RCTs A Pooling stent-retriever RCTs B Pooling RCTs with IV-TPA rate > 75% in control arms C Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.268Vol.,OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
3 / September 2015 http://j-stroke.org  277 Pooling all RCTs A Pooling stent-retriever RCTs B Pooling RCTs with IV-TPA rate > 75% in control arms C Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
Endovascular Recanalization Therapy: Meta-analysis http://dx.doi.org/10.5853/jos.2015.17.3.268 278 http://j-stroke.orgPooling all RCTs A Pooling stent-retriever RCTs B Pooling RCTs with IV-TPA rate > 75% in control arms C Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.268Vol.,OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
3 / September 2015 http://j-stroke.org  279Pooling all RCTs A Pooling stent-retriever RCTs B Pooling RCTs with IV-TPA rate > 75% in control arms C Figure 8.,Non-OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
Endovascular Recanalization Therapy: Meta-analysis http://dx.doi.org/10.5853/jos.2015.17.3.268 280 http://j-stroke.orgsome small trials would therefore not alter our results.,Non-OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.268Vol.,OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
3 / September 2015 http://j-stroke.org  28119.,Non-OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
Endovascular Recanalization Therapy: Meta-analysis http://dx.doi.org/10.5853/jos.2015.17.3.268 http://j-stroke.orgPooling all RCTs A Pooling stent-retriever RCTs B Pooling RCTs with IV-TPA rate > 75% in control arms C Supplementary Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.268Vol.,OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
3 / September 2015 http://j-stroke.orgSupplementary Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
Endovascular Recanalization Therapy: Meta-analysis http://dx.doi.org/10.5853/jos.2015.17.3.268 http://j-stroke.orgSupplementary Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.268Vol.,OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
3 / September 2015 http://j-stroke.orgSupplementary Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
Endovascular Recanalization Therapy: Meta-analysis http://dx.doi.org/10.5853/jos.2015.17.3.268 http://j-stroke.orgSupplementary Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/7b/d3/jos-17-3-268.PMC4635708.pdf
"Copyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/ff/jos-17-3-369.PMC4635709.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  369Updated Korean Clinical Practice Guidelines on  Decompressive Surgery for Malignant Middle  Cerebral Artery Territory Infarction  Dae-Hyun Kim,a Sang-Bae Ko,b Jae-Kwan Cha,a Keun-Sik Hong,c Kyung-Ho Yu,d Ji Hoe Heo,e   Sun-Uck Kwon,f Hee-Joon Bae,g Byung-Chul Lee,d Byung-Woo Y oon,b Jeong Eun Kim,h  Hyun-Seung Kang,h Dae-Hee Seo,i Sukh-Que Park,j Seung Hun Sheen,k Hyun Sun Park,l   Sung Don Kang,m Jae Min Kim,n Chang Wan Oh,o In Sung Park,p Joung-Ho Rhaq aDepartment of Neurology, Dong-A University College of Medicine, Busan, Korea bDepartment of Neurology, Seoul National University College of Medicine, Seoul, Korea cDepartment of Neurology, Inje University College of Medicine, Goyang, Korea dDepartment of Neurology, Hallym University College of Medicine, Anyang, Korea eDepartment of Neurology, Y onsei University College of Medicine, Seoul, Korea fDepartment of Neurology, University of Ulsan College of Medicine, Seoul, Korea gDepartment of Neurology, Seoul National University College of Medicine, Seongnam, Korea hDepartment of Neurosurgery, Seoul National University College of Medicine, Seoul, Korea iDepartment of Neurosurgery, Good Morning Hospital, Pyeongtaek, Korea jDepartment of Neurosurgery, Soonchunhyang University School of Medicine, Seoul, Korea kDepartment of Neurosurgery, Bundang Jesaeng General Hospital, Seongnam, Korea lDepartment of Neurosurgery, Inha University College of Medicine, Incheon, Korea mDepartment of Neurosurgery, Wonkwang University School of Medicine, Iksan, Korea nDepartment of Neurosurgery, Hanyang University College of Medicine, Seoul, Korea oDepartment of Neurosurgery, Seoul National University College of Medicine, Seongnam, Korea pDepartment of Neurosurgery, Gyeongsang National University School of Medicine, Jinju, Korea qDepartment of Neurosurgery, Inha University College of Medicine, Incheon, Korea  Correspondence:  Joung-Ho Rha  Department of Neurology, Inha  University Medical College,   27 Inhang-ro, Jung-gu, Incheon 22332,  Korea  Tel: +82-32-890-3668 Fax: +82-32-890-3864 Email: jhrha@inha.ac.kr Received: January 13, 2015 Revised: March 16, 2015 Accepted: April 2, 2015 This study was supported by a grant of the  Korea Healthcare Technology R &D Project  (HI10C2020), Ministry of Health and  Welfare, Republic of Korea.GuidelineJournal of Stroke  201 5;17(3):369- 376 http://dx.doi.org/10.5853/jos.2015.17.3.369 Introduction Clinical practice guidelines (CPGs), which provide systemic reviews of accumulated scientif - ic evidence, are used by clinicians to choose optimal treatment modalities.",Non-OADS,/arxiv_data1/oa_pdf/74/ff/jos-17-3-369.PMC4635709.pdf
"Decompressive Surgery for Malignant MCA Infarction http://dx.doi.org/10.5853/jos.2015.17.3.369 370 http://j-stroke.orgWe then narrowed this pool of articles down by limiting the  search to prospective, randomized clinical trials, pooled analyses,  and meta-analyses and found five such articles that were published  during this period.",OADS,/arxiv_data1/oa_pdf/74/ff/jos-17-3-369.PMC4635709.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.369Vol.,OADS,/arxiv_data1/oa_pdf/74/ff/jos-17-3-369.PMC4635709.pdf
3 / September 2015 http://j-stroke.org  371ings suggestive of cerebral infarction in more than 50% of the  MCA regions or a volume of cerebral infarction exceeding 145  cm3 on diffusion-weighted brain magnetic resonance imaging  (DWI).,Non-OADS,/arxiv_data1/oa_pdf/74/ff/jos-17-3-369.PMC4635709.pdf
"Decompressive Surgery for Malignant MCA Infarction http://dx.doi.org/10.5853/jos.2015.17.3.369 372 http://j-stroke.orgSurgical decompression for space-occupying cerebral  infarction (the Hemicraniectomy After Middle Cerebral  Artery Infarction with Life-Threatening Edema Trial  [HAMLET]) HAMLET ,4 a prospective multi-center randomized trial con - ducted in the Netherlands, compared decompressive surgery  within 96 hours of onset (longer than the intervals used in DEC - IMAL and DESTINY) and best medical treatment in patients  ages 18 to 60 years with space-occupying hemispheric infarction.",Non-OADS,/arxiv_data1/oa_pdf/74/ff/jos-17-3-369.PMC4635709.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.369Vol.,OADS,/arxiv_data1/oa_pdf/74/ff/jos-17-3-369.PMC4635709.pdf
3 / September 2015 http://j-stroke.org  373ing at least 50% of the MCA territory on CT performed less than  5 hours after the onset of stroke or hypodensity involving the en - tire MCA territory on CT less than 48 hours after stroke onset.,Non-OADS,/arxiv_data1/oa_pdf/74/ff/jos-17-3-369.PMC4635709.pdf
"Decompressive Surgery for Malignant MCA Infarction http://dx.doi.org/10.5853/jos.2015.17.3.369 374 http://j-stroke.orgtinent literature, timing itself is not related to complications, but  early reinsertion, before 3 months of storage has elapsed, is gen - erally recommended because of the risk of infection.22-27 Head - ache, seizures, and local neurological deficits are possible be - cause of sinking skin flap syndrome after the cerebral edema  subsides.",Non-OADS,/arxiv_data1/oa_pdf/74/ff/jos-17-3-369.PMC4635709.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.369Vol.,OADS,/arxiv_data1/oa_pdf/74/ff/jos-17-3-369.PMC4635709.pdf
"3 / September 2015 http://j-stroke.org  375lowing criteria: (1) clinical symptoms and signs of infarction in  the MCA territory, (2) NIHSS score of 16 points or more, (3)  decrease in the level of consciousness (defined as an NIHSS  item 1a score of at least 1 point), and (4) infarction of more than  50% of the total MCA territory on CT or an infarct volume  greater than 145 cm3 on DWI.",Non-OADS,/arxiv_data1/oa_pdf/74/ff/jos-17-3-369.PMC4635709.pdf
http://www.sign.,Non-OADS,/arxiv_data1/oa_pdf/74/ff/jos-17-3-369.PMC4635709.pdf
Decompressive Surgery for Malignant MCA Infarction http://dx.doi.org/10.5853/jos.2015.17.3.369 376 http://j-stroke.orgwith middle cerebral artery infarction.,Non-OADS,/arxiv_data1/oa_pdf/74/ff/jos-17-3-369.PMC4635709.pdf
"Copyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/9c/jos-17-3-377.PMC4635710.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  377Case Characteristics, Hyperacute Treatment, and  Outcome Information from the Clinical Research Center  for Stroke-Fifth Division Registry in South Korea Beom Joon Kim,a Jong-Moo Park,b Kyusik Kang,c Soo Joo Lee,c Y oungchai Ko,c Jae Guk Kim,c   Jae-Kwan Cha,d Dae-Hyun Kim,d Hyun-Wook Nah,d Moon-Ku Han,a T ai Hwan Park,e Sang-Soon Park,e  Kyung Bok Lee,f Jun Lee,g Keun-Sik Hong,h Y ong-Jin Cho,h Byung-Chul Lee,i Kyung-Ho Yu,i   Mi-Sun Oh,i Dong-Eog Kim,j Wi-Sun Ryu,j Ki-Hyun Cho,k Joon-T ae Kim,k Jay Chol Choi,l   Wook-Joo Kim,m Dong-Ick Shin,n Min-Ju Y eo,n Sung Il Sohn,o Jeong-Ho Hong,o Juneyoung Lee,p   Ji Sung Lee,q Byung-Woo Y oon,r Hee-Joon Baea aDepartment of Neurology, Seoul National University Bundang Hospital, Seongnam, Korea bDepartment of Neurology, Eulji General Hospital, Eulji University, Seoul, Korea cDepartment of Neurology, Eulji University Hospital, Daejeon, Korea dDepartment of Neurology, Dong-A University Hospital, Busan, Korea eDepartment of Neurology, Seoul Medical Center, Seoul, Korea fDepartment of Neurology, Soonchunhyang University Hospital Seoul, Seoul, Korea gDepartment of Neurology, Y eungnam University Medical Center, Daegu, Korea hDepartment of Neurology, Inje University Ilsan Paik Hospital, Goyang, Korea iDepartment of Neurology, Hallym University Sacred Heart Hospital, Anyang, Korea jDepartment of Neurology, Dongguk University Ilsan Hospital, Goyang, Korea kDepartment of Neurology, Chonnam National University Hospital, Gwangju, Korea lDepartment of Neurology, Jeju National University Hospital, Jeju, Korea mDepartment of Neurology, Ulsan University Hospital, Ulsan, Korea nDepartment of Neurology, Chungbuk National University Hospital, Cheongju, Korea oDepartment of Neurology, Keimyung University Dongsan Medical Center, Daegu, Korea pDepartment of Biostatistics, Korea University, Seoul, Korea qClinical Research Center, Asan Medical Center, Seoul, Korea rDepartment of Neurology, Seoul National University Hospital, Seoul, KoreaJournal of Stroke  201 5;17(3):377- 378 http://dx.doi.org/10.5853/jos.2015.17.3.377 ERRATUM: Table Correction   Journal of Stroke 2015;17(1):38-53 http://dx.doi.org/10.5853/jos.2015.17.1.38 On page 47, the definition of stroke progression was erroneously described in the previous version of article, and the correct defini - tion of “stroke progression” is as following; Corrected Table 5 END event in neurologically stable patients ≥ 24 hours  • May be attributable to peri-lesional edema • For cases with ≤ 24 hours after onset, END events not attributable to recurrent stroke",Non-OADS,/arxiv_data1/oa_pdf/a3/9c/jos-17-3-377.PMC4635710.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.377 378 http://j-stroke.orgTable 5.,Non-OADS,/arxiv_data1/oa_pdf/a3/9c/jos-17-3-377.PMC4635710.pdf
"Copyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/b5/jos-17-3-344.PMC4635711.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 344 http://j-stroke.orgAnterior Optic Pathway Compression Due to  Internal Carotid Artery Aneurysms: Neurosurgical  Management and Outcomes Wonhyoung Park,a Jung Cheol Park,a Kyunghwa Han,b Jae Sung Ahn,a Byung Duk Kwuna aDepartment of Neurosurgery, University of Ulsan College of Medicine, Asan Medical center, Seoul, Korea bBiostatistics Collaboration Unit, Gangnam Medical Research Center, Y onsei University College of Medicine, Seoul, Korea Correspondence:  Jung Cheol Park Department of Neurosurgery, Asan  Medical Center, 88 Olympic-ro 43-gil,  Songpa-gu, Seoul 05505, Korea Tel: +82-2-3010-3563 Fax: +82-2-476-6738 E-mail: neurosg@amc.seoul.kr Received: March 22, 2015 Revised: July 16, 2015 Accepted: August 3, 2015 The authors have no financial conflicts of  interest.Background and Purpose Compression of the anterior optic pathway results in visual defi - cits that can lead to the detection of unruptured aneurysms in the internal carotid artery  (ICA).",Non-OADS,/arxiv_data1/oa_pdf/9f/b5/jos-17-3-344.PMC4635711.pdf
"The In - ternational Study of Unruptured Intracranial Aneurysms Inves -tigators reported that 15.4% of patients with UIAs present with  cranial nerve deficits,1 and other studies report incidences of  2.2% and 8.8%.2,3 Oculomotor nerve palsy related to posterior  communicating artery aneurysm is one of the most common  cranial nerve deficits caused by UIAs,2,4-9 but, less commonly, Journal of Stroke  201 5;17(3):344- 353 http://dx.doi.org/10.5853/jos.2015.17.3.344",Non-OADS,/arxiv_data1/oa_pdf/9f/b5/jos-17-3-344.PMC4635711.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.344Vol.,OADS,/arxiv_data1/oa_pdf/9f/b5/jos-17-3-344.PMC4635711.pdf
"3 / September 2015 http://j-stroke.org  345visual deficits related to UIAs that originate from the internal  carotid artery (ICA) have also been reported.5,9-14 Because the intradural course of the ICA is close to the anteri - or optic pathway, some UIAs that arise in this location result in  some degree of visual deficit.10,11,14 The possible mechanisms for  visual deficits include the direct mass effects of the aneurysm on  the anterior optic pathway, compression of the optic nerve  against the bony structure by the aneurysm, and compromised  vascular supply to the anterior optic pathway.10,12,14 Neurosurgical management should be considered because  the risk of rupture is higher in patients with symptomatic UIAs  than asymptomatic UIAs, and management can alleviate symp - toms and prevent rupture.10,14-16 There are two general types of  treatment modalities for UIAs: surgery and endosaccular coil - ing.",Non-OADS,/arxiv_data1/oa_pdf/9f/b5/jos-17-3-344.PMC4635711.pdf
"Visual Symptom Caused by ICA Aneurysm http://dx.doi.org/10.5853/jos.2015.17.3.344 346 http://j-stroke.orgcoma, cataracts), were excluded.",Non-OADS,/arxiv_data1/oa_pdf/9f/b5/jos-17-3-344.PMC4635711.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.344Vol.,OADS,/arxiv_data1/oa_pdf/9f/b5/jos-17-3-344.PMC4635711.pdf
3 / September 2015 http://j-stroke.org  347predictors of favorable outcome using logistic regression analy - sis.,OADS,/arxiv_data1/oa_pdf/9f/b5/jos-17-3-344.PMC4635711.pdf
Visual Symptom Caused by ICA Aneurysm http://dx.doi.org/10.5853/jos.2015.17.3.344 348 http://j-stroke.org(40.0%).,Non-OADS,/arxiv_data1/oa_pdf/9f/b5/jos-17-3-344.PMC4635711.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.344Vol.,OADS,/arxiv_data1/oa_pdf/9f/b5/jos-17-3-344.PMC4635711.pdf
3 / September 2015 http://j-stroke.org  349mined to be an independent and significant predictor of im - provement in visual field defects caused by intracranial aneu - rysms (T able 4).,Non-OADS,/arxiv_data1/oa_pdf/9f/b5/jos-17-3-344.PMC4635711.pdf
"Visual Symptom Caused by ICA Aneurysm http://dx.doi.org/10.5853/jos.2015.17.3.344 350 http://j-stroke.orgperianeurysmal inflammation and edema.46,47 Turner et al.46 re- ported that HydroCoil (MicroVention, Aliso Veijo, California,  USA) component of the coil mass could be contributing to peri - aneurysmal edema and inflammation.",Non-OADS,/arxiv_data1/oa_pdf/9f/b5/jos-17-3-344.PMC4635711.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.344Vol.,OADS,/arxiv_data1/oa_pdf/9f/b5/jos-17-3-344.PMC4635711.pdf
"3 / September 2015 http://j-stroke.org  351experiences and literature reviews, we believe that removing an - eurysmal mass effects in the anterior optic pathway demon - strates a major impact on improving visual deficits.",Non-OADS,/arxiv_data1/oa_pdf/9f/b5/jos-17-3-344.PMC4635711.pdf
Visual Symptom Caused by ICA Aneurysm http://dx.doi.org/10.5853/jos.2015.17.3.344 352 http://j-stroke.orgNeurosurg 2010;73:11-16.,Non-OADS,/arxiv_data1/oa_pdf/9f/b5/jos-17-3-344.PMC4635711.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.344Vol.,OADS,/arxiv_data1/oa_pdf/9f/b5/jos-17-3-344.PMC4635711.pdf
3 / September 2015 http://j-stroke.org  353decompression of paraclinoid aneurysm--a revised technique.,Non-OADS,/arxiv_data1/oa_pdf/9f/b5/jos-17-3-344.PMC4635711.pdf
"Copyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/e7/jos-17-3-336.PMC4635712.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 336 http://j-stroke.orgEndovascular Management of Long-Segmental  Petrocavernous Internal Carotid Artery (Carotid S)  Occlusion Soonchan Park,a,b Eun Suk Park,c Jae Hyuk Kwak,a Dong-Geun Lee,a Dae Chul Suh,a Sun U. Kwon,d  Deok Hee Leea aDepartment of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea bDepartment of Radiology, Kyung Hee University Hospital at Gangdong, School of Medicine, Kyung Hee University, Seoul, Korea cDepartment of Neurosurgery, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea dDepartment of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea Correspondence:  Deok Hee Lee Department of Radiology, Asan Medical  Center, 88 Olympic-ro 43-gil, Songpa-gu,  Seoul 05505, Korea Tel: +82-2-3010-5944 Fax: +82-2-476-0090 E-mail: dhlee@amc.seoul.kr Received: March 17, 2015 Revised: July 5, 2015 Accepted: July 6, 2015 The authors have no financial conflicts of  interest.Background and Purpose Long-segmental thrombotic occlusion of the distal internal ca - rotid artery (ICA) sparing the cervical segment proximally and the supraclinoid segment dis - tally, which could be termed ’Carotid S occlusion’, has an unusual clinical presentation.",Non-OADS,/arxiv_data1/oa_pdf/b8/e7/jos-17-3-336.PMC4635712.pdf
For Journal of Stroke  201 5;17(3):336- 343 http://dx.doi.org/10.5853/jos.2015.17.3.336,Non-OADS,/arxiv_data1/oa_pdf/b8/e7/jos-17-3-336.PMC4635712.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.336Vol.,OADS,/arxiv_data1/oa_pdf/b8/e7/jos-17-3-336.PMC4635712.pdf
"3 / September 2015 http://j-stroke.org  337this disease entity, we have coined a new term, “carotid S occlu - sion,” in view of the relative preservation of the collaterals to the  ipsilateral anterior and middle cerebral arteries, which are sup - plied by collaterals of the retrograde ophthalmic artery and/or  the circle of Willis.",Non-OADS,/arxiv_data1/oa_pdf/b8/e7/jos-17-3-336.PMC4635712.pdf
"Endovascular Management of “Carotid S Occlusion” http://dx.doi.org/10.5853/jos.2015.17.3.336 338 http://j-stroke.orgIndications of revascularization The patients with acute stroke who presented within six hours  of onset of their symptoms were managed according to our insti - tution’s acute stroke management protocol.1 Endovascular thera - py was offered to patients who met the following criteria: 1)  acute stroke with no significant response to intravenous tissue  plasminogen activator (IV tPA) infusion; 2) acute stroke with  indications not for IV tPA but for intra-arterial thrombolysis;  and 3) subacute stroke with limited DWI high-signal lesion vol - ume along the ICA border-zone and with significant symptoms  and/or diffusion-perfusion mismatch.2 In patients with a sub - acute presentation, we applied very conservative indications in  terms of the DWI lesion volume, in order to avoid the possibility  of reperfusion injury in a larger infarction.",Non-OADS,/arxiv_data1/oa_pdf/b8/e7/jos-17-3-336.PMC4635712.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.336Vol.,OADS,/arxiv_data1/oa_pdf/b8/e7/jos-17-3-336.PMC4635712.pdf
"3 / September 2015 http://j-stroke.org  339Data collection and analysis The patients’ baseline characteristics, including demographic  data, are summarized in T able 1.",OADS,/arxiv_data1/oa_pdf/b8/e7/jos-17-3-336.PMC4635712.pdf
Endovascular Management of “Carotid S Occlusion” http://dx.doi.org/10.5853/jos.2015.17.3.336 340 http://j-stroke.org2-17).,Non-OADS,/arxiv_data1/oa_pdf/b8/e7/jos-17-3-336.PMC4635712.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.336Vol.,OADS,/arxiv_data1/oa_pdf/b8/e7/jos-17-3-336.PMC4635712.pdf
"3 / September 2015 http://j-stroke.org  341veloped after pre-stenting angioplasty, but it spontaneously and  immediately closed after balloon angioplasty in the segment.",Non-OADS,/arxiv_data1/oa_pdf/b8/e7/jos-17-3-336.PMC4635712.pdf
Endovascular Management of “Carotid S Occlusion” http://dx.doi.org/10.5853/jos.2015.17.3.336 342 http://j-stroke.orgThere were no patient deaths.,Non-OADS,/arxiv_data1/oa_pdf/b8/e7/jos-17-3-336.PMC4635712.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.336Vol.,OADS,/arxiv_data1/oa_pdf/b8/e7/jos-17-3-336.PMC4635712.pdf
3 / September 2015 http://j-stroke.org  343date our conclusions.,Non-OADS,/arxiv_data1/oa_pdf/b8/e7/jos-17-3-336.PMC4635712.pdf
"Copyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 282 http://j-stroke.orgStatins in Acute Ischemic Stroke: A Systematic  Review Keun-Sik Hong,a Ji Sung Leeb aDepartment of Neurology, Inje University Ilsan Paik Hospital, Goyang, Korea bClinical Research Center, Asan Medical Center, Seoul, Korea Correspondence:  Keun-Sik Hong Department of Neurology, Stroke Center,  Ilsan Paik Hospital, Inje University, 170 Juhwa-ro, Ilsanseo-gu, Goyang  10380, Korea  Tel: +82-31-910-7680 Fax: +82-31-910-7368 E-mail: nrhks@paik.ac.kr Received: March 17, 2015 Revised: April 2, 2015 Accepted: April 4, 2015 The authors have no financial conflicts of  interest.Background and Purpose Statins have pleiotropic effects of potential neuroprotection.",Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
In Journal of Stroke  201 5;17(3):282- 301 http://dx.doi.org/10.5853/jos.2015.17.3.282,Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.282Vol.,OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
"3 / September 2015 http://j-stroke.org  283addition, animal experiments have shown angiogenesis, neuro - genesis, and synaptogenesis in acute cerebral ischemia.9 Thereby,  statins are potentially neurorestorative as well as neuroprotective  in acute cerebral ischemia.",Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
"Statins in Acute Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.17.3.282 284 http://j-stroke.orgprestroke statin effect on mortality in patients with thrombolysis,  and 1 study for statin effect on post-stroke infection).",Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.282Vol.,OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
3 / September 2015 http://j-stroke.org  285Table 2.,Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
"Statins in Acute Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.17.3.282 286 http://j-stroke.orgStudy Publication N Region Center/design AgeWomen  (%)Prestroke  statin (%)Effect on initial stroke  severityTime point Effect on functional outcome Effect on mortality Ní Chróinín et al.472011 445 Ireland Population-based 71 49 30.1 Non-significant, median     NIHSS    5 vs. 590 days Significant, mRS 0-2    OR, 2.21 (1.00-4.90)Significant reduction    OR, 0.23 (0.09-0.58) Tsai482011 172 Taiwan Single 65 37 25 Significant,    Lower NIHSS, but unadjusted90 days Significant, mRS 0-2    OR, 4.82 (1.22-19.03)NR Biffi et al.492011 893 USA Single 66 40 14.1 Non-significant, proportion of     NIHSS > 8    P= 0.39 (unadjusted)90 days Non-significant, mRS 0-2    OR, 1.51 (0.94-2.44)NR Hassan et al.502011 386 Malaysia Single 64 38 29.3 NR Discharge NR Significant reduction    Unadjusted P= 0.013 Flint et al.51,522012 12,689 USA Multicenter 75 53 29.5 NR Discharge  or 1 yearSignificant, discharge to home    OR 1.21 (1.11-1.32) at dischargeSignificant reduction     at 1 year    HR, 0.85 (0.79-0.93) Hjalmarsson et al.532012 799 Sweden Single 78 52 22.9 Non-significant, proportion of     NIHSS < 8    OR, 1.32 (0.80-2.17)30 days NR Non-significant    HR, 0.56 (0.23-1.33) Aboa-Eboulé et al.542013 953 France Multicenter 75 56 13.3 Non-significant, median     NIHSS    4 vs. 4Discharge Non-significant, mRS distribution    OR 0.76 (0.53-1.09)NR Phipps et al.552013 804 USA Single 86 64 41.5 Non-significant, proportion of     NIHSS < 8    OR 1.08 (0.71-1.66)Discharge Non-significant, in-hospital mortality/hospice    OR, 1.08 (0.60-1.94)NR Martínez-Sánchez et al.562013 969 Spain Single 69 38 27.1 Significant, NIHSS < 6 OR, 1.249 (0.915-1.703) for     low-to moderate-dose     statin, 2.501 (1.173-5.332)     for high-dose statinDischarge Non-significant, mRS 0-2    OR, not providedNon-significant    OR, not provided Moonis et al.572014 1,618 USA Multicenter 67 52 14.3 NR Discharge Significant, discharge to home    OR, 1.67 (CI, 1.12-2.49)NR Cordenier et al.582011 1,179/ 9,337*Meta-analysis,  11 studiesNR NR 16.3 NR Discharge  or 90 daysNon-significant mRS 0-2 outcome    OR, 1.01 (0.64-1.61) at 90 daysSignificant redcution at     discharge    OR, 0.56 (0.40-0.78) Biffi et al.492011 11,695 Meta-analysis,  12 studiesNR NR 17.2 NR discharge  to 90 daysSignificant, favorable outcome    OR, 1.62 (1.39-1.88) for all, 2.01 (1.14-3.54) for LAA,        2.11 (1.32-3.39) for SVONR Ní Chróinín et al.592013 17,606/ 101,615*Meta-analysis,  27 studies64-76 33-61 4-48 NR 90 days Significant, mRS 0-2    OR, 1.41 (1.29-1.55)Significant reduction    OR, 0.71 (0.62-0.82) Provided ORs (95% CIs) are adjusted ORs otherwise indicated, and ORs from meta-analyses are pooled ORs.",Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.282Vol.,OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
"3 / September 2015 http://j-stroke.org  287findings) evaluating prestroke statin effect on initial stroke sever - ity, functional outcome or short-term mortality (T able 2).30-59  Prestroke statin effect on initial stroke severity Seventeen original articles were identified and summarized in  T able 2.",Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
Statins in Acute Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.17.3.282 288 http://j-stroke.org Prestroke statin effect on initial stroke severityA Prestroke statin effect on good functional outcomeB Prestroke statin effect on short-term mortality (OR)C Prestroke statin effect on short-term mortality (HR)D Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.282Vol.,OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
3 / September 2015 http://j-stroke.org  289Table 3.,Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
Statins in Acute Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.17.3.282 290 http://j-stroke.org In-hospital statin effect on good functional outcome In-hospital statin effect on short-term mortality (OR) In-hospital statin effect on short-term mortality (HR)A B C Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.282Vol.,OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
3 / September 2015 http://j-stroke.org  291Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
Statins in Acute Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.17.3.282 292 http://j-stroke.orgTable 5.,Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.282Vol.,OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
"3 / September 2015 http://j-stroke.org  2930.003, I2= 65%) (Figure 5C).",OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
Statins in Acute Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.17.3.282 294 http://j-stroke.orgFigure 5.,Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.282Vol.,OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
3 / September 2015 http://j-stroke.org  295Table 6.,Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
Statins in Acute Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.17.3.282 296 http://j-stroke.orgTable 7.,Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.282Vol.,OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
3 / September 2015 http://j-stroke.org  297the better functional outcome with prestroke statin use.,Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
"Statins in Acute Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.17.3.282 298 http://j-stroke.orgstroke, which would be of interest of topics on future investiga - tion.",Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.282Vol.,OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
3 / September 2015 http://j-stroke.org  299cardial infarction: a report of the American College of Cardiol - ogy Foundation/American Heart Association T ask Force on  Practice Guidelines.,Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
Statins in Acute Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.17.3.282 300 http://j-stroke.orgNeurol  2010;10:47.,Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.282Vol.,OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
3 / September 2015 http://j-stroke.org  30171.,Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
Statins in Acute Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.17.3.282 http://j-stroke.org0 0.2 0.4 0.6 0.8  0.5 1.0 2.0 5.0Standard error Odds ratio Supplemental  Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.282Vol.,OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
3 / September 2015 http://j-stroke.org0 0.2 0.4 0.6 0.8  0.2 0.5 1.0 2.0 5.0Standard error Odds ratio Supplemental Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
Statins in Acute Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.17.3.282 http://j-stroke.org0 0.2 0.4 0.6 0.8  0.5 1.0 2.0 5.0 10.0Standard error Odds ratio Supplemental Figure 10.,Non-OADS,/arxiv_data1/oa_pdf/1f/c9/jos-17-3-282.PMC4635713.pdf
"Copyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/3a/jos-17-3-359.PMC4635714.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  359Carotid Stump as a Cause of Recurrent Embolism– Endovascular Treatment in a Case of Congenital  Carotid Stump Syndrome Jonghwa Shin,a Jihoon Cha,b Pyoung Jeon,b Oh Y oung Banga Departments of Neurologya and Radiology,b Samsung Medical Center, Sungkyunkwan University, Seoul, KoreaLetter to the Editor Dear Sir: Cryptogenic stroke, a stroke for which there is no specific at - tributable cause after a comprehensive evaluation for the most  common causes, accounts for about one-fourth of stroke patients.",Non-OADS,/arxiv_data1/oa_pdf/4e/3a/jos-17-3-359.PMC4635714.pdf
"Carotid stump syndrome remains a rare entity, but it is a treat - able cause of recurrent retinal and hemispheric symptoms after Journal of Stroke  201 5;17(3):359- 361 http://dx.doi.org/10.5853/jos.2015.17.3.359",Non-OADS,/arxiv_data1/oa_pdf/4e/3a/jos-17-3-359.PMC4635714.pdf
Carotid Stump as a Cause of Recurrent Embolism http://dx.doi.org/10.5853/jos.2015.17.3.359 360 http://j-stroke.org 1st attack 2nd attack 3rd attack A B Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/4e/3a/jos-17-3-359.PMC4635714.pdf
http://dx.doi.org/10.5853/jos.2015.17.3.359Vol.,OADS,/arxiv_data1/oa_pdf/4e/3a/jos-17-3-359.PMC4635714.pdf
3 / September 2015 http://j-stroke.org  361stroke with advanced diagnostic techniques.,Non-OADS,/arxiv_data1/oa_pdf/4e/3a/jos-17-3-359.PMC4635714.pdf
"Copyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/cf/jos-17-3-379.PMC4635715.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  379Evolution of Endovascular Therapy in Acute  Stroke: Implications of Device Development Adithya Balasubramaian, Peter Mitchell, Richard Dowling, Bernard Yan Comprehensive Stroke Centre, Royal Melbourne Hospital, Parkville, Victoria, AustraliaJournal of Stroke  201 5;17(3):379- 379 http://dx.doi.org/10.5853/jos.2015.17.3.379 ERRATUM: Author's Name Correction Journal of Stroke 2015;17(2):127-137 http://dx.doi.org/10.5853/jos.2015.17.2.127 The first author’s name was misprinted.",Non-OADS,/arxiv_data1/oa_pdf/7a/cf/jos-17-3-379.PMC4635715.pdf
"320 http://j-stroke.orgCopyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/20/jos-17-3-320.PMC4635716.pdf
"Keywords Magnetic resonance angiography; Carotid artery, internal; Collateral circulationOriginal ArticleJournal of Stroke  201 5;17(3):320- 326 http://dx.doi.org/10.5853/jos.2015.17.3.320 Introduction Acute ischemic stroke by occlusion of internal carotid artery  (ICA) is known to have relatively high rate of ischemic progres - sion and recurrence.1 However, ICA occlusion can have variable  clinical courses – from no symptom to severe neurologic deficit  – according to the degree of collateral flow.2 Thus, the assessment of collateral flow in ICA occlusion is of great clinical significance.",Non-OADS,/arxiv_data1/oa_pdf/d0/20/jos-17-3-320.PMC4635716.pdf
"3 / September 2015 http://dx.doi.org/10.5853/jos.2015.17.3.320 http://j-stroke.org  321Accordingly, the presence of MCA flow has proven that it may  reduce initial stroke severity and be associated with early favor - able outcome.6 Recently, the advent of quantitative magnetic resonance angi - ography (Q-MRA) has enabled direct measurement of afore - mentioned intracranial flows.7,8 However, only a limited number  of studies have quantitatively assessed the degree of collateral  flow in ICA occlusion.",Non-OADS,/arxiv_data1/oa_pdf/d0/20/jos-17-3-320.PMC4635716.pdf
"Collateral Flow Quantification Using Q-MRA http://dx.doi.org/10.5853/jos.2015.17.3.320 322 http://j-stroke.orgthe volume of the infarction, MRI Alberta Stroke Program Early  CT score (ASPECTS) was calculated for each patient.13  mVFR calculation The mVFR was calculated at anterior cerebral artery (ACA),  MCA and posterior cerebral artery (PCA) in both ipsilateral  and contralateral sides to the occluded ICA.",OADS,/arxiv_data1/oa_pdf/d0/20/jos-17-3-320.PMC4635716.pdf
3 / September 2015 http://dx.doi.org/10.5853/jos.2015.17.3.320 http://j-stroke.org  323Quantitative mVFR T able 2 summarizes the results of the quantitative mVFR in  intracranial arteries.,Non-OADS,/arxiv_data1/oa_pdf/d0/20/jos-17-3-320.PMC4635716.pdf
"Collateral Flow Quantification Using Q-MRA http://dx.doi.org/10.5853/jos.2015.17.3.320 324 http://j-stroke.orgal flow adequacy, it is incapable of quantitatively demonstrating  collateral flow routes.8  The direct measurement of volume flow via collateral path - ways or intracranial arteries has not been commonly performed.",Non-OADS,/arxiv_data1/oa_pdf/d0/20/jos-17-3-320.PMC4635716.pdf
3 / September 2015 http://dx.doi.org/10.5853/jos.2015.17.3.320 http://j-stroke.org  325of total mVFR in ipsilateral cerebral circulation to contralateral  side also decreased in the symptomatic group.,Non-OADS,/arxiv_data1/oa_pdf/d0/20/jos-17-3-320.PMC4635716.pdf
Collateral Flow Quantification Using Q-MRA http://dx.doi.org/10.5853/jos.2015.17.3.320 326 http://j-stroke.org14.,Non-OADS,/arxiv_data1/oa_pdf/d0/20/jos-17-3-320.PMC4635716.pdf
"Copyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/11/jos-17-3-362.PMC4635717.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 362 http://j-stroke.orgMalignant Cerebral Venous Sinus Thrombosis in  Polycythemia Rohan Mahale, Anish Mehta, Kiran Buddaraju, Abhinandan K. Shankar, Srinivasa Rangasetty Department of Neurology, MS Ramaiah Medical College & Hospital, Bangalore, Karnataka, IndiaLetter to the Editor Dear Sir: Cerebral venous thrombosis (CVT) is a rare variety of cere - brovascular disease that can occur at any age and generally has a  favorable outcome.",Non-OADS,/arxiv_data1/oa_pdf/73/11/jos-17-3-362.PMC4635717.pdf
